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ABSTRACT
An aromatic-dependent [aroA] mutant of an ovine isolate of 
Salmonella typhimurium. S25/1, was shown to be avirulent and have 
a much reduced capacity to invade the organs of both conventional 
mice and sheep when compared with the virulent parent strain. Oral 
vaccination with the aroA strain resulted in the production of
Salmonella-specific immune responses in both mice and sheep, and 
the magnitude of these responses was related to the levels of
tissue colonisation by the avirulent salmonellae.
In vaccinated mice, high levels of Salmonella-specific IgM, IgG 
and IgA were detected in the serum, specific intestinal IgA was 
produced and there was evidence of specific cellular immunity. In 
vaccinated sheep, specific serum IgM was produced although 
specific IgG responses were very low and there was no evidence of 
specific coproantibody or specific T cells. Despite the different 
immune responses engendered in mice and sheep, both species were
highly protected from high lethal challenge doses of the wildtype
strain.
The ability of the S25/laroA strain to deliver recombinant 
heterologous antigens to the immune system of both mice and sheep 
was investigated. Strains expressing the major outer membrane 
protein [MOMP] of Chlamydia psittaci were shown to colonise murine 
tissues to similar levels as the non-recombinant strain and 
produced MOMP in vivo. MOMP-specific serum antibody and
MOMP-specific intestinal IgA were detected in some mice, although
Ill
these responses were low when compared with those to Salmonella. 
and there was no evidence of MOMP-specific T cells. In 
conventional lambs, no specific responses to MOMP could be 
detected, although the responses to Salmonella were very low in 
these animals.
The aroA strain was also constructed to produce the leukotoxin 
[cytotoxin] of Pasteurella haemolytica Al. however in vivo 
expression of the protein was very low. Consequently, only a 
small number of mice were seen to produce leukotoxin-specific 
antibody, and specific cell-mediated immunity was absent. When 
the strain was administered to germ-free lambs, reversion to 
virulence was seen which revealed instabilities in the vaccine 
strain, and in vivo expression of the protein was virtually lost 
after 24 h. Although there was no evidence of leukotoxin-specific 
antibody, leukotoxin specific cellular responses were
demonstrated. However the low responses to Salmonella and the
reversion to virulence seen in these lambs question the 
specificity of these responses.
This study therefore demonstrated the ability of a live Salmonella 
aroA strain to engender specific immune responses and to confer 
protection against experimental salmonellosis. However, although 
the vaccine vector potential of the strain was not clearly 
demonstrated, some of the problems associated with expression of 
foreign antigens in Salmonella were revealed allowing optimal 
strategies for expression to be applied in future studies.
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SDS = sodium dodecyl sulphate
SFV = Semliki Forest Virus
SI = stimulation index
sIgA == secretory IgA
STI = soyabean trypsin inhibitor
TBS Tris-buffered saline
TBST = TBS containing 0.1% Tween
T cell = T lymphocyte
TCID 
TcR g-d
=3 50% tissue culture infective dose
T cell receptor gamma-delta
Th = T helper
TNF = tumour necrosis factor
UDP = uridine di-phosphate
Vi antigen = virulence antigen
VD = variable domain
VS variable segment
xid = X-linked immune-defective gene
XLD = xylose lactose deoxycholate
Chapter 1 
General Introduction
1,1 Introduction
The Potential of Live Vaccines as Carriers of Cloned 
Heterologous Antigens to the Immune System
Potentially protective antigens have been identified for many 
parasites, pathogenic viruses and bacteria and pure antigen can be 
made by recombinant DNA technology for assessment in vaccination 
strategies. These proteins are poorly immunogenic unless they are 
administered with adjuvant, and parenteral delivery of purified 
proteins often fails to elicit strong serum antibody responses and 
is ineffective in eliciting secretory immune responses at mucosal 
surfaces and effective cell-mediated immunity [CMI]. In contrast, 
certain live vaccines such as Vaccinia and Salmonella are potent 
stimulators of the immune system without the need for adjuvant. 
Such live vaccines are less expensive to produce commercially than 
killed or subunit vaccines and do not produce the violent 
side-effects often associated with killed vaccines. Thus, 
strategies for expression of recombinant proteins in these live 
vaccines are being developed.
Several features of the Vaccinia vaccine limits its usefulness as 
a vaccine delivery system. It does not appear to be that effective 
as a carrier system, it has to be administered by injection, and 
the size of the virus limits the size of the recombinant protein
that can be introduced into the system. Oral Salmonella vaccines 
are of particular interest as one can use the natural route of 
infection, namely the oral route, which results in direct 
stimulation of the gut-associated lymphoid tissue [GALT] and 
induction of specific intestinal responses. Live avirulent 
salmonellas are able to traverse the gut and invade the 
reticuloendothelial system [RES] where they can persist for up to 
70 days, facilitating the induction of specific systemic humoral 
and cell-mediated immune responses. The fact that vaccination with 
Salmonella, unlike Vaccinia, may give useful protection against a 
currently important disease is also significant. Furthermore, 
because of the close relationship between Salmonella and 
Escherichia coli [E.colil the same techniques that have been 
developed for expression and overproduction of recombinant proteins 
in E.coli are at least partly applicable to Salmonella.
1.2 The Genus Salmonella
Salmonellosis is a worldwide infectious disease of humans and 
animals. It is an agricultural problem, causing great economic 
loss to the farming industry and the infected animals constitute a 
vast reservoir for the disease in humans. Humans may become 
infected with salmonellas by the consumption of contaminated water 
or animal products eg. poultry, eggs, beef, pork and milk, and 
animals may become infected with salmonellae by contact with human 
waste products. Thus the diseases in animals and man are linked, 
and may be summarised in the ’Salmonella cycle' [Figure 1.1].
Figure 1.1 The Salmonella Cycle
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There are over 2000 different serotypes of salmonellae, described
on the basis of somatic [0], flagellar [H] and capsular [Vi] 
antigens in the Kaufmann-White scheme [Le Minor, 1984], but only 
a small number are encountered frequently in disease.
As a member of the family Enterobacteriaceae, salmonellae may have 
the following characteristics: they are Gram-negative rods, which
may be motile due to the possession of peritrichous flagella or 
non-motile. They do not produce spores, and are facultative 
anaerobes, producing acid from glucose. They do not ferment lactose 
or sucrose.
1.3 Host Specificity
Salmonella may be considered in 3 groups based on their association 
with human and animal hosts [Williams and Miles, 1975], One group 
comprises host-adapted serotypes, including S.tvphi and paratyphi. 
which cause disease only in man; S.gallinarum and S.pullorum which 
cause disease only in poultry; and S.abortusovis. which causes 
disease only in sheep. A second group, which can be termed 
host-restricted, includes S.dub1in and S.choleraesuis which cause 
disease mainly in cattle and swine respectively, but are 
opportunistic pathogens of other animals. The third group consists 
of salmonellas that are not host-restricted and cause disease in 
all types of animals. Most salmonellae fall into this group, 
including S.typhimurium. which is the most frequent cause of 
salmonellosis in the United Kingdom. [Wray, 1985; Humphrey et 
al., 1988].
The vaccine strain used in experiments described in this thesis was 
constructed from an ovine isolate of S.typhimurium. so in the 
following sections particular references will be made to this 
serotype.
1.4 The Disease
Salmonellosis occurs in 3 major forms: enteritis, systemic
infection [typhoid in humans] and abortion, which only occurs in 
some animals. Some animal species are more prone to a particular 
form of the disease than others. Septicaemic spread of salmonellae 
may produce meningitis or septic arthritis.
There appears to be an association of serotype with a particular 
disease syndrome. S.typhimurium is commonly associated with 
enteritis, S.choleraesuis with septicaemia, S.tvphi and
S.paratyphi with enteric fever [typhoid] and S.dub1in with 
abortion.
Salmonella can be studied in laboratory rodents. S.typhi is only 
virulent for primates thereby precluding easy and extensive murine 
manipulations. However, mice infected with S.typhimurium develop a 
typhoid fever-like syndrome [MacKaness et al., 1966] and as a
consequence, the S.typhimurium mouse model has been used to test 
both the relative efficacy of live attenuated and killed vaccines 
and immunity against systemic infection with Salmonella species.
1.5 Invasiveness and Pathogenicity - Interaction of Salmonella 
with the Cells of the Immune System
Much of the information on the pathogenesis of Salmonella has come 
from the experimental models of mouse typhoid caused by 
S.typhimurium and S.enteriditis [Collins, 1971, 1972, 1974; Carter 
and Collins, 1974]. Salmonellae usually enter by the oral route. 
After encountering the mechanical and chemical defences of the host 
they are deposited in the intestine where they invade the 
enterocytes [Wray and Sojka, 1977; Turnbull, 1979]. The acidity of
the stomach and the presence of the normal commensal gut flora,
reduce the establishment and growth of salmonellae in the intestine 
[Nurmi and Rantala, 1973; Impey et al.. 1982].
Concepts of mucosal penetration by salmonellae have largely been 
formulated by Takeuchi [1967] who found that when salmonellae came 
within a critical distance of the brush border of enterocytes, the 
microvilli and tight junctions underwent degeneration. The
salmonellae then enter the cells through the microvilli or through
the gap junctions between the enterocytes [Takeuchi and Sprinz, 
1967] and pass through to the lamina propria where they come into 
contact with a wide array of immune effector cells, including 
macrophages, B lymphocytes [B cells], T lymphocytes [T cells], 
eosinophils and mast cells. Macrophages engulf the bacteria 
[Takeuchi and Sprinz, 1967] and there is a subsequent inflammatory
response, characterised by the presence in the intestine and lumen 
of large numbers of neutrophils [Nakoneczna and Hsu, 1980, 1983].
During the next 24 hours [h] , bacteria in the lumen and the 
enterocytes are cleared, but those in the lamina propria persist. 
Bacteria in the mucosa and submucosa are transported in the 
lymphatics to the regional lymph nodes. From the lymph nodes the 
salmonellas travel in the efferent lymph vessels into the blood 
circulation, from which they are filtered out by the specialised 
phagocytes of the RES, particularly those in the liver and the 
spleen. Failure to contain the infection may result in septicaemia 
and dissemination, often resulting in pneumonia, meningitis and 
septic arthritis [Wray and Sojka, 1977].
As we have seen, antigens of Salmonella encounter the cells of the 
immune system following direct penetration of the gut mucosa. 
Salmonella antigens and whole Salmonella bacteria may also reach 
subepithelial lymphoid tissue through absorption from the lumen via 
specialised epithelial cells [M cells] in Payer's patches which are 
distributed throughout the ileal mucosa [Owen et al.. 1986]. The 
M cells are thought to engulf the antigens by phagocytosis and pass 
them to the B cells, T cells and macrophages in the layer below.
1.6 Bacterial Virulence Factors - An Association with Structure
The ability of an organism to invade, multiply and cause 
pathological damage in a host, as well as avoiding host defences, 
is dependent on the virulence factors that it possesses. These may 
be in the form of surface-associated structures or released soluble 
compounds, and will be discussed in this section.
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Figure 1.2[B] A schematic diagram of the lipopolysaccharide 
molecule.
Gram-negative bacteria have a cell envelope consisting of a 
distinct outer membrane which lies external to a thin layer of 
peptidoglycan and the underlying cytoplasmic membrane [Figure 
1.2A], The structures of the envelope that may play an important 
role in Salmonella infection are discussed below.
1.6.1 Lipopolysaccharide FLPSI
The 0-antigen and its associated lipid A constitute LPS, which is 
unique to the outer membrane of Gram-negative organisms. The lipid 
A and lipopoprotein provide the lipid phase of the outer leaflet of 
the hilayer, whilst the 0-polysacharide antigen protrudes from the 
surface [Figure 1.2B]. The 0-antigen consists of 0-specific chains 
made up of repeating oligosaccharide units attached to a core 
oligosaccharide [Wilkinson, 1977; Luderitz et al.. 1982a,b]. The 
structure of the core is practically identical in all salmonellas, 
but varies between genera [for review, see Roantree, 1967]. The 
serological specificity is determined by the 0-antigens and there 
is a correlation between 0-specific antigens and the virulence of 
salmonellas [Roantree, 1967; Nakano and Saito, 1969; Edebo and 
Norman, 1970]. In Salmonella strains differing in only their 
0-antigens, virulence in mice is dependent on their specific
0-antigen composition [Valtonen, 1970; Valtonen et al.. 1975;
Lyman et al., 1977]. Mutants of Salmonella that have lost part or
all of the 0-antigen [rough mutants] are less virulent than their 
parents with complete LPS [Mintz and Deibel, 1983]. Rough mutants
are taken up more readily by macrophages than smooth strains
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[Liang-Takasaki et al.. 1982], being more sensitive to
opsonisation with antibody and complement [Thj^tta and Waller, 
1932; Rowley, 1954; Liang-Takasaki et al.. 1983; Saxen et al..
1987]. Following phagocytosis, rough mutants have less protection 
against lysosomal attack, and are more sensitive to the
bactericidal action of granule products than smooth strains
[Tagesson and Stendhal, 1973; Modrzakowsky and Spitznagel, 1979].
1.6.2 Toxins
Intestinal fluid secretion and cell destruction observed during 
Salmonella infection [Gianella et al.. 1976; Gianella, 1979] may be 
the result of toxin production by the organism. There are 3 types
of toxin, 2 being cell-associated and the other an exotoxin. The
endotoxin is an integral part of the outer membrane of
Gram-negative organisms and is equivalent to LPS and the cytotoxin 
is found in the outer membrane between the peptidoglycan and the
outer envelope. The Salmonella exotoxin is stored in the
periplasmic space between the peptidoglycan and the outer envelope,
1.6.2[a] Endotoxins
Endotoxins are heat-stable lipopolysaccharides. The lipid A part, 
consisting of fatty acids linked to 2 molecules of N-acetyl 
glucosamine, is where the toxicity resides [Rietchel et al..
1984]. Lipid A by itself is insoluble in water and hence lacks 
biological activity, so the polysaccharide moiety of LPS
contributes to toxicity by increasing the aqueous solubility of 
lipid A.
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Endotoxin is thought to cause most of the systemic effects of 
infection by Gram-negative bacteria, including thrombosis through 
activation of the coagulase system and destruction of vascular 
endothelium. It causes shock with characteristic symptoms 
including fever, changes in white blood cell counts, respiratory 
collapse and reduction in blood pressure, with death often a 
consequence.
The effects of endotoxin on immune regulation are also great. It 
activates macrophages, resulting in production of secretory 
products such as tumour necrosis factor [TNF], interleukin [IL]-1 
and prostaglandins, all implicated in shock [for review see 
Luderitz et al., 1982b]. LPS is a T cell-independent B cell
mitogen, so it can evoke polyclonal B-cell activation [Anderson et 
al., 1973; Rosenstreich et al.. 1973], possibly resulting in 
autoimmune disorders such as arthritis [Cooke et al., 1983].
Endotoxin may also cause the placental changes preceding abortion, 
as a result of Salmonella infection [Hall, 1973, 1974].
1.6.2[b] The Cytotoxin
Reitmeyer et al. [1986] have reported the existence of a cytotoxin
in Salmonella characterised by its ability to cause rounding and 
detachment of Chinese hamster ovary [CHO] cells. Situated in the 
outer membrane, it would be in an ideal position for direct
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contact with host cells. Indeed, one could speculate a role for it 
in enterocyte invasion and destruction as seen in gastroenteritis, 
or as an antiphagocytic device following physical contact with 
macrophages.
1.6.2[c] Exotoxins
Exotoxins are known to be responsible for the pathogenic effects 
seen in a number of diseases. In diarhoeal diseases caused by 
enteropathogens such as Vibrio cholerae fV.cholerae] and E.coli the 
exo toxin is known as an enterotoxln. The existence of a 
Salmonella enterotoxln has been controversial [Stephen et al.,
1985]. Enterotoxic activity has been demonstrated in culture 
filtrates and extracts [ Sandefur and Peterson, 1976; Sedlock and 
Deibel, 1978; Peterson et al.. 1981; Wallis et al.. 1986], and
the results of test systems set up suggest that such an enterotoxln 
may resemble shiga-toxin [O'Brien et al., 1982] and E.coli
heat-stable toxin, but most evidence suggests that it resembles 
cholera toxin [Sandeflur and Peterson, 1977; Jiwa, 1981; Wallis et 
al., 1986; Chopra et al.. 1987a,b]. However, Shukla and Sharma
[1985] have demonstrated an enterotoxln in several strains of 
Salmonella. including S.typhimurium. that is not related
antigenically to cholera toxin. The discrepancy in the nature of 
Salmonella enterotoxln suggests that there could be a range of 
toxins as is observed in E.coli.
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1.6.3 Capsules
External to the envelope components, many Gram-negative bacteria, 
including Salmonella. possess exopolysaccharide layers called the 
glycocalyx [Costerton et al., 1981]. Exopolysaccharides can be
divided into homo- and hetero-polysaccharides. Homopolysaccharides, 
seen in Salmonella species, are composed of single-sugar, 
long-chain molecules such as cellulose, levan and gluean polymers. 
Heteropolysaccharides, such as those seen in Klebsiella species, 
are composed of 2 or more monosaccharides and frequently contain 
uronic acids. The capsule of S.typhi has been shown to be 
responsible for bacterial virulence and was therefore termed the Vi 
[for virulence] antigen. Vi+ strains are more serum-resistant and 
less readily phagocytosed by macrophages [Felix and Pitt, 1951] 
and cause more cases of infection in human volunteers [Hornick et 
al, 1970] than Vi- strains. Capsules have been postulated to 
protect bacteria from the environment by a number of mechanisms. 
They may reduce phagocytosis by reducing macrophage-Salmonella 
collisions required for optimal phagocytosis. Capsules may also 
provide steric hindrance to the opsonic effects of antibody and 
complement bound to the bacteria, thereby reducing macrophage 
attachment. The shielding from the immune system of subcapsular 
determinants which may be more antigenic may also be affected by 
capsules. However, in some cases where capsules are potent
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immunogens, phagocytosis may be enhanced.
1.6.4 Flagella
Flagella are used in the serotyping of some bacterial species such 
as Salmonella species and E.coli and are responsible for the 
motility of an organism. A flagellum is a 10-20 nanometres 
filament of protein embedded in the cytoplasmic membrane.
Flagella play a role in the in vitro invasiveness of S.typhimurium 
by facilitating attachment to cells [Jones et al.. 1981; Khoramian 
et al., 1990]. The motility of the organism also facilitates
invasion and survival within macrophages in vitro [Tomita et al., 
1981; Tomita and Kanegasaki, 1982; Fields et al.. 1986]. However 
the contribution of flagella to in vivo virulence has been more 
controversial. Past reports suggested that flagella are required 
for full expression of virulence of S.typhimurium in mice 
[Carsiotis et al.. 1984; Weinstein et al.. 1984]. However more 
recent studies have shown that non-flagellated strains of 
S.typhimurium are as virulent as flagellated strains [Carsiotis 
et al.. 1989; Lockman and Curtiss III, 1990; Jones et al.. 1992].
One virulence factor conferred by flagella that is well understood 
is the ability flagellate bacteria to avoid immune recognition 
through phase variation of their flagellar H antigen, which is
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characterised by the existence of 2 types of H antigen in a 
particular clone [reviewed by lino, 1969]. The phenomeno was 
first described for S.typhimurium but has since been recognised in 
many other species.
1.6.5 Fimbriae
Fimbriae are filamentous appendages of many Gram-negative bacteria 
and are shorter, thinner and straighter than flagella. They 
consist of a protein called pilin and are not involved in motility 
[Otow, 1975]. Fimbrial antigens have been shown to facilitate 
mucosal attachment by enteric pathogens [Stocker and ifakela, 1986; 
Isaacson and Kinsel, 1992] and hence have been called adhesins. 
Adherence is assumed to be a prerequisite for invasion [Freter, 
1981], and loss of adhesiveness results in a decrease in virulence 
[Gahring et al., 1990]. A variety of fimbriae have been identified 
on various Salmonella serotypes [Muller et al., 1991].
S.typhimurium possesses Type I fimbriae which are referred to as 
mannose-sensitive [MS] adhesins becauses they bind to 
D-mannose-containing receptors on cell surfaces and the binding is 
inhibited by D-mannose. In vitro studies showed that the MS 
adhesins are involved in attachment of S.typhimurium to HeLa and 
HEp-2cells [Tavendale et al.. 1983] and to rat enterocytes 
[Lindquist et al.. 1987]. However the role of MS fimbriae in the 
pathogenesis of S.typhimurium in vivo is controversial. Fimbriated 
strains were shown to be better than non-fimbriated forms in
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causing infection in mice [Duguid et al.. 1976; Tanaka and 
Katsube, 1978]. Conversely, it has been shown recently that 
fimbriated strains are less invasive in mice than non-fimbriated 
strains [Lockman and Curtiss III, 1992].
1.6.6 Virulence Plasmids
Autonomous plasmids of Salmonella have been shown to encode 
essential virulence determinants. Such virulence plasmids have been 
reported in S.typhimurium [Baird et al.. 1985] and in other 
serotypes [Terakado et al.. 1983; Nakamura et al.. 1985; Barrow
et al.. 1987; Kawahara et al.. 1988; Barrow and Lovell, 1988].
Studies on the role of these plasmids have suggested their 
involvement in mannose-resistant adhesion and invasion of HeLa 
cells [Jones et al., 1982] , resistance to the bactericidal action
of serum and complement [Helmuth et al.. 1985; Vandenbosch ^
al■, 1987] and in establishing a progressive systemic infection in
the RES [Gulig and Curtiss III, 1987; Hackett and Wyk, 1986; 
Heffernan et al.. 1987]. A gene, mka. has been isolated on the 
S.typhimurium virulence plasmid and has been shown to be necessary 
for intracellular growth [Taira and Rhen, 1989].
1.7. Host Resistance to Salmonella
Natural resistance to S.typhimurium infection is regulated by 
several genes. In the first few days following infection, control 
of virulent S.typhimurium is an inherent property of macrophages 
and is regulated by the Ity [immunity to typhimurium] gene 
[Hormaeche, 1979b; O'Brien, 1986] which is expressed in
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macrophages [Llssner et al., 1983]. The suceptibility allele Ity^
Is present in strains of mice such as BALB/c and C57BL/6. The 
mechanism of action of the Ity gene is unknown. There is debate as 
to whether the Itv gene regulates bacterial growth [Hormaeche et 
al., 1981] or bacterial killing [Lissner et al.. 1983; Van Dissel 
et al.. 1985] of salmonellae within macrophages. Its action is 
not dependent on the activation of macrophages by T cells [Briles 
et al.. 1986; O'Brien and Metcalf, 1982] or by LPS [Briles et 
al., 1986]. Equivalent genes that regulate macrophage function in
Mycobacterium bovis [beg] and Leishmania donovani [Ishl infection 
have also been found [Taylor and O'Brien, 1982; Skamene et al.. 
1982; Brown et al.. 1982]. These genes have been mapped to mouse 
chromosome 1 where the Ity gene is also located, suggesting that 
all 3 genes may be identical.
Susceptibility to S.typhimurium is also increased in C3H/HeJ mice 
that carry the Lps^ [defective for LPS response] gene [O'Brien et 
al., 1980], as they are resistant to the mitogenic effects of
endotoxin [O'Brien et al., 1985]. The production of cytokines such
as TNF and IL-1 in response to endotoxin, which have both been 
implicated in resistance to S.typhimurium infection [Tite et al., 
1991; Morrissey and Charrier, 1991], is decreased in Lps^ mice 
[Beutler and Cerami, 1986]. The Xid [X-linked immune-defective]
gene also renders mice more susceptible to S.typhimurium as they 
are B cell-defective and produce only low levels of 
Salmonella-specific Immunoglobulin [Ig] G whereby they succumb in 
the late phase of disease. A gene linked to the Major
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Histocompatibility Complex [MHC], H-2^ [Hormaeche et al.. 1985]
and another gene present in DBA/2 mice and C57L mice also increase 
the susceptibility of mice to S.typhimurium in the late phase of 
infection [O'Brien et al., 1984].
1.8. Acquired Immunity to Salmonella
1.8.1 T-Independent Mechanisms
s dStrains of mice containing the Ity and Lps genes, as well as SCID
[severe combined immune-deficient] and athymic mice, have been used
to study the relative contributions of specific and non-specific
mechanisms of immunity to S.typhimurium. Temperature-sensitive
mutants of Salmonella have been used to study acquired immunity in
s bgenetically susceptible mice. Genetically susceptible \Ity , H-2 ]
mice develop resistance to reinfection with the same kinetics as 
genetically resistant A/J mice [Ity^. H-2 ]^ but exhibit a defect
in bacterial clearance in the late phases of primary infection 
[Nauciel, 1990; Nauciel et al.. 1988, 1990]. This suggests that
resistance to reinfection and clearance of the primary infection 
may be mediated by different mechanisms and that non-specific 
immune mechanisms are important in the early stages of infection.
Immunity to facultative intracellular bacteria is assumed to be a 
result of macrophage activation by T cell-derived IFN-g [Nathan et 
al.. 1983; Hahn and Kaufmann, 1981; Fukazawa et al.. 1983]. in
SCID mice which have no T or B cells, S.typhimurium infection still 
results in macrophage activation by IFN-g [Bancroft et al., 1987].
Also, in vivo treatment with anti-cluster of differentiation
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antigen [CD] 4 or anti-CDS antibody does not suppress resistance to 
reinfection in the early stage [Nauciel, 1990] in contrast to the 
effects of anti-IFN-g treatment which greatly reduced resistance 
[Nauciel and Espinasse-Maes, 1992]. Taken together these findings
suggest that in the early stage of infection, resistance is 
independent of T cells and is regulated by IFN-g. The source of 
this IFN-g for macrophage activation is now thought to be natural 
killer [NK] cells [Bancroft et al.. 1989; Nauciel, 1990; 
Nauciel and Espinasse-Maes, 1992].
+Administration of anti-asialo GMl [a marker on NK cells] to SCID 
mice blocked IFN-g production in vitro. macrophage activation in 
vivo and increased mortality rates [Bancroft et al.. 1989; 
Nauciel, 1990]. The role of NK cells in resistance to 
S.typhimurium is further supported by the findings of Schafer and 
Eisenstein [1992] who demonstrated that protection against virulent 
S.typhimurium challenge induced by an aroA strain of S.typhimurium 
was mediated by NK cells.
NK cells have been shown to produce IFN-g in response to 
stimulation with bacterial antigen [Welsh, 1984; Klirapel et al., 
1988] in the the presence of macrophages [Kawase et al.. 1983; 
Blanchard et al.. 1986; Bancroft et al.. 1989]. It is thought 
that NK cells produce IFN-g following stimulation with Salmonella 
in the presence of macrophage-derived TNF [Bancroft et al.. 1989; 
Nauciel, 1990; Nauciel and Espinasse-Maes, 1992]. Both these 
cytokines have been shown to effect macrophage activation [Kagaya
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et al.. 1989; Bermudez and Young, 1988] resulting in enhanced
bacterial killing through the generation of reactive oxygen 
intermediates [Edwards III et al.. 1992]. As cytotoxic cells, NK 
cells may also augment resistance to Salmonella infection through 
direct killing [Garcia-Peharrubia et al.. 1989] or by
antibody-dependent cell cytotoxicity [Lowell et al., 1979].
The T-independent hypothesis of acquired resistance to Salmonella 
assumes that macrophages are able to kill the salmonellae following 
activation with IFN-g from NK cells. However there is much 
controversy regarding the ability of salmonellae to survive and 
multiply within host phagocytes. Descriptions of salmonellae as 
facultative intracellular parasites [Suter, 1956; Collins, 1974; 
Buchmeier and Heffron, 1989; Charing et al.. 1990; Vladoianu et 
al., 1990] imply that they are able to achieve this, perhaps by
preventing macrophage phagosome-lysosme fusion [ Buchmeier and 
Heffron, 1991]. However others have shown that macrophages from 
peritoneal exudates of infected mice can kill ingested salmonellae 
[Nakoneczna and Hsu, 1980, 1983; Van Zwet et al., 1975; Lin et
al., 1989]. Killing within neutrophils as well as within macrophges 
has also been demonstrated [Briles et al.. 1981; Beckerdike et 
al., 1974; Rest et al.. 1978; Modrakowski and Spitznagel, 1979].
Vladoianu et al. [1990] and Buchmaier and Heffron [1989] studied
intracellular survival within a wide range of macrophage types and 
concluded that intracellular survival by Salmonella may depend on
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the macrophage source. However the Isolation of genes that control 
the ability of macrophages to kill salmonellae suggests that the 
bacteria are susceptible to the anti-bacterial mechanisms that 
exist within macrophages.
1.8.2 T-Denendent Mechanisms
Previous studies have demonstrated a role for T cells in resistance 
to S.typhimurium [Blanden et al.. 1966; Collins, 1974; Lindberg and 
Robertsson, 1983]. Although T cells appear not to be involved in 
the resistance to reinfection in the early stages, they do play a 
role in the clearance of the primary challenge from the spleen 
[Nauciel 1990]. In euthymie mice, levels of salmonellae in the 
spleen decreased between weeks 2 and 3 after challenge, whereas 
levels continued to increase in athymic mice [Nauciel, 1990]. 
Furthermore, the ability to clear salmonellae more rapidly from 
the spleen can be adoptively transferred into naive mice with CD4+ 
cells from Salmonella-vaccinated mice, and administration of 
anti-CD4 antibody greatly reduces the ability of vaccinated mice to 
clear the salmonellae from the spleen. CD4+ T cells are likely to 
exert their effects through the production of IFN-g for macrophage 
activation [Mossman and Coffman, 1987], the induction of 
delayed-type hypersensitivity [DTH] responses and in the production 
of cytokines that augment B cell proliferation [Hahn and Kaufmann, 
1981].
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In vivo and in vitro depletion experiments showed that the 
depletion of CD8+ cells slightly but significantly depressed the 
clearance of salmonellae from the spleen [Nauciel, 1990]. The 
involvement of CD8+ T cells as well as CD4+ T cells in immunity 
to Salmonella is consistent with the results of genetic
restriction analysis performed by this laboratory. They localised 
the region of the H-2 complex involved in the control of Salmonella 
clearance to the D region, which encodes Class I MHC molecules and 
to a chromosomal segment between K and E which encodes Class II MHC 
molecules suggesting a role for both T cell subsets in immunity to 
Salmonella [Nauciel et al., 1990].
The role of CD8+ cytotoxic T lymphocytes [CTLs] may be related to 
their ability to lyse infected target cells and/or produce IFN-g 
[Kaufmann, 1988]. However, for CD8+ cells to be invoved in 
immunity to Salmonella. the generally accepted rules for antigen 
presentation would have to be broken. Antigen association with 
Class 1 is generally restricted to proteins that are newly 
synthesised within the cell [Monaco, 1992]. Antigens taken up by 
phagocytosis are exogenous and are presented by Class 2 MHC 
molecules, So for CD8+ CTLs to be Involved in immunity to 
Salmonella, exogenous microbial antigens must be presented by Class 
1 molecules. Evidence exists for the association of exogenous 
peptides with Class 1 molecules [Staerz et al.. 1987]. Some 
bacteria produce compounds, e.g. Listeria produce listeriolysin-0, 
which destroy the phagosome [Gaillard et al., 1987] thereby
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exogenous antigen enters the cytoplasm where it may gain access to 
Class 1 processing and recycling pathways. Furthermore, live 
Salmonella vaccine strains have been shown to elicit CD8+ T cells 
to expressed heterologous antigens providing further evidence for 
the ability of exogenous antigens to be presented with Class 1 
molecules [Sadoff et al.. 1988; Tite et al.. 1990; Aggerwal at al.. 
1990].
1.8.3 The Role of Specific Antibody in Salmonella Infection
Adoptive transfer experiments have demonstrated a role for B cells 
in protection from Salmonella [Hochadel and Keller, 1977; Morris, 
1976] and this is supported by the susceptibility of Xid mice to 
S.typhimurium infection [O'Brien et al., 1981]. Passive
immunisation experiments have demonstrated the effectiveness of
specific antibody against crude extracts of rough bacteria [Kussi 
et al., 1979] and antigens against the 0-antigen of LPS [Svenson
and Lindberg., 1981; Svenson et al.. 1979] in affording
protection from virulent challenge. However, the level of 
protection afforded by antibodies is strongly influenced by
experimental conditions, such as the mouse strain and route of
inoculation [Collins, 1969; Nauciel et al.. 1981; Eisenstein et 
al., 1984]. The multifactorial effects of antibodies should allow
them to play an important role in both the T - independent and 
T-dependent mechanisms of acquired resistance to S.typhimurium 
discussed previously.
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Brown and Hormaeche [1989] examined the specificity of the 
antibodies produced during Salmonella infection. They found that 
antibodies were produced with specificity for more than 30 
antigens, including LPS, outer membrane proteins, lipoprotein, 
flagella and capsule. Such antibodies would play a role in negating 
the virulence properties of these structures and in neutralising 
bacterial toxins and adhesins [Jones et al., 1988].
Saxen and Makela [1982] compared the efficiencies of different 
anti-Salmonella Ig isotypes in providing protection of mice from 
salmonellosis. They found that IgM antibodies were much more 
protective than IgG or IgA [Saxen et al., 1984] even though the
concentrations of each were similar. The efficiency of IgM is due 
to the enhanced activation of complement by the IgM bound to the 
bacterium, promoting opsonisation via the C3b receptors on 
macrophages [Rabinovitch, 1975] and direct complement lysis.
IgM is also a stong agglutinating antibody. These findings were 
supported by Duran and Metcalf [1987] who found that S.typhimurium 
stimulates clonal expansion of cells secreting IgM, IgG^ and IgA, 
but very little IgG^ is produced. However Collins et al. [1988]
showed that intradermal inoculation of heat-killed S.dub1in 
protected rats against a lethal intraperitoneal challenge in the 
absence of a good 0 or H agglutination response. As the protective 
factor in this case was IgG^^, agglutinating antibodies may not be 
essential for protection. IgG is an opsonic antibody, binding via
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its Fc region to Fc receptors on phagocytes, promoting phagocytosis 
of the salmonellae. Specific opsonic antibody may also bind in this 
way to the Fc receptors on T cells, K cells and NK cells thereby 
mediating cell cytotoxicity.
As well as the production of serum IgG and IgM, there is also a 
significant rise in the levels of specific sIgA in the gut 
following oral administration of Salmonella [Bartholomeuz et al., 
1986, 1990; Forrest, 1988] which is important in protection
[Hohmann et al.. 1979, Michetti et al.. 1992]. Following oral 
vaccination, bacterial antigen is taken up by M cells and presented 
to the immune cells in the Payer's patches which are subsequently 
primed. Following priming, the B cells switch on membrane IgA 
[mIgA] production, and the mIgA+ B cells leave the Peyer's patches 
and return to the blood via the mesenteric lymph nodes and the 
thoracic duct. It is thought that at this time T helper [Th] 2
cells produce IL-5 which acts on B cells inducing them to switch 
from mIgA production to secretory IgA [sIgA] production. This sIgA
is transported across the gut epithelium, during which it
dimerises, and the sIgA dimer is deposited in the lumen [reviewed 
by McGhee et al., 1992]. As it is not opsonic and does not combine 
with complement, the major anti-bacterial activity of sIgA appears 
to be inhibition at the mucosal surface. It is resistant to 
proteolysis and hence forms an "antiseptic paint" preventing
mucosal penetration, effecting neutralisation of enterotoxins and 
reducing bacterial motility.
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1.9 Live Salmonella Vaccines
Despite some success with killed Salmonella vaccines when used as 
whole-cell vaccines [Hertzberg et al.. 1972; Marecki et al.. 1975; 
Eisenstein and Angermann, 1978; Angermann and Eisenstein, 1980] or 
as subunit vaccines [ Kuusi et al. . 1979; Killion and Morrison,
1986], live Salmonella vaccines provide the best protection against 
challenge with virulent salmonellae [Collins, 1974; Lindberg and 
Robertsson, 1983]. The most widely tested live Salmonella vaccines 
are galE and aroA mutants which are discussed below,
1.9.1 Galactose E Gene [gal El Mutants
Gal E gene-defective mutants of Salmonella were first isolated by 
Fukasawa and Nikaido [1959] as galactose-sensitive mutants which 
undergo lysis in its presence. They are characterised by a block 
in the enzyme uridine di-phosphate [UDP]-galactose-4-epimerase and 
consequently cannot convert glucose to galactose, a component of 
Salmonella core oligosaccharide and 0-repeat units. Without an 
external supply of galactose, only incomplete cell wall LPS is 
formed [Osborn et al.. 1962, 1968] and the organisms are avirulent 
and poorly immunogenic. When galactose is supplied exogenously, as 
is the case for vaccine preparation, the organisms synthesise 
normal LPS and become Immunogenic but lyse due to the intracellular 
accumulation of toxic amounts of UDP-galactose and 
galactose-1-phosphate. Strains grown on galactose can therefore 
establish a limited infectiom in mice, before eventually being 
cleared.
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One gal E strain of S.typhi. designated Ty21a, was found to afford 
protection against virulent Salmonella challenge in the mouse 
typhoid model [Germanier and Purer, 1971]. In human field trials
in Egypt and Chile, which are areas endemic for typhoid, Ty21a 
was shown to afford up to 96% protection, lasting for up to 3 
years [Wahdan et al.. 1982; Levine et al.. 1987; Black et al.. 
1983; Ferreccio et al.. 1989]. Oral administration of Ty21a to 
human volunteers produces strong specific mucosal sIgA responses
[Sarasombath et al.. 1987; Cancellieri and Fara, 1985;
Bartholomeuz et al.. 1986, 1990] serum antibody [Sarasombath et
al.. 1984; Bartholemeuz et al.. 1990; Forrest et al.. 1988],
and strong CMI [Sarasombath et al., 1987].
1.9.2 Aromatic A Gene TaroAl Mutants
Another approach to the development of attenuated mutants was
prompted by the work of Bacon et al. [1951] who surveyed
biochemical mutants of S.typhi and found that strains dependent on 
aromatic compounds or purines were unable to kill mice, even though 
they still possessed a wide array of virulence determinants. 30 
years later this observation was followed up by Hoiseth and Stocker 
[1981] who constructed S.tvphimurium strains with genetically 
defined mutations in the aroA gene. The aroA gene codes for one of 
a series of enzymes involved in the synthesis of chorismic acid. 
This is the only intermediate from which bacteria can synthesise 
all their aromatic metabolites including the aromatic amino acids 
enterochelin, dihydroxybenzoate [DHB], and p-aminobenzoic acid
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[PABA], which is a precursor for folate and nucleotide synthesis. 
A block in this pathway, making a Salmonella strain dependent on 
external aromatic metabolites should cause a loss of virulence in 
vivo because PABA and DHB are not found in mammalian tissues, and 
no efficient alternative route exists for their synthesis in 
bacteria.
Hoiseth and Stocker [1981] made use of the tendency of a 
tetracycline-resistance transposon, TnlO. to cause DNA alterations 
within the transposon itself, sometimes extending into the 
adjacent chromosomal genes such as aroA. causing inactiv^ion of 
this gene and development of aromatic-dependence. The S.tvphimurium 
aroA-defective mutants were found to be highly attenuated in mice 
and have proved to be effective vaccines against virulent 
Salmonella challenge [Hoiseth and Stocker, 1981; Killar and 
Eisenstein, 1985; O'Callaghan et al.. 1988]. Vaccination 
results in the production of specific serum and mucosal humoral 
immune responses [Sigwart et al.. 1989] and specific CMI [Killar
and Eisenstein, 1985] to the vaccine strain.
Following the success of the studies in mice, aroA strains of 
Salmonella were tested in larger animals and have given promising 
results as live [oral or parenteral] vaccines in calves [Robertsson 
et al.. 1983; Smith et al.. 1984a,b], sheep [Mukkur et al.. 
1987; Mukkur and Walker, 1992] and poultry [Cooper et al.. 1992], 
though none of these vaccines have been adequately field tested.
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The results with aroA S.tvphimurium and aroA S.dublin encouraged 
the development of aroA mutants of S.typhi with the purpose of 
vaccine trials in humans. A second attenuating mutation to an aroA 
strain is generally considered necessary if candidate strains are 
ever to be used commercially, as single transduction events could 
result in reversion to wildtype. Mutation to a purine requirement 
causes reduced virulence in S.typhi [Bacon et al., 1950] and in
other serotypes [McFarland and Stocker, 1987]. However, strains 
with mutations in both the aroA and purA genes are less effective 
as vaccines in mice than single mutants as they are less able to 
persist in the host tissues [O'Callaghan et al.. 1988; Sigwart et 
al., 1989]. Alternatively, strains with mutations in different aro 
genes are as invasive as single mutant strains [Dougan et al., 
1988], and human trials with these strains are underway [Tacket et 
, 1992] .
1.10 Expression of Heterologous Antigens in Live Salmonella 
Vaccine Strains
In evaluating the potential of vaccine vectors such as galE and 
aroA mutants of Salmonella. certain important questions must be 
answered. Is the vaccine safe with no chance of reversion to 
wildtype? Is the vaccine effective in eliciting specific immune 
responses to both the vaccine strain and the heterologous antigen? 
What is the location of the heterologous antigen when expressed by 
the vaccine strain e.g cytoplasmic, cell surface or extracellular 
and is this important in the elicitation of an immune response?
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Initially, Salmonella vaccine strains were used to express antigens 
from related enteric pathogens. Formal et al. [1981] expressed
Shigella sonnei antigens into Ty21a, and mice vaccinated with the 
hybrid strain raised antibodies to both the Shigella and Salmonella 
antigens. Clements and El-Morshidy [1984] expressed the non-toxic 
B subunit of heat-labile enterotoxin [LT-B] of E.coli from Ty21a, 
and a good anti-toxin response developed in mice following 
intraperitoneal injection. LT-B expressed from both S.enteriditis 
[Clements et al. . 1986] and S. tvphimurium [ Maskell et al.. 1987]
aroA strains elicited both sIgA and serum IgG as did the K88 
fimbrial adhesin of enterotoxygenic E.coli expressed from galE and 
aroA strains of S.tvphimurium. [Stevenson and Manning, 1985; 
Dougan et al., 1986; Maskell et al., 1986]. Combined Salmonella
vaccines have also elicited humoral and secretory responses to 
outer membrane proteins of Brucella abortus [Stabel et al., 1990]
and group B meningococci [Tarka et al., 1989].
All the aforementioned bacterial antigens were expressed on the 
surface or secreted extracellularly by the vaccine strain. In 
contrast, most of the potentially protective protein antigens from 
viruses and parasites which have been expressed in salmonellae 
accumulate in the cytoplasm of the vaccine strain. Although it is 
difficult to obtain surface expression of these hybrid proteins, 
Salmonella vaccines of this type can can elicit immune responses to 
cloned intracellular antigens. When administered orally to mice.
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specific humoral and cellular immune responses were evoked to 
E.coli B-galactosidase, expressed from aroA S.tvphimurium. 
illustrating that surface expression may not be necessary for the 
development of immunity [Brown et al., 1987].
Furthermore, Guzman et al. [1991] expressed the filamentous
haemagglutinin [FHA] of Bordetella pertussis from aroA 
S.tvphimurium and detected FHA-specific IgA and IgG in the lungs of 
mice following oral immunisation, demonstrating the ability of 
live Salmonella vaccines to prime at one mucosal surface thereby 
eliciting antibody production at another. The FHA was expressed in 
the cytoplasm of the vaccine strain as insoluble inclusion bodies 
suggesting that the insoluble nature of the protein does not affect 
its immunogenicity.
Sadoff et al. [1988] expressed the circumsporozoite protein [CSF]
of Plasmodium berghei from the cytoplasm of a live Salmonella 
strain and demonstrated CSP-specific CMI and protection from 
sporozoite challenge in mice in the absence of anti-CSP antibodies. 
Further studies showed that immunity was mediated through the 
induction of specific CD8+ cells, since in vivo elimination of 
CD8+ cells abrogated protection. [Sadoff et al.. 1988; Aggarwal 
et al., 1990]. A 69 K [kilodalton] protein of Leishmania major
expressed from the cytoplasm of aroA S.tynhimurium elicited 
specific CD4+ T cells in mice which produced IL-2 and IFN-g 
following antigen stimulation in vitro. [Yang et al., 1990] .
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In this thesis, I examined the the immune response to both the 
major outer membrane protein [MOMP] of Chlamydia nsittaci 
r C.psittacil and the leukotoxin [cytotoxin] of Pasteurella 
haemolvtica A1 \P.haemolytica Al] expressed from the cytoplasm of 
an aroA strain of S.tynhimurium. The following sections discuss the 
economic importance of both Pasteurella and Chlamydia and the 
biological and immunological importance of the proteins selected 
for expression,
1.11 C.nsittaci. Ovine Abortion of Ewes TOAEI and the MOMP
C.nsittaci is a member of the genus Chlamydia. It has a broad 
spectrum of hosts and has been recovered from a wide range of 
domestic and wild birds, and mammals. C.nsittaci is the causative 
agent of ovine enzootic abortion [OEA], which is the major cause of 
lamb loss in sheep farming in the UK [Aitken, 1983] and OEA 
strains of C.nsittaci can cause abortion and severe illness in 
pregnant women [Buxton et al., 1986]. Man can also become infected 
with avian strains of C.nsittaci which cause a serious and 
sometimes fatal respiratory illness called psittacosis [Schachter 
and Dawson, 1978].
C.psittaci is an obligate intracellular parasite with a complex 
developmental cycle that takes place within the cytoplasm of the 
host cell. In most cases C.psittaci causes only a subclinical 
infection, but under conditions of stress, illness or during 
pregnancy, the organism can invade mucosal surfaces and gain entry
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to other organs and tissues, causing clinical disease. As a 
result, C.psittaci can cause epidemics in farm animals with serious 
economic consequences. Most notable among these are respiratory 
disease and enteritis in domestic poultry, abortion in ruminants, 
arthritis in lambs and calves, and pneumonia and conjunctivitis in 
various species.
OEA causes abortion of the foetus about 2-3 weeks before the end of 
the normal gestation period. There are no clinical signs of the 
disease until abortion occurs, when the foetal membranes appear 
necrotic with gross thickening of intercotyledonary spaces and are 
rich in chlamydial elementary bodies [EBs], the infectious form of 
the organism. Lambs are usually born dead or are weak and die 
within a few days.
The initial commercial vaccine against OEA consisted of inactivated 
EBs [McEwen et al., 1951] and although this vaccine did not
eliminate the disease, it reduced the incidence of OEA to an 
economically acceptable level for many years up until the mid-1970s 
[Foggie, 1973]. However, outbreaks of OEA have increased and so 
more effective vaccine strategies are being sought.
Current chlamydial vaccine design is based on the major outer 
membrane protein [MOMP], which is the most abundant protein in the 
cell envelope of the EB. It is a 39-40 K protein which comprises 
60% of the protein mass in the outer membrane [Caldwell et al., 
1981; Salari and Ward, 1981] and is by far the best characterised
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chlamydial antigen. Antigenically, MOMP is very complex and 
possesses a hierarchy of epitopes bearing genus-, species-, 
subspecies- and serotype-specificity [Caldwell et al.. 1981;
Caldwell and Schachter, 1982; Stephens et al.. 1982, 1984, 1988;
Newhall et al., 1986]. Structural studies of MOMPs by peptide
mapping suggest that each MOMP represents a serological mosaic of 
antigenic determinants located on 5 conserved regions alternating 
with 4 variable segments [VS][also referred to as variable domains 
[VD][Caldwell and Judd, 1982; Ma et al.. 1987]. Molecular analysis 
of the MOMP gene of C.trachomatis serotypes have confirmed these 
findings and have located these epitopes to specific VS of the MOMP 
[Baher et al.. 1988; Stephens et al.. 1988; Conlon et al..
1988]. VSl and VS2 contain neutralising antibody recognition 
sites [Baehr et al., 1988] and VS3 has been shown to contain T
cell epitopes that provide help for the production of these 
neutralising antibodies [Allen et al., 1991]. Also it has been
shown that of 9 peptides delineating the MOMP protein, only the
one encompassing VS3 was recognised by Chlamydia-specific T cell 
lines [Ishizaki et al., 1992].
Antibodies to specific epitopes on MOMP demonstrably interfere with 
the infection process at a stage after EB internalisation [Caldwell 
and Perry, 1982] and C.trachomatis infectivity can be neutralised 
with anti-MOMP Ig [Caldwell and Perry, 1982] and MOMP-specific 
monoclonal antibodies [Peeling et al., 1984]. However, CMI plays
the most important role in the resolution of C.trachomatis 
pneumonitis in mice [Ramsey et al.. 1989], and in a mouse model
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of C.nsittaci. CMI was better correlated with protection than 
humoral immunity [Buzoni-Gatel et al.. 1987]. Both CD4+ and CD8+ 
cells were shown to be important [Williams et al., 1984], although 
CD8+ cells may have the dominant role [Buzoni-Gatel et al., 1992].
Other animal models of Chlamydia infection have shown that 
protection from reinfection is mediated by mucosal antibody and is 
T cell-dependent [Williams, 1988; Rank, 1988].
A MOMP-enriched vaccine has been shown to protect against abortion 
following experimental challenge of ewes with live organisms [G.E. 
Jones, personal communication], however the mechanisms invoved in 
protection have yet to be elucidated. Although there are elevated 
levels of MOMP-specific antibody in post-abortion animals, and 
ewes do not abort twice, passive transfer experiments demonstrated 
that post-abortion serum antibodies were not protective against OEA 
[G.E. Jones, personal communication]. MOMP-specific T cells are 
present in post-abortion animals [Dawson et al.. 1986a,b; Huang, 
1988; McCafferty, 1992] but their role in protection from OEA has 
yet to be elucidated.
1.12 F.haemolvtica and the Leukotoxin
Amonst the infectious diseases affecting livestock, respiratory 
diseases are of particular importance, causing great economic loss 
in the sheep farming industry throughout the world. Pneumonic 
pasteurellosis, caused by the Pasteurella species P.haemolytica or 
P.multicida. is the most common form of fatal respiratory disease
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in sheep, accounting for 70% of pneumonias [MAFF, 1980]. 
P.haemolytica has been shown to be the more significant of the 2 
species [Gilmour, 1978, 1980] and was the one examined in this
thesis.
P.haemolytica is a small Gram-negative pleomorphic rod being 
aerobic and facultatively anaerobic and is haemolytic on 
sheep-blood agar. Strains of P.haemolytica can be classified into 2 
biotypes A and T, which denote arabinose fermentation and trehalose 
fermentation respectively. Within these biotypes there are 15 
different serotypes [Fraser et al., 1982], identifiable by an
indirect haemagglutination test [Biberstein et al., 1960].
Smith [1961] showed that the disease in sheep caused by 
P.haemolytica fell into 2 distinct syndromes, each of which is 
generally associated with one of the 2 biotypes. Biotype A causes 
enzootic pneumonia affecting sheep of all ages [Montgomerie et al., 
1938]. Morbidity and mortality may be up to 10% of the flock and 
sheep which recover may remain chronically infected. Stress factors 
may play an important role in the development of disease, and 
factors such as climate, dipping, viral infection and
anti-helminthic treatment have all been postulated as predisposing 
the animals to disease [Gilmour, 1978]. The T biotypes cause a 
systemic disease which is a causes of death in older sheep [Stamp 
et al., 1955].
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Despite some success with both live and heat-killed Pasteurella 
vaccines [Dungal, 1931; Cameron, 1966] and the widespread use of 
the currently available formalin-killed whole-cell vaccines 
Heptovac-P [Hoechst, UK, Ltd] and Carovac [Pitman-Moore, UK], 
doubts about their efficacy have been expressed [Gilmour, 1980; 
Gilmour et al., 1983] and deaths of both ewes and lambs in
vaccinated flocks have been reported [ADAS, 1984]. There appears 
to be a need for more effective vaccine strategies.
One of the most important virulence factor of all P.haemolytica 
serotypes is the leukotoxin which is an exotoxin that specifically 
kills leukocytes of sheep [Sutherland et al.. 1983, 1985], cattle 
[Benson et al.. 1978] and goats [Chang et al.. 1982; Richards et 
al., 1982], but not those of non-ruminants [Sutherland et al.,
1983]. As the leukotoxin is lethal for cells involved in immunity, 
it is likely to be an important pathogenic determinant. In 
experimental pasteurellosis of sheep, high numbers of the organism 
are recovered from the lungs in the early stages of disease [Sharp 
et al.. 1978; Rushton et al., 1979] which may be due to in the
impaired alveolar macrophage function as a result of leukotoxin 
activity. The leukotoxin has also been shown to inhibit the 
production of chemotactic factors by bovine alveolar macrophages 
[Markham et al., 1982].
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Leukotoxin activity can be neutralised by antibodies produced in 
calves by vaccination with live P.haemolytica [Baluyut et al., 
1981] and several studies have correlated resistance to bovine 
pasteurellosis with antibody titres to the cytotoxin [Shewen and 
Wilkie, 1982, 1983; Cho et al.. 1984; Gentry et al.. 1985].
Vaccines incorporating leukotoxin have therefore been tested for 
their ability to induce protective immunity from Pasteurella.
Leukotoxic activity is present in bacterium-free culture 
supernatant from logarithmic phase cultures, and vaccination of 
calves with P.haemolytica culture supernatant has been shown to 
Induce resistance to experimental challenge [Gentry et al.. 1985; 
Hosier et al.. 1986, 1989; Shewen and Wilkie, 1987]. However this 
culture supernatant contained other soluble antigens, as well as 
leukotoxin. Conlon et al. [1991] were unable to protect lambs from 
pasteurellosis using only recombinant leukotoxin [rec leukotoxin] 
although the leukotoxin increased the efficacy of a whole cell 
vaccine. Therefore aroA S.tvphimurium expressing leukotoxin would 
be unlikely to protect against pasteurellosis unless it was 
administered with other Pasteurella components.
1.13 Objectives of Thesis
1) To compare the virulence of the aroA and wildtype strains of an 
ovine isolate of S.typhimurium. S25\l, in mice and lambs.
2) To examine the immune responses elicited to the aroA vaccine 
strain following oral vaccination of mice and lambs.
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3) To demonstrate the ability of the aroA strain to protect mice 
and lambs from virulent challenge with wildtype S25/1.
4) To assess the vaccine vector potential of the aroA strain by 
examining the immune responses in mice and lambs to expressed 
heterologous antigens [MOMP and leukotoxin] following oral 
inoculation.
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Chapter 2 
Materials and Methods
2.1 Chemicals
All chemicals used throughout the course of the work described 
in this thesis were of analytical grade from BDH Chemicals Ltd, 
Poole, Dorset, UK, unless otherwise stated.
2.2 Bacterial Methods
2.2.1 Culture Media
The formulae of media are listed in Appendix 1.
2.2.2 Storage of Bacterial Strains and Culture Conditions
Bacteria from a single colony were grown overnight at 37°C in
Luria-Bertani [LB] broth. 1.4 ml of culture was added to 0.6 ml
of glycerol [50%v/v] in 1.5 ml Nunc plastic vials [Gibco], and
stored at -70°C. Strains were grown by scratching the surface 
of the frozen material with a sterile loop and subculturing on 
LB agar or LB broth as required. Bacteria were routinely 
cultured in LB broth with shaking or on LB agar at 37^C for 16 
h. Antibiotics were added to the media when required.
2.2.3 In Vitro Growth Rates
To determine the growth rates of all the strains used, 1 ml of
an overnight LB broth culture was sub-cultured into fresh LB
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broth and Incubated at 37^C with shaking. Aliquots were taken at 
various times and the UV absorbance measured at 600nra using a 
single beam UV digital spectrophotometer [Cecil Instruments, 
Cambridge, UK]. The results are shown in Appendix 6.
2.2.4 Preparation and Determination of the Viable Count of an 
Inoculum Culture
A 16-h culture of the bacterial strain was spun on a Beckman 
J2-21 centrifuge at 7500g for 10 minutes [min] to pellet the 
cells. The cells were washed twice for 10 min in 
phosphate-buffered saline [PBS][see Appendix 5] and resuspended 
in the appropriate volume of PBS. Viable counts were estimated 
by measuring the UV absorbance of culture at 600nm using a 
single beam digital spectrophotometer. The number of colony 
forming units [no. CFU] per ml [no. CFU/ml] equivalent to 
specific Optical Density [OD] goOnm ^^adings were determined 
using the spreading plate method as described. Ten-fold 
dilutions of the samples [of known were prepared in PBS
and 100 ul aliquots were spread on each of 3 dry LB agar plates, 
with or without antibiotics, depending on the strain. After 
incubation of the plates at 37°C for 16 h, the colonies were 
counted and the no. CFU/ml was calculated from the average of 
the 3 plates.
2.2.5 Identification Of Bacteria
Confirmation that a particular organism was a Salmonella species 
was obtained by examining sugar fermentation using API 50 CHE
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galleries [obtained from API Laboratory Products Ltd, 
Basingstoke, Hampshire, UK], The galleries were inoculated 
according to the manufacturers instructions, incubated at 37°C, 
and examined after 3, 6, 24, 48 and 96 h.
The S.typhimurium serotype of an organism was confirmed by the 
detection of Salmonella H antigens or Salmonella 0 antigens 
using commercial slide agglutination tests [Difco].
The wildtype strain of S.typhimurium was distinguished from the 
aroA strain by plating onto XLD [Xylose Lactose Deoxycholate] 
medium where the wildtype strain produced black colonies due to 
the production of H^S, and the aroA strain [HgS-] produced pinky 
yellow colonies.
The wildtype and mutant strains were also distinguished by 
comparing their ability to grow on minimal agar and on minimal 
agar containing the appropriate aromatic compounds and amino 
acids [see Appendix IF]. Virulent, aromatic-independent
strains will grow on minimal agar irrespective of the presence 
of aromatic compounds whereas avirulent, aromatic-dependent 
strains will not grow on minimal agar unless the aromatic 
metabolites are added.
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2.2.6 Construction of Bacterial Strains
Construction of an Aromatic-Dependent Mutant of an Ovine Isolate 
of S.typhimurium
The work made use of a transposon insertion, aroA554::TnlO. from 
the weakly pathogenic strain LT2, originally used by Hoiseth and 
Stocker [1981] to demonstrate that mutation of the aroA gene of 
S.typhimurium prevented the production of important aromatic 
compounds thus rendering the strain avirulent.
The aroA554: :TnlO region from LT2 was transduced into S25/1 [see 
Table 2.1] using the high-transducing Salmonella-specific phage 
P22 HT105/1 int. The transposon TnlO encodes for tetracycline 
resistance and allowed transductants to be easily selected. 
S25/laroA554: :TnlO was grown on Bochner media [Bochner et al., 
1980] which selects for tetracycline-sensitivity. Single 
colonies resulting from this selection process were further 
screened to ensure tetracycline-sensitivity, a dependence on 
the major aromatic compounds and a smooth phenotype. An isolate 
with the correct genotype was grown in liquid selection media 
and repeatedly subcultured and plated to ensure that no 
reversion to wildtype occurred. Hereinafter, this isolate is 
referred to as S25/laroA.
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Construction of Plasmid-Bearing Strains
Plasmids pC, pD and pALl2 used in this thesis were all pUC8 
derivatives [see Table 2.1] and were constructed by inserting 
the appropriate DNA fragment into the multiple cloning site of
pUC8 [see Figure 2.1]. The pUC8 plasmid without an insert of
foreign DNA was also used.
Attempts to transform S25/laroA with the plasmids were
inefficient owing to the smooth phenotype and tended to select 
for rough variants. For this reason the plasmids were
transferred to S25/laroA by first transforming the rough 
S.tvphimurium strain LB5010. Transformants, obtained by 
selecting for ampicillin-resistance were grown on medium 
containing glucose and galactose, allowing the lesion in the 
galE gene of LB5010 to be overcome and a smooth phenotype to be 
obtained. P22 HT105/1 int was then used to transduce the 
plasmids into S25/laroA.
The resulting strains S25/laroA[pC], S25/laroA[pD],
S25/larpA[pAL12] and S25/laroA[pUC8], abbreviated to pC, pD, 
pAL12 and pUC8 respectively, were checked for possession of the 
appropriate plasmid [see 2.3] and Western blotting was performed 
on whole cell lysates to ensure the expression of the 
appropriate plasmid encoded protein [see 2.5]. Slide 
agglutination tests were performed on all the strains to check 
that a smooth phenotype had been maintained.
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Table 2.1 BACTERIAL STRAINS, BACTERIOPHAGE AND PLASMIDS
STRAIN DESCRIPTION SOURCE
LT2aroA554::TnlO Weakly pathogenic strain
of S.tvphimurium with a 
TnlO [tetracycline
resistance] insertion in 
the aroA gene.
S25/1
LB5010
S25/laroA
Virulent ovine isolate of 
S■tvphimurium.
Rough mutant f galEI of 
S.tvphimurium. The
mutation prevents the 
formation of complete LPS 
when grown on tryptic-soy 
broth without sugars [1]
Derivative of S25/1 
rendered avirulent by a 
mutation in the aroA gene 
preventing the synthesis 
of important aromatic 
compounds.
Prof. G. Dougan, 
Imperial College, 
London
Prof. K. Linklater, 
Scottish Agricul­
tural Colleges
Prof, G. Dougan, 
Imperial College, 
London
Dr. J. J. Oliver, 
MRI, Edinburgh
P22 HT105/1 int High-transducing phage
specific for smooth 
strains of Salmonella
containing 
factor 12.
0-antigen
Dr. G. D . Baird, 
MRI, Edinburgh
pUC8 General purpose cloning 
vector [2] carrying 
ampicillin-resistance and 
a variety of unique 
restriction sites located 
between the lac
promoter-operator region 
and the a region of the 
lacZ gene.
Pharmacia, 
Milton Keynes, 
UK
pC pUC8 with 857bp Bam HI- 
Pst I fragment from 3' 
end of the major outer 
membrane protein (MOMP) 
gene of Chlamydia 
psittaci encoding amino 
acid residues 140-367 of 
the protein.
Dr T. W. Tan, 
MRI, Edinburgh
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pD pUC8 with 1251bp Eco RI 
fragment of MOMP encoding 
amino acid residues 1-367 
of the protein (does not 
include the leader
peptide sequence),
Dr. T. W. Tan, 
MRI, Edinburgh
pALl2 pUC8 with 687bp Eco RV- 
Mae I fragment of the 
leukotoxin gene encoding 
amino acid residues 721- 
950 [the carboxy-terminal 
end] of the protein.
Dr. A. Lainson, 
MRI, Edinburgh
References
1. McLachan and Sanderson, 1985
2. Vieira and Messing, 1982.
Fig 2.1 Construction of Recombinant Plasmids
B
lacZ^H
Plac,
pUC8 
2700 bp
lad
EV
MOMP (C-terminal)
M B
MOMP
Ma H
LEUKOTOXIN (C-terminal)
3557 bp
3951 bp
pAL12 
3387 bp
1. pC - Derived by replacing the Bam Hl-Pst I region of the multiple cloning site of pUC8 with a 857 bp fragment encoding 
the C-terminal part of the Major Outer Membrane Protein (MOMP) of Chlamydia psittaci.
2. pD - Derived by inserting a 1251 bp EcoRl fragment carrying the complete MOMP gene into the Eco R1 site of pUC8.
3. The coding region of the genes are represented by hatched shading with the solid region depicting the variable domains for 
both pC and pD.
4. pAL 12 - Derived by inserting a 687 bp Eco RV/Mae I fragment (containing a Hind HI site), carrying the C-terminal 
part of the leukotoxin gene, into the Hind HI site of pUC 8.
The coding region of the gene is represented by hatched shading.
5. A-Acc I, B-Bam HI, E-Eco RI, EV-Eco RV, H-Hind HI, M-Msp I, Ma-Mae I, P-Pst I, S- sma I.
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2.3 Nucleic Acid Methodology
2.3.1 Preparation of Small Quantities of Plasmid DNA 
from Bacteria bv Alkaline Lvsls
10 ml of LB broth, containing ampicillin, was inoculated with a 
single colony of the recombinant strain [either pD, pC, pAL12 or 
pUCS] harbouring the plasmid. Following overnight incubation,
1.5 ml of the culture was placed in an Eppendorf tube and spun 
in a microfuge for 2 min at 5000g. The supernatant was removed, 
the pellet dried by draining the tube and the bacterial cells 
disrupted by resuspending the pellet in 100 ul cold lysis mix, 
containing 4 mg/ml lysozyme [Sigma], 50 mM glucose, 10 mM 
ethylenediaminetetraacetic acid [EDTA] and 25 mM Tris-HCl [pH 
8,0] with vortexing. After 5 rain at room temperature [RT], 200
ul alkaline sodium dodecyl sulphate [SDS] [0.2 M NaOH, 1% SDS] 
was added to the suspension, which was then mixed by inverting
the tube several times and left on ice for 5 min. 150 ul of
cold 3 M potassium acetate was then added with mixing and the 
tube left on ice for a further 5 min to remove the chromosomal 
DNA. The tube was then spun for 2 min at 5000g in a microfuge 
and the proteins precipitated by adding an equal volume of
phenol; chloroform [mixed 1:1], vortexing and spinning for 2 min
at 13000 rpm in a microfuge. The supernatant, containing plasmid 
DNA, was transferred to a fresh Eppendorf tube and 2 volumes of 
100% ethanol added with vortexing. After 5 rain at RT the tube 
was spun for 5 min at 5000g in a microfuge and the supernatant 
removed. To wash the plasmid DNA, 1 ml of 70% ethanol was
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added with vortexing and the tube was then spun at 5000g in a 
microfuge for 5 min. The supernatant was removed and all traces 
of liquid removed from the pellet, which was then resuspended 
in 50ul of IX TE [10 mM Tris base, 1 mM EDTA], pH 8.0.
2.3.2 Restriction Enzvme Digestion of Plasmid DNA
Restriction enzymes were obtained from Boehringer Mannheim, 
Lewes, Sussex, UK, unless otherwise stated. Reactions typically 
contained 0.2-1 ug of DNA [Maniatis et al.. 1982]. To 7 ul of 
plasmid DNA solution was added 2ul of 0.15 mg/ml DNase-free 
RNase, followed by 1 ul of the appropriate lOX digestion buffer 
[Boehringer Mannheim]. 1 ul of the appropriate restriction
enzyme was added and the contents of the tube were mixed by 
vortexing. Digestion was allowed to proceed at 37^C for 2 h.
2.3.3 Agarose Gel Electrophoresis of Plasmid DNA
After digestion, plasmid DNA was analysed in 0.6% [w/v] agarose 
gels in a horizontal system using a Wide Mini Sub Cell apparatus 
[Biorad, Hemel Hempstead, Herts, UK]. Agarose gels were prepared 
by boiling Ultra Pure, low melting point agarose powder 
[Bethseda Research Laboratories [BRL], Gaithersburg, MD, USA] 
in Tris-borate buffer [see Appendix 5] until the solution was 
clear. The molten agarose was cooled and the gel was poured. 
The DNA samples were mixed with 4 ul of gel loading dye [4 mM 
urea, 50% [w/v] sucrose, 50mM EDTA, 0.1% [w/v] bromophenol 
blue] prior to loading onto the gel. Electrophoresis was carried 
out at RT in Tris-borate buffer containing 0.5 ug/ml ethidium
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bromide [Sigma], after which time, the nucleic acid was 
visualised on a UV transilluminator of 302 nm. The fluorescing 
bands were photographed with a Polaroid MP-4 Land camera, using 
a Polaroid type 667 film and a yellow Kodak Wratten filter.
2.4 Preparation of Bacterial Lvsates for Sodium Dodecvl
Sulphate FSDS1-Polyacrylamide Gel Electrophoresis FPAGEI
A single Salmonella colony was inoculated into LB broth
[containing ampicillin when culturing recombinant strains] and 
incubated at 37°C with shaking for 18 h. 1 ml of culture was
placed in an eppendorf and spun at 5000g for 5 min. The
supernatant was discarded and the pellet resuspended in Laemmli 
sample buffer containing 2-ME and bromophenol blue [see Appendix
2] and stored at -20^C for future electophoresis and 
immunoblotting [see below].
2.5 Protein Methodology
2.5.1 Separation of Proteins bv Reducing BPS-PAGE
This procedure was carried out using a modification of the 
method of Laemlli [1970]. For mini gels [80mm x 60mm], the 
Biorad apparatus [Mini Protean II] was used, in conjunction
with an EPS 500/400 powerpack [Pharmacia Ltd, Milton Keynes,
Herts, UK], according to the manufacturers instructions. The
compounds and solutions used in the preparation and running of
gels are listed in Appendix 2. Samples for electrophoresis 
generally consisted of whole bacterial cell preparations 
[prepared as described above] or preparations consisting of
51
predominantly one protein such as MOMP or leukotoxin. Bacterial 
lysates were resuspended in 100 ul of sample buffer and MOMP or 
leukotoxin preparations were diluted 1:2 in sample buffer. All 
samples were further denatured by boiling for 2 min, prior to 
loading onto the gel. Samples and prestained molecular weight 
markers [Biorad] were loaded onto the stacking gel and run at 
200 V until the dye front had reached the bottom of the 
resolving gel.
2.5.2 Electrotransfer and Immunoblotting
This procedure was based on the method of Burnette [1981] using 
a Tris [20 raM]-glycine [150 mM] blot buffer containing 20% 
methanol. SDS-PAGE was carried out as described before and the 
gel was equilibrated for 15 min in cold blot buffer, before 
electro-transfer onto nitrocellulose [Schleicher and Schuell, 
Dassel, Germany]. Briefly, the nitrocellulose was cut to size 
and equilibrated with transfer buffer for 20 min. 
Electrotransfer was carried out on Biorad blotting apparatus 
[Biorad] between pre-rinsed graphite electrodes in a transfer 
sandwich containing from anode to cathode : 3 sheets of 3 mm
filter paper [Whatman], pre-soaked in transfer buffer; One 
sheet of pre-wetted nitrocellulose; equilibrated gel; 3 sheets 
of filter paper pre-soaked in blot buffer. Care was taken to 
eliminate air bubbles between the individual layers by rolling 
with a pasteur pipette. The transfer was performed with a 
constant voltage of 100 v for 1 h during which the system was 
cooled with an ice block. After the transfer, the blotted
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nitrocellulose was rinsed with distilled water and stained in 
Ponceau S stain [Sigma] for 2-5 min, to check that transfer had 
taken place. The major bands were marked with a pen and the 
Ponceau stain was removed through several changes of distilled 
water. The nitrocellulose was then washed x3 in Tris-buffered 
saline [TBS][10 mM Tris-HCl, 0.95% [w/v] NaCl, pH 7.4], after
which time it was ready for immunoscreening.
2.5.3 Screening of Blotted Proteins with Specific Antisera or 
Monoclonal Antibodies
The nitrocellulose blot was incubated overnight at RT in TBS 
containing 50% horse serum to block sites that had not been 
bound by protein. After 3 washes with TBS containing 0.1% Tween 
[TBST] the appropriate antiserum or monoclonal antibody, diluted 
in PBS containing 3% foetal calf serum [PCS][Sigma], was added
in a volume sufficient to cover the nitrocellulose. When serum
was being tested for the presence of antibodies specific for the 
blotted proteins, the blot was cut into strips, and each strip 
probed individually with an individual serum sample. The blot 
was then incubated for 2 h at RT, after which time the blot was 
washed x5 with TBST to remove unbound antibody. The appropriate
conjugate was added to the blot for 90 min. Anti- mouse IgG
conjugates were either alkaline phosphatase [AP]-labelled or 
horseradish peroxidase [HRP]-labelled [both Sigma], Anti-sheep 
IgG conjugates [both AP- and HRP-labelled] were produced by Mr. 
A. Dawson, MRI. Following a further 5 washes in TBST, the
enzyme substrate was added. For the AP substrate, the buffer
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was a solution containing 100 mM Tris [pH 9.5], 50 mM MgCl^,
100 mM NaCl and 66 ul of nitroblue tétrazolium [Sigma]. After 
the solution had dispersed throughout the buffer, 33 ul of 
5-bromo-4-chloro-3“indolyl phosphate [Sigma] was added, and the 
reaction was stopped by submerging the blot in PBS containing 
50mM EDTA after the colour had developed. For the HRP 
substrate, 1 mg/ml of diaminobenzoate [Sigma] was added to 20 
ml of lOmM Tris-HCl and a few drops of H2 O2  added. The reaction 
was stopped by submerging the blot in distilled water.
2.6 Animal Experiments
2.6.1 Mice
All mice used throughout the course of the work were BALB/c 
[H-2^] of either sex and aged 6-12 weeks, unless otherwise 
stated. Mice were housed in cages [max 5/ small cage, 20/ large 
cage] at 22°C, with 10-12 h lighting and fed and watered ad 
libitum. Mice were anaesthetised using halothane [ICI 
Pharmaceuticals, Macclesfield, Cheshire, UK].
2.6.2 Lambs
Conventional Blackface Suffolk crosses, aged 6-9 months and of 
either sex, were used in experiments invoving the 
non-recombinant strains of Salmonella [Chapter 4]. Lambs were 
housed in an open pen and fed on hay and ruminant A nuts 
[Dalghetty, Edinburgh, UK].
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Conventional 10 day-old Finn lambs were used in the experiment 
involving the pD and pC strains of Salmonella [Chapter 5], 
housed in negative-pressure maintenance isolators [Moredun
Animal Health, Edinburgh] and fed 4 times daily with UHT milk.
Germ-free Finn lambs were used in the experiment involving the 
pAL12 strain of Salmonella [Chapter 6]. Pregnant ewes underwent 
hysterectomy, and the sealed uterus was passed through a 
germicidal trap into an isolator bubble. Using sterile 
techniques, the lambs were transferred into positive-pressure 
maintenance isolators, which were converted to negative 
pressure immediately prior to infection, 5 days post-partum. 
The lambs were fed 4 times daily with UHT milk.
Before use, rectal swabs were taken from all lambs and 
inoculated into 10 ml of selenite broth enrichment media [see 
Appendix 1] which was subsequently incubated at 37°C with 
shaking for 16 h. A loopful of broth was streaked onto an XLD 
plate and any lambs which were found to be excreting salmonellas 
were discarded.
2.6.3 Inoculations
Bacterial strains were administered orally to mice using 1ml 
syringes [Becton Dickinson [BD], Dun Laoghaire, Co.Dublin, 
Ireland,] with 21 gauge [ga] needles [BD], that were sheared of 
the tips using wire cutters, filed and covered with medical
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grade catheter tubing [Durai Plastics and Engineering, Durai, 
NSW, Australia.]. Oral inoculations did not exceed doses of 
200 ul. Oral inoculation of lambs was performed using a 10 ml 
syringe [BD] to administer doses of up to 10 ml. Intravenous 
administration involved warming the mouse in a light box, or 
massaging the tail, to allow an increasd flow of blood to the 
tail, and injecting up to 50 ul into the tail vein using a 26 
ga needle [BD]. Intraperitoneal inoculations were carried out 
using 26 ga needles to administer doses of up to 1 ml. 
Intradermal injections involved injection of 100 ul of the 
appropriate preparation into the neck [mice] or flank [sheep] 
skinfold with a 26 ga needle. Following all injections, the 
point of needle insertion was swabbed with 70% alcohol to clean 
the wound.
2.6.4 Blood Collection
Blood was collected from the tail vein of mice. The mice were
either warmed in a light box or the tail was massaged, after
which time the tail vein was nicked with a scalpel blade and the
blood was collected into capillary tubes [Hawksley, Lancing,
Sussex, UK] which were then sealed with Crystaseal wax 
[Hawksley]. The blood was spun for 5 min on a micro-haematocrit 
centrifuge [Hawksley] and the part of the tube containing the 
serum was removed using a diamond-tipped pen and the serum 
collected. Blood was also removed from mice following cutting of 
the hepatic vein of anaethetised animals, when it was not
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necessary to keep the animals alive. Lambs were bled from the 
jugular vein into Vacutainer tubes [BD] using Vacutainer needles 
[BD]. The tubes were spun at 300g for 5 min and the serum 
collected. All serum was stored at -20°C.
2.6.5 Lavage Technique for the Collection of Murine sIgA
Mice were fed every 15 min for 1 h with 0.5 ml 48.5 mM 
polyethylene glycol [molecular weight 3350] [Sigma]. 20 min
after the last feed, the mice were culled and the small 
intestines and caeca washed out twice with 5 ml of ice-cold 50 
mM EDTA containing 0.1 mg/ml soyabean trypsin inhibitor 
[STI][Sigma] [EDTA/STI]. After bringing the samples up to 6 ml 
with ice-cold PBS, they were vortexed vigorously, transferred
to 50 ml centrifuge tubes and spun at 2500g for 10 min on a 
Beckman J2-21 centrifuge, to remove large debris. 3 ml of the 
supernatant was then transferred to round-bottomed polycarbonate 
centrifuge tubes and spun at 69,000g at 4°C for 20 min on a 
Beckman R-7 ultracentrifuge. 30 ul of
phenylmethyl-sulfonylfluoride [PMSF][Sigma] in 95% ethanol, and 
30 ul of 2% sodium azide were then added to 2 ml samples of 
clarified supernatant and after incubation for 15 min on ice, 
100 ul of FCS [Sigma] was added. The samples were then aliquoted 
in 1 ml volumes and stored at -70°C.
2.6.6 Isolation of Ovine Coproantibody
Faecal samples from lambs were collected into plastic tubs, 
weighed and an exact volume of ice-cold EDTA/STI solution added.
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Samples were transferred to Stomacher "80" bags [Seward 
Medical, London, UK] and homogenised in a Stomacher "80" lab 
blender [Seaward]. Homogenates were then transferred to 50 ml 
centrifuge tubes which were spun at 25,000g for 10 min on a 
Beckman J2-21 centrifuge. The brown supernatant, termed faecal 
extract, was aliquoted in 1ml volumes and stored at -20°C 
following addition of 1% sodium azide to a concentration of 
0 .01%.
2.6.7 Measurement of Specific DTH Responses
In mice, specific DTH responses were determined following 
injection of antigen into the hind footpads. Prior to testing, 
the thickness of both hind footpads in mm was measured using 
dial-gauge calipers [Kroeplin, Germany]. Anaesthetised mice 
were injected into the left hind footpad with 50 ul of a 
heat-killed preparation of S25/laroA containing approximately 2 
X 10^ CFUs/ml which had been killed by boiling for 20 min. The 
opposite hind footpad was injected with 50 ul of saline. 24 and 
48 h following injection, the footpad thickness was measured as 
before and the increase in thickness of the footpads determined 
by subtracting the pre-injection value from the post-injection 
value. The antigen-specific increase in thickness was obtained 
by subtracting the increase in the opposite footpad which had 
been injected with saline.
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In lambs, the same procedures were performed following the
intradermal injection of heat-killed S25/laroA or saline into 
the flank skinfold,
2.6.8 Production of Antibody to Specific Antigen in Mice bv 
Administration with Complete Freunds Adjuvant TCFAl
Preparations of MOMP or leukotoxin were diluted 1:2 with sterile 
distilled water before being mixed in an equal volume of CFA
[Sigma]. The mixture was vortexed until the suspension was
fully emulsified, when a clear layer [representing the CFA] was 
no longer formed. The emulsion was injected either 
intraperitoneally, or into the neck skinfold of mice. 14 days 
later the same antigen preparation was emulsified in Incomplete 
Freunds Adjuvant [ICFA][Sigma] as before and injected in the 
same way. After a further 7-14 days, the mice were bled and
the sera stored at -20°C.
2.7 Pathogenesis Studies
2.7.1 Clinical Evaluation of Mice and Lambs After Infection 
Following inoculation of both mice and lambs, the appetite, 
respiratory state and demeanour of the animals was closely 
observed. In lambs, the rectal temperatures were recorded daily
and the no. CFU per gram [no. CFU/g] of faeces of the
inoculated strain was determined for at least 7 days post­
infection. The percentage dry weight [%DW] of the faeces was 
also determined by weighing faecal samples and cooking in a
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microwave until all the water had evaporated. The weights of 
the dried samples were then expressed as a percentage of the 
original weight. The presence of haemoconcentration was 
investigated in lambs by determining the packed cell volume 
[PCV] of the blood. Blood was placed in a capillary tube and 
spun for 5 min on a micro-haematocrit centrifuge. The PCV of 
the blood was obtained using an Hawksley micro-haematocrit 
reader.
2.7.2 Enumeration of Bacterial Growth in Mice and Lambs
At intervals after inoculation with Salmonella. mice and lambs 
were culled and tissue and faecal samples taken. From mice, the 
liver, spleen, Peyer's patches and various regions of the gut 
were examined and samples of heart, lung, hepatic lymph node, 
spleen, kidney, mesenteric lymph node, abomasum, ileum, 
caecum and colon were taken from lambs. All samples were taken 
into Stomacher "80" bags which had been pre-weighed. Tissue 
samples from lambs were also fixed in formalin for future 
histopathological studies. Following weighing of the samples, 
9 ml of PBS was added and the samples homogenised in a stomacher 
"80" lab blender, then poured into plastic universal containers 
[Bibby Sterilin Ltd, Stone, Staffs, UK]. 1 ml of homogenate 
was plated onto XLD medium and left to air dry. All plates were 
incubated for 18 h at 37°C, before estimations of viable counts 
were made. Counts were expressed as the no. CFU\g of organ [or 
faeces].
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If the organism could not be detected after direct plating onto 
XLD agar, 1 ml of organ homogenate was inoculated into 10 ml of 
selenite broth. Following overnight culture at 37^C with 
shaking, 100 ul of culture was spread onto XLD and the plate 
incubated overnight at 37°C.
In lambs, the organism was detected in blood either by direct 
plating of 1 ml of whole blood onto XLD agar, or by inoculation 
of 1 ml of whole blood into nutrient broth [see Appendix 1] or 
into selenite broth, followed by overnight culture and 
subsequent spreading onto XLD agar plates.
2.7.3 Estimation of the Viable Counts of Ampleillin-Resistant 
Colonies of S25/laroA in the Tissues and Faeces of Mice 
In mice, the proportion of bacteria retaining the ampicillin- 
resistance plasmid was determined in each organ. XLD plates 
containing the colonies were dried for 15 min at 37^G and an 
exact impression of the colonies were made onto paper filters 
[Whatman International Ltd, Maidstone, Kent, UK]. A round 
plastic block was covered with 2 sheets of tissue paper on top 
of which was placed a filter, held firmly in place with a metal 
band-clamp. The surface of the dried XLD plate was placed 
carefully onto the filter and pressure applied. The XLD plate 
was removed and the impressions of the colonies could be seen on 
the filter. A dry LB agar plate containing ampicillin was placed 
on top of the filter, and pressure applied as before. Both the
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XLD and LB-ampicillin plates were then incubated at 37°C for 16 
h. After this time, the number of colonies on each plate type 
were counted and the percentage of colonies that were 
ampicillin-resistant was recorded.
2.8 Immunological Assays
2.8.1 Enzvme-Linked Immunosorbent Assays FELISAsI
2.8.1.1 Preparation of Coating Antigens
The recombinant MOMP [rec MOMP] protein [kindly donated by Dr.A 
Herring, MRI] was produced in S25/1 and purified by gel 
filtration in a Bio-gel P-60 column [Biorad]. The protein 
fraction was resolubilised in lOmM NaPO^, pH 6.8, containing 
0.1% SDS and lug/ml used for coating. Two antigen preparations 
were used for the detection of anti-Salmone11a antibodies. 
Initially a live bacterial suspension containing 3 x 10^ CFU/ml 
of S25/laroA was used to coat plates. Subsequently, plates 
were coated with 1 ug/ml of LPS, extracted from a culture of 
S25/laroA [see below].
2.8.1.1a Extraction of LPS from a Culture of S25/laroA
The LPS was extracted from the S25/laroA salmonellae by the hot 
phenol water extraction method [Westphal and Jann, 1965]. A 1 
litre overnight culture of S25/laroA was spun down at 3300g for 
45 min, washed twice in PBS, and lyophilised. The dried cells 
were resuspended in 50 ml of distilled water and then mixed with 
an equal volume of 90% [v/v] phenol at 68°C. The mixture was 
shaken vigorously for 10 min at 68°C, then cooled down quickly
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on ice before centrifugation at 3300g to deposit the cells. The 
resulting upper aqueous layer was removed without disturbing the 
interface and an identical volume of distilled water was added 
to the remaining mixture before a second phenol extraction was 
carried out. Again the aqueous layer was removed and the 2 
aqueous layers combined and dialysed against running water for 
48 h. After centrifugation at 3300g for 30 min to remove any 
debris, the volume of the sample was then reduced by half on a 
rotary evaporator for 1-2 h . The concentrated sample was spun at 
368,000g for 90 min on a Beckman R-7 ultracentrifuge. After 2 
washes in PBS, the pellet containing LPS was resuspended in 5
ml PBS, freeze dried and was stored at 4°C.
2.8 .1.2 Measurement of Antibody bv ELISA
The full composition of buffers used in the following protocol
are listed in Appendix 3. 100 ul of antigen in bicarbonate
coating buffer, pH 9.6, was added to each of 96 wells of a 
flat-bottomed microtitre plate [type 129A, Dynatech
Laboratories, Billinghurst, Sussex, UK] and incubated for a 
minimum period of 2 h at RT. The plate was then washed x4 with 
PBS containing 0.1% Tween 20 [PBST], with the final wash being 
left on for 1 h. The plate was then dried on tissue paper, after 
which 1 0 0  ul of test sample was added in duplicate to the wells 
and doubling dilutions were made down the columns of the plate 
with ELISA buffer, pH 7.2 [Shafren and Tannock, 1989].
Following a 1 h incubation at 37°C, the samples were removed 
and the plate washed x4 with PBST. Following drying of the
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plate, 100 ul of conjugate, appropriately diluted in PBST 
containing 0.25% bovine serum albumin [BSA] was added to the 
wells and the plate incubated at RT for 90 min. AP-labelled 
conjugates, specific for murine Igs, were obtained from Sigma 
and diluted 1:1000. HRP-labelled conjugates, specific for ovine 
Igs, were produced at MRI by Mr. A. Dawson and diluted 1:8,000, 
1:10,000 and 1:5,000 for IgM, IgG and IgA-specific conjugates 
respectively. The conjugate was removed and the plate washed x4 
with PBST. Following drying, 100 ul of the appropriate 
substrate was added to the wells. Where the conjugate was 
AP-labelled, the substrate was lug/ml p-nitrophenyl phosphate 
[PNPP] [Sigma] in 10% diethanolamine buffer, pH 9.8, and the 
reaction was stopped after 30 min at 37°C by the addition of 50 
ul/well of 3M NaOH. In assays incorporating HRP-labelled
conjugates, the substrate was O.lmg/ml 0-phenylenediamine [OPD] 
[Sigma], in citrate phosphate buffer, pH 5, to which was 
added 0.1 ul/ml of 30% [w/v] H^O^ [Sigma], and the reaction was 
stopped after 20 min at 37°C with 50 ul/well of 2M H^SO^. Plates 
were read on a "Titertek Multiskan" multichannel
spectrophotometer [Flow Laboratories, Irvine, Ayrshire, UK] at 
a wavelength of 405nm for assays where the substrate was PNPP, 
and at a wavelength of 492nm where the substrate was OPD. In 
murine assays, the OD of infected mouse serum was corrected by 
subtracting the OD of normal mouse serum [NMS] while in ovine 
assays, the OD of infected lamb serum was corrected by 
subtracting the OD of the pre-infection serum from the same 
lamb.
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2.8.2 Tissue Culture Experiments
2.8.2.1 Media
A full list of the contents of media are given in Appendix 4.
2.8 .2.2 Preparation of Murine Spleen Cells
Spleens were asceptically removed from mice and placed in 
sterile plastic universal containers containing 2  ml of
supplemented Hank's balanced salt solution [sHBSS]. The spleens 
were placed in plastic Petri dishes and the cells flushed out by 
injecting 10 ml sHBSS. The cell suspension was spun twice at 
300g and the pellet resuspended in sHBSS for counting. The 
cells were counted after the addition of 2 0  ul of cell 
suspension to 20 ul of 0.1% nigrosin in an improved Neubauer 
chamber and after one final wash, the cell concentration was 
adjusted to 2 x 10^/ml in supplemented RPMI 1640 medium [sRPMI 
1640].
2.8 .2.3 Preparation of Ovine Peripheral Blood Mononuclear Cells 
rPBMGI
Blood was collected in 20 ml Vacutainers containing 200 ul of 
preservative-free heparin [lOOOu/ml]. After thorough mixing, the 
blood was transferred to plastic universal containers and spun 
at 450g for 30 min. The "buffy coat" containing the lymphocytes 
was then removed with a Pasteur pipette, layered on top of 5 ml 
of Lymphoprep [Nycomed Pharma As, Oslo, Norway] and centrifuged 
at 650g for 30-40 min. The cells at the interface were washed
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by centrifugation x3 at 300g for 6  min in sHBSS, resuspended in 
supplemented Iscove's Modification of Dulbecco's Medium [sIMDM] 
and counted in an improved Neubauer chamber [see 2.8 .2.2] . The 
cell concentration was adjusted to 2 x 10^/ml in sIMDM.
2.8.2.4 Separation of B and T Lymphocytes using Nvlon Wool
Scrubbed nylon fibre [3 denier, 3.81 cm [Fenwal Labs, 
Deerfield, XL, USA] was boiled in 6  changes of distilled water 
for 1  h for each change, rung out and left to dry. 600 mg of 
washed nylon wool was packed into a 1 0  ml syringe, and after 
adding 6  ml of PBS to wet the nylon, the plunger was replaced. 
The column was then stored until use. For purification of 
cells, the column was washed through with approximately 50 ml 
of sRPMI 1640 and, after the wool was completely soaked , the 
outlet catheter was closed using a crocodile clip and sRPMI 1640 
was added until a liquid head of approximately 1  ml had formed. 
The top of the column was sealed with sterile tape and the 
column was incubated for 2 h at 37°C in 5% CO^. After 
incubation of the column, a maximum of 1 0  ^spleen cells in 2  ml 
of sRPMI 1640 at 37°C was layered gently onto the column, 
followed by 1 ml of warm medium. The column was resealed and 
returned to the incubator in an upright position for a minimum 
of 45 min. "Enriched" T cells were then eluted with 20 ml of 
medium, spun down, counted and resuspended to a concentration 
of 2 X 10^ cells/ml in sRPMI 1640. The column was then washed 
through with 50 ml of warm medium to remove the null cells. B 
cells were eluted by adding a further 1 0  ml warm medium and
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rapidly inserting the plunger and compressing the wool as hard 
as possible. This was repeated twice and the "enriched" B cells 
collected, spun down, counted and resuspended to a 
concentration of 2 x 10^ cells/ml in RPMI 1640 medium.
2.8.2.5 Lymphocyte Transformation Tests TLTTsI
Lymphocytes were stimulated in vitro with Concanavalin A [ConA]
[Sigma], LPS [extracted from S.minnesotal [Sigma], dilutions
of a washed culture of heat-killed S25/laroA [containing 5 x 10^
CFU/ml] or with different preparations of soluble antigen [MOMP
and leukotoxin] which were g-irradiated prior to use. One
preparation of MOMP was separated by SDS-PAGE and blotted onto
nitrocellulose. The MOMP was then removed from the
nitrocellulose for use in LTTs as described. The nitrocellulose
strip containing the protein was first placed onto a piece of
2
filter paper, covered in cellophane and 2  mm pieces excised 
using a scalpel blade and a ruler which had been washed in 70% 
ethanol to precipitate contaminating proteins. The squares were 
incubated in 0.5 ml of dimethyl sulphoxide [DMSO] [Sigma] for 1 
h at RT to dissolve the nitrocellulose. The nitrocellulose was 
resolubilised [to allow removal of the DMSO] by the addition of 
1 ml of sterile 0.05M bicarbonate buffer, pH 9.6, added 
dropwise to the bijoux during vigorous mixing in a vortex mixer. 
After 1 h at RT, the DMSO was removed by washing x3 in HBSS on a 
microfuge at 5000g for 5 rain. The nitrocellulose was 
resuspended in 1 ml of sRPMI 1640 medium and stored at -20°C.
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To perform the LTT, 100 ul of a cell suspension containing 2 x 
10^ cells/ml in sIMDM [see Appendix 4] was added to the wells of 
96-well, flat-bottomed microtitre plates [Nunc, Paisley, 
Strathclyde, UK], 100 ul of antigen or mitogen preparation was 
added to the cells in triplicate, giving a final volume of 2 0 0  
ul/well. The plate was incubated for 4-6 days at 37°C in 5% CO^ 
in air, after which time the cells were pulsed with 0.5 
uCi/well tritiated thymidine [Amersham International pic. 
Amersham, Bucks, UK]. Following a further 18-h incubation, 
the cells were harvested using an automatic cell harvester 
[Flow] and the radioactivity incorporated into DNA was 
determined by counting on a liquid scintillation counter 
[Canberra Packard, Pangbourne, Berks, UK], Triplicates where 
the standard errors were greater than 20% were discarded. The 
results for stimulated cells were expressed either as net counts 
per minute [CPM] or as a stimulation index [SI], calculated by 
subtracting or dividing the counts obtained using unstimulated 
cells respectively.
2.8 .2. 6  Cytokine Assays
Cell supernatants were removed for analysis of IFN-g or IL-2 
activity after 1-4 days of culture with specific antigen as 
described above, and stored at -20^C.
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2.8.2.6[a] IFN Assays
Bioassays were used to measure levels of IFN-g. Murine IFN 
assays were carried out using the murine L929 fibroblast cell 
line as target cells, while ovine IFN was measured using ST- 6  
cells, an ovine adenocarcinoma of the small intestine. Both 
cell types were maintained in sIMDM in 20 ml tissue culture 
flasks [Nunc] and passaged twice weekly. After removal of 
culture medium, the cells were washed twice with PBS that had
been warmed to 37°C in a waterbath and 5 ml of trypsin
[0.25%]/versene [0.02%] in IMDM was added for 4 min at 37°C in 
5% CO^. The released cells were washed x3 in sHBSS by 
centrifugation at 300g, counted and adjusted to the appropriate 
concentration in sIMDM [see 2.8 .2.2]. 5 x 10^ ST- 6  cells, or 3
3
X 10 L929 cells in 100 ul of sIMDM were plated out in
flat-bottomed, 96-well microtitre plates [Costar[UK]Ltd, High 
Wycombe, Bucks, UK] and after incubation for 24 h [L929] or 72 h 
[ST-6 ] at 37°C in 5% CO^ in a humidified incubator, the medium 
was removed and 1 0 0  ul of test supernatant was added in
duplicate to the cells. In some cases, the test samples were 
serially diluted in serum-free sIMDM to titrate any IFN that was 
present. Following overnight incubation, the medium was 
removed from the plate and replaced with 200 ul of sIMDM/2% FCS 
containing 100 50% tissue culture infective doses [TCID^^] of 
Semliki Forest Virus [SFV] [supplied by Dr. A.G. Morris, 
Warwick, UK], which had been titrated previously on foetal lamb 
kidney cells and the concentration calculated by the 
Spearman-Karber method [Grist et al., 1966]. The plate was
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returned to the incubator for 48 h when the amount of cytopathic 
effect [CPE], evident by the destruction of the monolayer as a
result of the rounding of the cells, was evaluated visually
using an inverted microscope. The titre of IFN-g was given as 
the inverse of the highest dilution which reduced CPE by 50%. In 
ovine assays, various dilutions of a standard preparation of
recombinant ovine IFN-g [supplied by Dr. M. Scott, Wellcome,
Beckenham, Kent, UK] and protective to ST- 6  at 1 u/ml] were used 
as a positive control. Recombinant murine IFN-g, produced in 
the supernatant of transfected CHO cells [supplied by Dr. A.G.
Morris], served the same purpose in murine assays.
To determine that the IFN in the supernatants was IFN-g, prior 
to the assay, the samples [including the positive controls] were 
incubated for 2-3 h at 37°C in 5% CO^ with neutralising 
monoclonal anti-IFN-g antibodies. For the murine assay, an IgG 
rat anti-mouse IFN-g monoclonal antibody [R46A2, [Spitalny and 
Havell, 1984], supplied by Dr A. McI. Mowat, Western
Infirmary, Glasgow, UK] was used, while a mixture of 2 murine
monoclonal antibodies [IFN9 and IFN2 [Wood et al. 1990]
supplied by Dr. P.R. Wood, Parkville, Australia] originally 
raised against bovine IFN-g, but which neutralise ovine IFN-g 
[Entrican et al. 1992], was used in ovine assays. A control
monoclonal antibody, specific for Border Disease Virus [BDV] 
and with no specificity for IFN-g, was added to the samples and
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positive controls in parallel with the IFN-g specific monoclonal 
antibodies, and the differences between the titres of the 
respective samples with or without the anti-IFN-g monoclonal 
antibodies was Interpreted as being due to IFN-g.
2.8.2.6[b] Measurement of IL-2 Activity
This assay was based on the ability of IL-2 [both murine and 
ovine] to cause the proliferation of the mouse cytotoxic T cell 
line, CTLL, which is dependent on IL-2 and IL-4 for growth and 
survival in culture. CTLL cells [obtained from Dr Tony Lammas, 
University of Birmingham, UK] were maintained in sIMDM in 
24-well tissue culture plates [Nunc] in 5% CO^ at 37^C and fed 
every 3 days with 20 u/ml recombinant IL-2 [Sera-Lab Ltd, 
Crawley Down, Sussex, UK]. The cells were harvested 3 days
following feeding with IL-2, washed twice in sHBSS by
centrifugation at 300g and resuspended at 1 X 10^/ml in sIMDM. 
1 0 0  ul of cell suspension was added to individual wells of a
96-well microtitre plate [Nunc, Gibco] and 100 ul of test
lymphocyte supernatant [from both and murine and ovine cells] 
added in triplicate. The plates were incubated for 1-2 days at 
37°C in 5% CO^, after which 0.5 uCi of tritiated thymidine was 
added to each well and the plates returned to the incubator for 
18 h and incorporation into DNA assayed as described previously 
[see 2 .8 .2 .5].
As CTLL cells may also be dependent on IL-4, the presence of 
IL-2 in the supernatants was confirmed by incubation with an 
anti-mouse IL-2 monoclonal antibody [obtained from Dr. R.
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Bujdoso, Royal Veterinary College, Edinburgh, UK] for 1-3 h 
before performing the assay. A control monoclonal antibody, 
specific for BDV, was added as a control and the differences 
between the titres of the respective samples with or without the 
anti-XL-2 monoclonal antibody was interpreted as being a result 
of the presence of IL-2.
2.8.2.7 Analysis of Cell Surface Phenotype bv Flow Cytometry
Flourescence-Activated Cell Sorting [FACS] analysis was used to 
determine which subpopulation of ovine T cells was responding to 
specific antigen in an LTT. 1 ml of ovine PBMC, at a 
concentration of 2 x 10^/ml in sIMDM, were cultured in 24-well 
tissue culture plates [Nunc] with 1 ml of a heat-killed 
S.tvphimurium suspension containing 2 x 10^ CFU /ml [240 ug/ml 
protein]. After 5-7 days in culture at 37^C in 5% CO^, the 
cells were washed and counted. 1  ml aliquots, containing 1  x 
10^/ml cells in supplemented Earle's balanced salt solution 
[sEBSS] were dispensed into polypropylene centrifuge tubes 
[Labsystems [UK] Ltd., Basingstoke, Hants, UK], pelleted by 
centrifugation and 1 0 0  ul of the appropriate monoclonal antibody 
added. The monoclonal antibodies used were mouse anti-sheep 
CD4, CDS, T cell receptor gamma-delta [TcR g-d] [all kindly 
gifted by Dr. C. McKay, Basel Institute for Immunology, 
Switzerland], Ig light chain [LC] and anti-BDV as a negative 
control [both kindly provided by D. Deane, MRI]. After 1 h on 
ice, the cells were washed twice in sEBSS at 300g, resuspended 
in 50 ul of a 1:25 dilution of fluorescein-labelled rabbit
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anti-mouse IgG conjugate [Dako Ltd., High Wycombe, Bucks, 
UK], and incubated on ice in the dark for 1 h. Following a 
further 2 washes, 30 ul of propidium iodide was added to each
tube for 2-5 min to allow identification and gating out of dead 
cells during analysis. After 2 washes in sEBSS, the cells were 
fixed in 400 ul of 1% paraformaldehyde in sEBSS and stored at 
4°C in the dark until ready to be read on a FACSAN Flowcytometer 
[BD]. Cytometric analysis was kindly performed by D. Deane, 
MRI, using Lysis 1 software [BD].
2.9 Statistical Analysis
All analysis was done using the "Minitab" statistical 
computer-programme package [Minitab, State College, Pa, USA], 
Significance testing between grouped data was done using the 
two-sample Student's t-test, unless otherwise stated.
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Chapter 3
The Immune Response in Mice following Oral 
Vaccination with S25/laroA
3.1 Introduction
The aim of this project was to test the safety and efficacy of an 
aromatic-dependent mutant of S.tvphimurium in sheep. However before 
doing this, it was necessary to test out the vaccine strain in 
inbred rodents. Murine infection with the natural mouse pathogen 
S.tvphimurium is the most widely accepted model for studying 
immunity to typhoid fever and has been used to test both the 
relative efficacy of live attenuated and killed Salmonella 
vaccines.
In this chapter, I investigated the ability of a live aroA
vaccine strain, constructed from an ovine isolate of S.tvphimurium 
[S25\l], to confer immunity from salmonellosis in BALB\C mice. 
The relative virulence and invasiveness of the aroA strain was 
determined by comparison with the wildtype strain. The persistence 
of the vaccine strain in the tissues was determined following 
inoculation of high and low doses, and was correlated with both 
the vaccine-specific primary humoral and cell-mediated immune 
responses engendered, and to the levels of protection observed 
following wildtype challenge.
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3.2 Results
3.2.1 Virulence of the Wildtype and aroA Strains of S25/1 for Mice
Forty mice were randomly allocated into 4 groups of 10 mice. Group
A was inoculated orally with 2 x 10^ CFU of the wildtype S25\l
strain, while Group B received an identical dose of the S25/laroA
2
strain. Groups C and D received oral doses of 2 x 10 CFU of the 
wildtype and S25/1 aroA strains respectively. The mortality rate 
of each of the 4 groups is recorded in Table 3.1. Mice infected 
with the higher dose of the wildtype strain became ill after 3-5 
days, developing a scruffy appearance, diarhoea, and loss of 
appetite, and all died within 8  days. 5 mice receiving the lower 
dose of the wildtype strain died within 8  days of challenge. Thus 
as few as 200 wildtype S25/1 organisms are capable of establishing 
a lethal infection in mice. However, none of the mice receiving 
either the high or low doses of the S25/laroA strain died or
developed any clinical symptoms. These results confirm the results 
of preliminary studies with the wildtype and aroA strains of S25/1 
which showed a difference of 7 log values between the Lethal Dose 
50s [LD^qS] of the 2 strains [J.J. Oliver, unpublished 
observations].
3.2.2 Comparison of the Invasive Capacities of the Wildtype and
aroA Strains of S25M in Mice
I next assessed the invasive capacities of the aroA and wildtype 
strains. 50 mice were allocated into 2 groups of which one was
inoculated orally with 5 x 10^ CFU of the wildtype strain and the
other with an identical dose of the aroA strain. 5 mice from each
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TABLE 3.1
Mortalities following Oral Inoculation with the 
ffildtvoe and aroA Strains of S25/1
DAYS POST-CHALLENGE
1 2 3 4 5 6 7 8
GROUP A 0 0 0 2 1 1 3 3
GROUP B 0 0 0 0 0 0 0 0
GROUP C 0 0 0 0 0 1 3 1
GROUP D 0 0 0 0 0 0 0 0
GROUP A received 10^  CFU wildtype S25/1
GROUP B received 10^ CFU S25/laroA
GROUP C received 10^ CFU wildtype S25/1
GROUP D received 10 CFU S25/laroA
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group were culled on each of days 2, 3, 4, 6  and 8
post-infection. The organs were removed and the no. of CFU\g was 
calculated. The results are displayed in Figure 3.1. As before, all 
mice given virulent organisms became ill after day 4. In parallel, 
there was progressive splenic enlargement and by day 8 , the livers 
and spleens became yellow in appearance and developed large 
necrotic lesions. Congealed blood could be seen throughout the 
length of the gut which was blackened as a result of necrosis 
and/or ischaemia.
By day 2, the spleens, Peyer's patches and livers were already 
harbouring large numbers of the organism and high numbers were 
being excreted in the faeces. The levels in the tissues and faeces 
continued to rise until the experiment was terminated on day 8 , 
consistent with the development of severe enteritis and systemic 
typhoid.
In contrast, the mice given the aroA strain showed no clinical 
symtoms at any time and the spleens and guts looked normal. In 
parallel, only small numbers of the organism could be recovered 
from any tissues, and although substantial levels were detectable 
in the faeces 24-48 h post-infection, the levels fell rapidly 
thereafter. Thus the S25/laroA strain has a much reduced capacity 
to invade and colonise murine tissues.
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Figure 3.1 Comparison of the Invasive Capacities of the Wildtype
and aroA Strains of S25/1 in Mice After Oral Infection
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Mice were inoculated orally with 5 x 10 CFU of either the wildtype 
or the aroA strain. 5 mice from each group were culled on the 
stated days post-infection and the mean no. CFU/g for each group 
determined on each time-point for faeces, liver, spleen and 
Payer's patches. Levels are expressed as log^^ CFU/g.
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3.2.3 Persistence of S25/laroA in the Organs of Mice After 
Oral Inoculation with High and Low Doses
Having demonstrated the reduced invasive capacity of the aroA
strain compared with wildtype, it was sought to determine the
length of time that the aroA strain could persist in the murine
tissues following oral inoculation of both high and low doses. Mice
7 2
were infected orally with either 5 x 10 CFU or 5 x 10 CFU of
S25/laroA and 5 mice from each group culled at regular intervals
until day 42 for the low dose and day 90 for the high dose. Organs
were removed and the no. CFU\g of tissue determined. In the mice
given the lower dose, the organism was absent from the liver,
spleen and Peyer's patches of all the mice at all of the times
tested. Low levels [10-100 CFU /g] were detected in the faeces of
2
5/65 mice tested. It would appear that a dose of 5 x 10 CFU of 
the S25/laroA strain was insufficient to effect invasion of the 
Peyer's patches and subsequent colonisation of the internal organs.
The levels recovered from mice given 5 x 10^ CFU S25/laroA are 
shown in Figure 3.2. The number of organisms recovered from faeces 
was maximum 6-9 days post-infection. The levels were high in all 
of the mice at this time. From day 12 there was a considerable drop 
in the levels, which were often vastly different in individual 
mice. High numbers could still be isolated from some mice on 
termination of the experiment, 90 days post-infection.
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Figure 3.2 Persistence of S25/laroA in the Faeces and Tissues of 
Mice After Oral Infection
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Mice were inoculated orally with 5 x 10 CFU of the S25/laroA 
strain. 5 mice were culled on the stated days post-infection and 
the mean no, CFU/g determined on each time-point for faeces, liver, 
spleen and Peyer's patches. Levels are expressed as log^^ CFU/g.
80
The levels of S25\laroA in the livers of the mice was variable. 
Levels were detected on day 6  and rose steadily, peaking on day 18 
after which time there was a gradual decrease in numbers. However, 
the organism could still be recovered from some mice on day 78 
post-infection. The levels of bacteria recovered from the spleens 
were very similar to those found in the liver. Levels could be
detected 6  days post-infection, peaking on day 9 after which there 
was a gradual decrease. Again, bacteria could still be recovered 
from some mice up to 6 6  days post-infection. On days 78, 84 and
90, all the spleens tested were free from bacteria. The organism
was recovered from the Peyer's patches on day 6 . The highest 
levels were seen on day 9, after which the levels dropped, 
although substantial numbers were seen until day 42. By day 60, 
the organism could no longer be Isolated.
This unusual persistence of the organism in the faeces could be a
result of the mice continually re-infecting themselves by 
coprophagy, rather than as a consequence of the initial infection. 
To test this, in a separate experiment, 6  mice were inoculated 
orally with 7 X 10^ CFU S25/laroA. The mice were housed 
individually in cages in which the bottoms had been removed and 
replaced with stainless steel grills. The grills allowed the 
faeces to fall through the bottom, where it was collected onto 
plastic trays and examined for the presence of S25/laroA over a 
period of 70 days. The no. CFU\g of faeces was calculated on a
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TABLE 3.2
Recovery of Salmonellae from the Faeces of Mice Infected Orally 
with 10  ^ CFU of S25/laroA and Housed Separately in Grill-Bottomed 
Cages
No. CFU/g of Faeces
DAYS POST-INFECTION
MOUSE 3 7 15 24 34 41 48 70
1 NT 1 x1 0 ^ 2 x1 0 ^ 4x10^ 4x10^ 3x10^ 2 0 0 300
2 1 x1 0 ^ 1 x1 0 ^ 6 x1 0 ^ 1 x1 0 ^ 8 x1 0 ^ 5x10^ 4x10^ 1 x1 0 ^
3 NT 1 x1 0 ^ 8 x1 0 ^ 2 x1 0 ^ 2 x1 0 ^ NT 3x10^ 900
4 2 x1 0 ^ 5x10^ 4x10^ NT NT NT 4x10^ 2 x1 0 ^
5 1 x1 0 ^ 7x10^ 4x10^ 2 x1 0 ^ NT NT 2 x1 0 ^ 0
6 NT 1 x1 0 ^ 7x10^ 0 6 x1 0 ^ 0 4x10^ 2 0 0
NT= Not Tested
0 = Not detected following direct plating onto XLD medium.
6  mice, housed in grill-bottomed cages, received 7 x 10 CFU of 
S25/laroA and the no. CFU/g of faeces determined at times 
post-infection.
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number of time-points for each mouse. It was found that the 
organism could still be recovered from the faeces of all mice 
48 days post-infection, and from 5 of the mice on day 70 [Table 
3.2] .
3.2.4 Primary Immune Responses in Mice After Oral Inoculation 
with High and Low Doses of S25/laroA
I next examined the correlation between the levels of colonisation 
by the aroA vaccine strain described above, with the generation of 
specific primary immune responses. The levels of specific serum 
and mucosal antibody, as well as the specific T cell
responsiveness, were examined in the mice receiving either 5 x 10^ 
CFU or 5 X 10^ CFU of the S25/laroA.
3.2.4.1 Specific Antibody Responses in Mice Infected with 5 x 10  ^
CFU S25/laroA
ELISAs were developed to detect serum IgM, IgG and IgA antibodies 
and mucosal sIgA antibodies against S25/laroA LPS. The changes in 
the levels of IgM and IgG with time post-infection are shown in 
Figure 3.3. Serum IgA levels are shown in Figure 3.5, together 
with the sIgA levels.
Serum IgM
In most animals, serum IgM antibodies began to appear 18-21 days 
post-infection, although levels were detected as early as day 15 in
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Figure 3.3 Salmonella-Specifle Serum Antibody Responses in Mice
Inoculated Orally with 10  ^ CFU of S25/1 aroA
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Mice were orally Inoculated with 5 x 10 GPU of the S25/laroA 
strain and the sera tested in an ELISA for both Salmonella-specific 
IgM and IgG at times post-infection. Each point represents the mean
O D . o f  5 mice at a 1:200 serum dilution. 405nm Mean O D . v a l u e s  405nm
are expressed as a percentage where 1 0 0 % represents *^ 4^ Q5 nm ^ ^
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some mice. Serum IgM rose to very high levels by days 21-28 in all 
mice, remaining high until day 37 when levels declined 
considerably. However, some IgM could still be detected in all the 
mice tested on day 90.
Serum IgG
Levels of IgG generally appeared slightly later [1-5 days] than 
those of IgM in the same mice. From day 21, the levels continued to 
rise steadily in all mice, reaching a plateau from day 28-35. 
There was very little variation in the levels of IgG produced by 
the mice with all mice producing high levels. At the end of the 
experiment, 6  mice were retained to determine how long the titres 
of serum IgG remained at this high level plateau. At 250 days 
post-infection, it was found that 3\6 of the mice retained these 
high IgG levels, 2\6 of the mice had reduced levels [*^ 4^05nm 
1.3-1.4] and 1 mouse had no detectable IgG at this time.
Serum IgA
Serum IgA levels appeared slightly later than IgG levels and 
continued to rise steadily in all mice until day 36, after which 
time there was a gradual decrease in the levels, with only low 
levels present on termination of the experiment on day 90.
Mucosal leA
Gut lavages were taken from both unchallenged mice and from mice 
vaccinated 28 days previously. The levels of total and sIgA in the 
gut are shown in Figure 3.4, The lavage samples of both vaccinated
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Figure 3.4 Comparison of the Levels of Salmonella-Specific and
Total sIgA in the Intestines of aroA Vaccinated and
Unvaccinated Mice
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The levels of total and Salmonella-specific intestinal IgA were 
examined in [A] unvaccinated mice, and [B] mice that had been 
vaccinated previously with 5 x 10^ CFU S25/laroA. Each graph shows 
the mean OD of doubling dilutions of lavage samples from 5 mice, 
OD values are expressed as a percentage where 100% represents
°^405nm
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Figure 3.5 Salmonella-Specific Intestinal and Serum IgA in Mice
Inoculated Orally with 10  ^ CFU of S25/laroA
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Mice were Inoculated orally with 5 x 10^ CFU of the S25/laroA 
strain and the sera and gut washes tested in an ELISA for 
Salmonella-specific IgA at times post-infection. Each point 
represents the mean ^^4 9 5 ^  of 5 mice at a 1:200 serum dilution or 
1:4 lavage dilution.
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TABLE 3.3
Confirmation of the Specificity of Anti-Salmonella 
IgM Antibodies Detected bv ELISA
Post-Vaccination Serum
coating antigen S25/laroA LPS E.coli LPS
°^405nm 1 . 2 1 1.25 1.30 1 . 2 0 0.18 0.18 0.17 0.18
Normal Mouse Serum [NMS]
coating antigen S25/laroA LPS E.coli LPS
^^405nm 0 . 2 0 0.19 0.18 0 . 2 0 0 . 2 0 0.19 0.16 0.19
Sera from 4 uninfected mice [NMS] and 4 mice infected orally with 
5 X 10^ CFU S25/laroA 30 days previously [post-vaccination serum] 
were diluted 1 : 1 0 0  and tested for specificity against both 
Salmonella and E.coli LPS in an ELISA.
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and unvaccinated mice contained high levels of non-specific sIgA as 
expected. However only the vaccinated mice contained
Salmonella-specific sIgA. The time course of the sIgA response
showed that the levels of specific sIgA were low until 3 weeks post 
infection when they started to rise rapidly [Figure 3.5]. At day 
34, the levels reached a plateau, falling around 48 days 
post-infection. Interestingly the kinetics of the sIgA response
mirrored that of the serum IgA with sIgA levels appearing slightly 
earlier. Intestinal sIgA and serum IgA levels also correlated well 
in individual animals. Both sIgA and serum IgA could still be
detected on day 90, albeit at low levels, suggesting that the
S25/laroA vaccine strain was still stimulating the gut mucosa at 
this late stage.
The specificity of the antibody responses to the immunising 
organism was determined by testing sera from 4 unvaccinated an 4 
vaccinated mice [removed on day 28] on plates coated with either 
Salmonella LPS or E.coli LPS [Sigma]. The responses are shown in 
Table 3.3. None of the sera from infected mice had IgM antibodies 
against the LPS derived from E.coli [CDs were similar to those
obtained with NMS] confirming the specificities of the response to 
the immunising organism. Identical results were obtained for IgG 
and IgA [results not shown].
3.2.4.2 Salmonella-Specific DTK Responses in Mice following Oral 
Inoculation with 5 x 10  ^CFU S25/laroA
The specific DTK responses of the mice to S.typhimurium were
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Figure 3.6 Salmonella-Specific DTH Responses in Mice Inoculated
Orally with 10  ^ CFU of S25/laroA
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Mice were inoculated orally with 5 x 10 CFU of the S25/laroA 
strain and the Salmonella-specific increases in footpad thickness 
determined at the stated times post-infection. Each point 
represents the mean increase in nun of 5 mice. 3 unvaccinated mice
produced increases of 0 , 0.04 and 0.01mm, highlighting the
specificity of the test.
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measured as an indication of the T cell responsiveness of the mice 
to the vaccine strain. The increases in thickness of the hind 
footpads of the vaccinated mice following injection of heat-killed 
S25/laroA are shown in Figure 3.6, Large specific increases in 
skin thickness were detected as early as 9 days after infection and 
remained constant until 6 weeks post-vaccination, and then 
increased until the termination of the experiment on day 90. All 6 
mice maintained after this time still had large responses on day 
191 [mean 0.52mm+/-0.07mm].
3.2.4.3 Evaluation of the Specific Cellular Responses in Mice 
After Oral Inoculation with 5 x 10  ^CFU of S25/laroA 
Using the LTT
Further studies were undertaken to characterise the T cell 
responses elicited by the vaccine strain. Mice inoculated orally 
with 5 X 10^ CFU of the S25/laroA strain were culled on day 30
post-vaccination, and the spleen 
cells removed and cultured for 5 days in vitro with heat-killed 
S25/laroA in an LTT. The proliferative responses of vaccinated and 
unvaccinated mice are shown in Tables 3.4A and 3.4B respectively. 
All vaccinated mice produced high proliferative responses to 
specific antigen that were significantly higher [p<0.05] than those 
of the unvaccinated mice. However, 4 unvaccinated mice had 
proliferative responses similar to those found in a number of the 
vaccinated mice. One possible explanation for these results could 
be that the conventional uninfected mice used in these experiments 
had intestinal flora which cross-reacted with S.typhimurium.
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TABLE 3.4A
Proliferative Responses of Spleen Cells from S25/laroA-Vaccinated
Mice following Stimulation with Salmonella Antigen in an LTT
MOUSE NO. 1 2 3 4 5 6
MAX. CPM 56,773 51,178 64,438 25,471 53,920 23,472
MAX. SI 269 913 209 454 804 326
MOUSE NO. 7 8 9 1 0 1 1 1 2
MAX. CPM 27,684 29,400 43,936 33.900 31,188 33,031
MAX. SI 124 544 708 305 234 206
12 mice were inoculated orally with 5 x 10^ CFU of S25/laroA and 
30 days later, spleen cells were cultured with Salmonella antigen 
in an LTT and the proliferative responses recorded.
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TABLE 3.4B
Proliferative Responses of Spleen Cells from Unvaccinated Mice
following Stimulation with Salmonella Antigen in an LTT
MOUSE NO. 1 2 3 4 5 6
MAX. CPM 2,751 658 22,140 32,662 3,340 25,026
MAX. SI 41 6 2 2 0 355 2 0 116
MOUSE NO. 7 8
MAX. CPM 18,107 5,368
MAX. SI 177 41
Spleen cells from 8  unvaccinated mice were cultured with Salmonella 
antigen in an LTT and the proliferative responses recorded.
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This hypothesis was tested by assaying the responses of spleen 
cells from unvaccinated germ-free mice. The results are shown in 
Table 3.5. The responses were not significantly different from 
those of the unvaccinated conventional mice. Again, 3 of the mice 
produced responses equal to those obtained with vaccinated mice 
[see Table 3.3] while the other 3 produced the expected lower 
levels. Thus, reduction of the intestinal flora of normal mice 
had no effect on their ability to respond to stimulation with the 
Salmonella antigen.
An alternative explanation for the high proliferative responses in 
unvaccinated mice was that the high levels of LPS in the antigen 
preparation caused polyclonal stimulation of the B cells in certain 
spleen cell cultures. To investigate this possibility, spleen 
cells from 5 uninfected mice were pooled and passed over nylon wool 
to separate the individual lymphocyte populations. As shown in 
Table 3.6, intact spleen cells responded to both ConA and LPS, 
while the enriched B cell population responded well to LPS and 
poorly to ConA and the reverse was true for the enriched T cell 
population. The intact spleen cells also responded strongly to 
stimulation with the S25/laroA preparation as did the purified B 
cell population. However, the enriched T cell population also 
responded to the antigen, although this was significantly less 
[p<0.01] than the responses of intact spleen cells. Thus the 
antigen preparation appeared to stimulate both B and T cells in the 
spleen cell population from uninfected mice.
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TABLE 3.5
Proliferative Responses of Spleen Cells from Unvaccinated Mice
Placed in an Isolator following Weaning
MOUSE NUMBER
1 2 3 4 5 6
MAX. CPM 3,984 5,936 39,358 10,290 31,162 12,097
MAX. SI 92 1 2 1 634 228 426 104
Spleen cells were cultured with Salmonella antigen in an LTT and 
the proliferative responses recorded.
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TABLE 3.6
Proliferative Responses of Enriched Lymphocyte Populations 
from Unvaccinated Mice following Stimulation with Salmonella
Antigen in an LTT
MAX. CPM
Unseparated B Cells T Cells
ConA 42,243 +/- 2,231 7,261 V -  897 76,735 +/- 1354
LPS 32,126 +/“ 2,326 48,693 +/- 1745 4,221 V -  532
S25/1 aroA 38,563 +/- 1,874 31,035 +/“ 2,564 21,392 +/- 2,132
Whole spleen cells, as well as both nylon-wool-enriched B and T
cell populations from uninfected mice were cultured with ConA,
LPS and Salmonella antigen in an LTT, and the proliferative 
responses recorded. Each value represents the mean of 3 mean 
triplicate CPM values +/- 1 standard error.
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The results of LTTs were inconclusive in illustrating
Salmonella-specific T cell responsiveness in vitro in vaccinated 
animals and contrasted with the specific DTH responses in vivo. To 
study the presence of Salmonella-specific T cells further, I 
examined for the presence of IFN-g and IL-2 in supernatants of 
spleen cells stimulated with ConA or antigen,
3.2.4.4 IFN-g
Lymphocyte supernatants were tested for the presence of IFN by 
examining their ability to confer an antiviral state on a murine 
fibroblast cell line, L929. Tables 3.7A and 3.7B show the IFN-g 
titres of supernatants from 1 2  vaccinated and 1 2  unvaccinated mice 
respectively. The vaccinated mice were the same mice shown in
Table 3.4A, culled 30 days post-vaccination. Of the unvaccinated 
mice, mice 1-6 are the same as mice 1-6 in Table 3.4B and mice 7-12 
are those mice shown in Table 3.5. Supernatants of unstimulated 
cells from each mouse were used as negative controls. Unstimulated 
cells from either vaccinated or unvaccinated mice did not produce 
IFN of any kind, at any time, while ConA-stimulated cells from 
both groups all produced low amounts of IFN-g. Cells from all 12 
vaccinated mice produced high levels of IFN-g following stimulation 
with all 4 antigen dilutions, while only one of the 6  conventional 
unvaccinated mice [mice 1-6] produced IFN-g, at very low levels and 
only at the higher antigen dilutions. Interestingly, 3 of these 
mice had also responded in the LTT. Of the 6  unvaccinated mice
that were placed in an isolator [mice 6 -1 2 ], again only 1  of 6
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TABLE 3.7A
Production of IFN-g bv Spleen Cells from S25/laroA-Vacclnated Mice 
following Stimulation with Salmonella Antigen
IFN-g TITRES
MOUSE NUMBER
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2
Unstimulated 0 0 0 0 0 0 0 0 0 0 0 0
ConA 4 4 2 < 2 4 4 2 2 4 2 2 < 2
S25/laroA [60ug] > 8 > 8 > 8 > 8 > 8 2 0 2-4 4 >4 >4 4
S25/laroA [24ug] 4-8 2 4 2 2 4 0 > 8 > 8 >4 >4 >4
S25/laroA [1 2 ug] 8 8 > 8 2 2 8 4 8 2 >4 >4 >4
S25/laroA [6 ug] 4 4 4 < 2 2 4 2-4 4 2 >4 >4 >4
Spleen cells from 12 mice, vaccinated 30 days previously with 
7
5 X 10 CFU S25/laroA. were cultured without antigen, with ConA 
and with decreasing dilutions of Salmonella antigen for 4 days when 
the titres of IFN-g in the supernatants were determined.
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TABLE 3.7B
Production of IFN-g bv Spleen Cells from Unvaccinated Mice 
following Stimulation with Salmonella Antigen
IFN-g TITRES
MOUSE NUMBER
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2
Unstimulated 0 0 0 0 0 0 0 0 0 0 0 0
ConA 2 4 8 2 4 4 2 4 < 2 < 2 2 2
S25/laroA [60ug] 0 0 < 2 0 0 0 0 0 < 2 0 0 0
S25/laroA [24ug] 0 0 < 2 0 0 0 0 0 < 2 0 0 0
S25/laroA [1 2 ug] 0 0 < 2 0 0 0 0 0 < 2 0 0 0
S25/laroA [6 ug] 0 0 0 0 0 0 0 0 < 2 0 0 0
Spleen cells from 12 unvaccinated mice were cultured without 
antigen, with ConA and with decreasing dilutions of Salmonella 
antigen for 4 days when the titres of IFN-g in the cell 
supernatants were determined.
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mice produced IFN-g, although 3 responded strongly in an LTT. Thus
the production of IFN-g did not correlate well with the
proliferative responses of lymphocytes from unvaccinated mice and
appears to be a better indication of specific T cell responsiveness
after infection. In later experiments [results not shown], it was
7shown that mice examined 80 days post-vaccination with 5 x 10 
S25/laroA produced similar levels of IFN-g to those described above 
on day 30, highlighting the specific T cell responsiveness in these 
animals at such a late stage. These findings are thus consistent
with the strong DTH responses in vaccinated mice at both times.
3.2.4.5 IL-2
I also attempted to detect IL-2 in the same supernatants from the 
cultures described above, using a CTLL bioassay. However this 
proved unsuccessful as the cell line did not grow well in culture 
and I was unable to obtain reproducible results.
2
3.2.4. 6  Specific Immune Responses in Mice Infected with 5 x 10 
CFU of S25/laroA
2
In the mice which received 5 x 10 CFU S25/laroA. no
Salmonella-specific antibody of any isotype could be detected in 
either the serum or the intestine. However, small DTH responses 
were seen in most mice 6  days post-infection [Fig 3.7], suggesting 
a low level of T cell responsiveness in these animals.
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Figure 3.7 Salmonella-Specific DTH Responses in Mice Inoculated
Orally with 10  ^CFU of S25/laroA
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Mice were inoculated orally with 5 x 10 CFU of the S25/laroA
strain and the Salmonella-specific increases in footpad thickness
determined at the stated times post-infection. Each point
represents the mean increase in ram of 5 mice.
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TABLE 3.8
Proliferative Responses and IFN-g Production to Salmonella Antigen 
by Spleen Cells from Mice Infected Orally with 5 x 10  ^CFU of S25/1 
aroA
MOUSE NUMBER
Max. CPM 23,220 14,440 28,386 21,550 1 0 , 2 2 0 8,138
Max. SI 124 78 145 105 63 87
IFN-g TITRE 0 0 2 < 2 0 0
Mice were inoculated with 5 x 10 CFU S25/laroA and 35 days later, 
spleen cells were cultured with Salmonella antigen in an LTT, and 
the proliferative responses examined. The IFN-g titres of the cell 
supernatants were also determined.
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Spleen cells were removed from 6  of these mice on day 35 and 
examined for proliferative responses and IFN-g produced after 
stimulation with Salmonella antigen in an LTT [Table 3.8], The 
proliferative responses were significantly less [p<0 .0 1 ] than those 
of mice given 5 x 10^ CFU of S25/laroA [Table 3.4A] and not 
significantly different from the responses of unvaccinated mice 
[Table 3.4B], Furthermore, only 2 mice produced IFN-g and at very 
low levels.
3.2.5 Oral Immunisation with S25/laroA Protects Mice from 
Subsequent Challenge with a Lethal Dose of tfildtvne S25M
The results described above show that 5 x 10^ CFU of the vaccine
strain was capable of establishing a limited infection in mice and
2
induced specific primary immune responses, whereas 5 x 10 CFU did 
not colonise mice and induced little or no specific immunity. I 
next examined whether the levels of specific immune responsiveness 
generated by the 2  doses correlated with the ability to confer 
protection from a lethal challenge dose of the wildtype strain. 4
7
groups of mice were challenged with 5 x 10 CFU of the wildtype
S25/1. Groups 1 and 2 [10 mice each] had been vaccinated 40 days
7 2
previously with 2 x 10 CFU and 2 x 10 CFU respectively of S25/1
aroA. Group 3 [5 mice] had been challenged 40 days previously with
2
a sublethal dose [2 x 10 CFU] of wildtype S25/1, and Group 4 
comprised an unvaccinated control group. The mortality rates are 
shown in Table 3.9. All the mice which had been infected first 
with 2 X 10^ CFU S25/laroA [Group 1] were protected from virulent 
challenge and showed no clinical signs of infection. However like
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TABLE 3.9
Ability of Primary Oral Infection with the Wildtype or aroA 
Strains of S25/1 to Protect Against Lethal S .typhimurlum Challenge
DAYS POST-INFECTION
1 2 3 4 5 6 7 8
GROUP B 0 0 0 0 0 0 0 0
GROUP C 0 0 0 0 0 2 3 0
GROUP D 0 0 0 2 1 3 2 2
GROUP E 0 0 0 0 4 2 2 2
Primary Immunisation: 
7GROUP B 
GROUP C 
GROUP D
10 CFU S25/laroA 
10^ CFU wildtype 525/1 
10^ CFU 525/laroA
GROUP E : unvaccinated control
Mice were vaccinated with the stated doses, and 40 days later were 
challenged with 5 x 10^ CFU wildtype 525/1 and the lethalities 
recorded.
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the unvaccinated mice, all the mice which had received a primary
2infection of 2 x 10 CFU of either the aroA or wildtype strains 
developed severe clinical signs and succumbed to infection between 
days 4 and 8  post-infection. Clearly, the higher dose of the 
vaccine strain was required to evoke protection of the mice from 
virulent challenge. However it is important to note that sublethal 
doses of the virulent strain were also incapable of evoking 
protective immunity to a lethal challenge dose.
3.3 Discussion
The initial studies described in this chapter sought to
characterise the infection in mice following administration of the
virulent wildtype S25\l strain. The minimum following oral
2
challenge of BALB\c mice was estimated to be 10 CFU. This is in 
accordance with the findings of Hormaeche [1979a] who found that 
BALB\c mice were the most susceptible of all the mouse strains 
assessed by i.v. challenge. The similarity in the intravenous and 
oral LD^^s of virulent 5.tynhimurium highlights the ability of the 
strain to multiply in the gut lumen and to invade the enterocytes.
My comparative studies with the S25/laroA vaccine strain showed at
least a 7 log doses difference in the minimum oral for the
aroA and wildtype strains in BALB\c mice. This is consistent with
11previous work showing that mice can tolerate doses of up to 1 0
CFU of an aroA strain [Maskell et al.. 1987]. Despite its lack of
virulence, the S25/laroA strain colonised the RES, with 
significant numbers of bacteria being recovered from the livers and
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spleens. Although the in vivo growth rate was much slower and 
overall levels much lower than the virulent parent strain, the 
vaccine strain could still be isolated from the livers and spleens 
80 days post-infection and from the Peyer's patches after 60 days. 
Similar findings have been reported by Dougan et al. [1986] and
Maskell et al. [1986], although they could not recover the strain
consistently beyond 6  weeks post-infection. Others have failed to 
show such longterm persistence of aroA S.tvphimurium in the tissues 
following oral vaccination, with the organism being totally 
cleared as early as day 14 in some systems [Hayes et al., 1991].
However these workers used C3H/He/01a mice which are less 
susceptible to Salmonella [Hormaeche, 1979a].
All mice vaccinated orally with 10^ CFU of S25/laroA produced 
Salmonella LPS-specific antibody in the serum and the intestine and 
levels of serum IgG were still detected 250 days after challenge. 
Levels of intestinal IgA peaked on day 42 but were still detectable 
on day 90. Hohmann et al. [1979] decribed similar kinetics of
the sIgA response after oral inoculation with Salmonella. However, 
Hayes et al. [1991], failed to detect specific sIgA [and serum
IgA] following vaccination with an aroA mutant of S.tvphimurium 
which they attributed to low level intestinal persistence of the 
vaccine strain in C3H/He/0la mice. The sustained sIgA response to 
S25/1 aroA was expected, as the Peyer's patches and faeces of the 
mice harboured the vaccine strain for 6 6  and 90 days respectively. 
The persistence of the organism in the faeces was a result of 
primary challenge and not coprophagy by the mice.
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An interesting finding from the studies of sIgA production was the 
similarity in the antibody profiles for serum amd intestinal IgA, 
suggesting that mucosal sIgA produced in response to local 
stimulation with the oral vaccine may have leaked to the
circulation or that there was simultaneous priming of the local and 
systemic immune systems by the vaccine strain. However, the levels 
of serum IgA declined rapidly [with the sIgA levels] unlike the 
serum IgG levels which remained high, suggesting that there was
limited systemic priming of IgA-producing B cells.
Such an association of serum and gut IgA has not been reported in 
humans following oral vaccination with Ty21a [Labrooy et al.,
1980; Bartholemeuz et al.. 1990]. They found no correlation between 
the peak levels of anti-typhoid IgA in intestinal fluid and the 
anti-typhoid serum polymeric IgA antibody or total anti-typhoid 
serum antibody. The inability of Hayes et al. [1991] to detect
either gut or serum IgA in the presence of specific IgG, coupled 
with the results with S25/laroA. suggests that there can be 
systemic priming of IgG-producing B cells without a serum IgA 
response and that serum IgA may only be detectable in the presence 
of an intestinal IgA response.
As well as producing strong humoral responses, mice vaccinated
7with 10 CFU of S25/laroA produced specific DTH responses in vivo 
which remained strong 6  months after vaccination. However it is 
controversial whether systemic DTH correlates with protective
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immunity, as although early reports demonstrated a close 
relationship between the DTH response in mice and resistance to 
Listeria and Mycobacteria [MacKaness, 1967; Collins and
MacKaness, 1968], later reports contradict these findings by 
showing that both resistant and susceptible strains of mice showed 
positive DTH response to S.tvphimurium and that immune BALB/c mice 
did not produce a specific DTH response [Hormaeche, 1979a],
Due to the controversy surrounding DTH and protective immunity, I 
also performed LTTs using spleen cells from mice infected orally 
with S25/laroA. These mice had strong proliferative responses to 
Salmonella antigen up to 70 days post-vaccination. However 
unvaccinated mice also responded to the antigen due to LPS 
contamination in the preparation. Non-specific responses of this 
kind were not found using peritoneal exudate T cells from 
aroA-vaccinated immune C3H/HeJ mice whose B cells cannot respond 
LPS [Killar and Eisenstein, 1985]. I therefore separated T and B 
cells to try and characterise the proliferative response in 
unvaccinated mice. Both B and T cell-enriched populations 
responded to the Salmonella antigen suggesting that the 
proliferative responses were a consequence of both LPS stimulation 
of B cells and non-specific T cell proliferation, perhaps as a 
result of cross-reactive antigens. However there is the possibility 
that low levels of B cells were present in the purified T cell 
population although this contamination would have to have been 
great to account for the high proliferative responses obtained.
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In addition, I examined for the production of the cytokines IFN-g 
and IL-2, Only cells from vaccinated mice produced IFN-g, 
suggesting that there was indeed a specific T cell response in 
vaccinated mice. Production of IL-2 by the same cells was not 
determined as the assay proved unreliable. If this production of 
IFN-g by specific T cells also takes place in vivo. it may be an 
important factor in establishing protection against virulent 
S.tynhimurium challenge as it has shown that recombinant IFN-g is 
able to activate macrophages for increased anti -Salmonella activity 
[Kagaya et al. 1989] and administration of anti-IFN-g to mice
greatly enhances the virulence of S.tvphimurium [Muotiala and 
Makela, 1990].
My studies also demonstrated the ability of S25/laroA to protect
against virulent oral challenge with a high lethal dose of the
wildtype strain. Mice vaccinated orally with 10^ CFU of S25/laroA
were protected from 10^ CFU of the wildtype strain. In contrast,
2
the mice receiving either 10 CFU of aroA or wildtype S25\l, which 
were not colonised, succumbed to a lethal virulent challenge dose. 
Thus, colonisation of the internal organs by the S25/laroA strain 
appears to be a prerequisite for the development of protective 
immunity by the vaccine strain. Although it is impossible to 
conclude from my results the nature of the protective mechanisms, 
the strong vaccine-specific humoral and cell-mediated immune 
responses in vaccinated mice would suggest that both antibody and T 
cells are required for optimal levels of protection.
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Chapter 4
The Immune Response In Lambs following 
Oral Vaccination with S25/laroA
4.1 Introduction
Following the characterisation of the mucosal and systemic immune 
responses elicited in mice after oral inoculation with the S25/1 
aroA strain, I next assessed the behaviour of the same strain in 
sheep, as the vaccine potential of the S25/laroA strain was to be 
exploited in this species.
The experiments described in this chapter were designed to compare 
the invasive capacities of the wildtype and aroA strains of S25/1 
in lambs and to determine whether the aroA vaccine strain could 
protect against virulent challenge. In parallel, the persistence of 
the mutant strain in the tissues was determined following 
inoculation of different doses and was correlated with the 
vaccine-specific humoral and cell-mediated immune responses 
produced.
4.2 Results
4.2.1 Estimation of the Lethal Dose of the Wildtype S25\l Strain 
for Lambs
I first determined the lowest dose of the wildtype strain that was 
lethal for lambs to allow studies comparing the invasiveness of the
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wildtype and aroA strains. In addition, I wished to establish a 
dose for wildtype challenge of aroA-vaccinated animals.
3 lambs, numbered 1-3, were infected orally with 7 x 10^^, 6  x 10^^
9
or 8 X 10 CFU of the wildtype strain respectively. The clinical 
symptoms of all 3 lambs after infection were similar, although the 
onset of severe symptoms was dose-dependent. All 3 lambs developed 
elevated temperatures [increases of 1.9°-2.3°C] 24-48 h after
challenge, which remained high until death. Diarrhoea, as 
represented by a severe drop in the %DW of faeces, was seen and 
there was an increase in the %PCV of the blood. Salmonellae could 
also be isolated from the blood from day 3 in lambs 1 and 2. Weight 
loss [7-9% of body weight] and lethargy were observed and there was 
excretion of high numbers of salmonellae in the faeces [1 0 ^-1 0  ^
CFU/g] .
Lambs 1, 2 and 3 were culled in extremis on days 3, 4 and 7
respectively and the no. CFU/g of tissue determined [Table 4.1].
Lambs 1 and 2 contained high levels of the organism in all the 
tissues tested. Lamb 3 harboured the organism in all tissues 
except the bronchial lymph node, but only the levels in the gut 
were comparable to those recovered from the previous 2  animals.
4.2,2 Oral Infection of 5 Lambs with 9 x 10  ^CFU of Wildtype S25\l
Having established that 8  x 10^ CFU of the wildtype S25\l strain 
was capable of causing a lethal infection, another 5 lambs were 
given a similar dose to characterise the infection further. 5 lambs
Ill
TABLE 4.1
Recovery of Wildtype S25/1 from the Organs of 
Lambs After Oral Infection
No. CFU/g of Tissue
LAMB NO. 1 2 3
DOSE OF S25/1 7 X 1 0 CFU 6 X 1 0 CFU 8  X 10^ CFU
CULLED* DAY 3 DAY 4 DAY 7
HEART 1 X 1 0 ^ 4 X 1 0 ^ 500
LUNG 1 X 1 0 ® 1 X 1 0 ^ 4 X 1 0 *^
BRONCHIAL LN 1 X 1 0 ® 2 X 1 0 ^ 0
LIVER 1 X 1 0 ^ 1 X 1 0 ^ 5 X 1 0 ^
HEPATIC LN 9 X 1 0 ^ 5 X 1 0 ^ 4 X 1 0 ^
SPLEEN 4 X 1 0 ® 1 X 1 0 ^ 4 X 1 0 ^
KIDNEY 4 X 1 0 ® 4 X 1 0 ^ 600
MESENTERIC LN 3 X 1 0 ® 1 X 1 0 « 5 X 1 0 ®
ILEUM 9 X 1 0 ^ 1 X 1 0 ^ 2 X 1 0 ^
CAECUM 2 X 1 0 ® 2 X 1 0 « 6 X 1 0 ®
COLON 4 X 1 0 ® 1 X 1 0 « 6 X 1 0 ®
LN = Lymph Node 
0 = Organism not detected, even after enrichment
.11 103 lambs [Np. 1-3] were challenged orally with 7 x 10"'"', 6  x 10
or 8  X 10 CFU of wildtype S25/1 respectively, culled in
extremis on the stated days post-infection*, and the no. CFU/g of 
tissue determined for each lamb.
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9
were infected orally with 9 x 10 CFU of the wildtype S25\l strain 
and culled in the acute phase of infection on days 2, 3, 4, 5
and 7 for lambs numbered 4-8 respectively. Lambs 4-7 developed a 
lethal infection as described above, with elevated temperatures 
24-48 h post-infection, and a gradual decrease in %DW of faeces 
which culminated in persistent diarrhoea in those animals that 
survived beyond 3 days [Figure 4.1]. There was a significant 
increase in the %PCV of the blood of these lambs [p<0.05] rising 
from a mean pre-infection level of 36,6% [range 33.4 to 40.1] to 
44.1% [range 41,2 to 47.3]. Although the organism was not found in 
the blood, high levels [10^-10^ CFU\g] of virulent salmonellae 
could be isolated from the faeces of all these animals. Lamb 8  did 
not appear clinically ill at any time, although elevated 
temperatures [increases of 1.6-2.5°C] were recorded.
Lamb 4, culled 48 h post-infection, contained high levels of the 
organism in all regions of the gut, but the internal organs were 
either free of the organism or harboured very low levels, 
suggesting that the passage of the organism out of the gut required 
at least 48 h. Lambs 5, 6  and 7 harboured high numbers of the
organism in all tissues [Table 4.2]. In lamb 8 , only the hepatic 
lymph node harboured the challenge strain, presumably accounting 
for the absence of severe disease in this animal.
Histopathological studies, kindly performed by Dr John Gilmour, 
MRI, showed that in lambs 4 and 6  , villi were absent, while lambs 
6  and 7 showed evidence of follicle depletion of the Peyer's
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Figure 4.1 Clinical Responses in Lambs Inoculated Orally with
10^ CFU of Wildtype S25/1
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5 lambs [No. 4-8] were Inoculated orally with 9 x 10 CFU of 
wildtype S25/1 and the mean rectal temperature [A] and mean %DW of 
faeces [B] determined on each day post-challenge. *The %DW values 
of Lamb 8  were discarded as they were markedly different from the 
other 4 lambs.
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TABLE 4.2
Recovery of Wlldtvpe S25/1 from the Organs of Lambs After
Q
Oral Infection with 10 CFU
No. CFU/g of Tissue
LAMB NO. 4 5 6 7 8
CULLED* DAY 2 DAY 3 DAY 7 DAY 5 DAY 7
HEART 0 1 X 10^ 2 X 10^ 5 X 10® 0
LUNG 0 5 X 10^ 5 X 10® 1  X 1 0 ® 0
BRONCHIAL LN 0 3 X 10^ 5.5 X 10® 2  X 1 0 ^ 0
LIVER 950 1 X 10^ 406 5 X 10® 0
HEPATIC LN 7 X 10^ 4.5 X 10^ 8 8 0 1  X lo"^
SPLEEN 375 7 X 10^ 5 X lo'^ 3 X 10® 0
KIDNEY 0 2.5 X 10^ 0 93 0
MESENTERIC LN 6  X 10^ 2.5 X 10^ 3 X 10^ 4 X 10® 0
ILEUM 1  X 1 0 ^ 1  X 1 0 ^ 3 X 1 0 ® 3 X 10® +
CAECUM 7.5 X 10^ 2.5 X 10^ 4 X 10^ 2.5 X 10^ NT
COLON 4 X 10^ 2  X 1 0 ® 4 X 10® 6  X 1 0 ® NT
LN = Lymph Node
+ = Organism only detected after enrichment in selenite broth 
0 = Organism not detected, even after enrichment 
NT = Not tested
5 lambs [No. 4-8] were infected orally with 9 x 10 CFU of wildtype 
S25/1, culled in extremis on the stated days* post-infection and 
the no. CFU/g of tissue determined for each lamb.
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patches and necrosis of the overlying epithelium. In lambs 4 and 
5, which were culled earlier, the GALT was normal, suggesting 
that damage to the Peyer's patches is a sign of progressive 
disease. In all 5 lambs, there was extensive liver damage in the
form of hepatocyte necrosis and there were large numbers of
neutrophils in the lymph nodes of lambs 4, 5 and 6 .
9
4.2.3 Oral Infection of Lambs with 10 CFU S25/laroA
To compare the relative virulence of the wildtype and aroA strains,
9
7 lambs were inoculated orally with an identical dose [9 x 10 CFU]
of S25/laroA and culled on days 3, 6 , 9, 15, 20, 25 and 30 for
lambs numbered 9-15 respectively. No increase in rectal
temperature was noted in any of the lambs and the %DW of faeces and
the %PCV of the blood remained constant throught the course of the
experiment. Within 24-48 h post-infection, large numbers of the
4 5organism could be found in the faeces [10 -10 CFU\g], but after 3 
days organisms were rarely isolated from the faeces and were never 
isolated from the blood of any of the animals at any time. On 
necropsy, the organism could be found in the mesenteric lymph node 
of 6  of the 7 lambs [Table 4.3]. However, isolation of the 
organism from the other organs was infrequent, with only 1  or 2  of 
the organs tested from each lamb harbouring only very low levels. 
There was no histological evidence of the gastrointestinal or liver 
damage that was noted in the lambs given the wildtype strain.
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TABLE 4.3
Recovery of S25/laroA from the Organs of Lambs
9
After Oral Infection with 10 CFU
No. CFU\g of Tissue
Lamb No. 9 1 0 1 1 1 2 13 14 15
CULLED* DAY 3 DAY 6 DAY 9 DAY 15 DAY 20 DAY 25 DAY 30
HEART 0 680 0 0 0 0 0
LUNG 0 25 0 0 0 0 0
BRONCHIAL LN 0 0 0 0 0 0 0
LIVER 50 0 0 0 0 13 1 0
HEPATIC LN 0 260 0 0 0 0 0
SPLEEN 0 3 0 0 1 0 + 0
KIDNEY 0 6 0 0 0 + 0
MESENTERIC LN 215 35 25 5 1 0 0 14
ABOMASUM 0 0 0 0 0 0 +
ILEUM + + 0 0 0 0 0
CAECUM + + 0 0 0 0 0
COLON + + + 0 0 15 0
LN = Lymph Node
+ = Organism only detected after enrichment in selenite broth 
0 == Organism not detected, even after enrichment
7 lambs [No. 9-15] were inoculated orally with 9 x 10 CFU of S25/1 
aroA. culled on the stated days* post-infection and the no. CFU/g 
of tissue determined for each lamb.
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4.2.3.1 Humoral Immune Responses in Lambs After Oral Infection
with 10  ^CFU of S25/laroA
The sera from the 3 lambs that were maintained beyond 15 days 
[lambs 13, 14 and 15] were examined for the presence of antibodies
to the vaccine strain. Lambs 14 and 15 produced no specific serum
IgM or IgG antibody, however lamb 13 produced both specific IgM
and IgG antibodies [Figure 4.2]. IgM appeared on day 5, peaked 
between days 8  and 1 1  and gradually decreased thereafter, although 
detectable levels were still seen on termination of the experiment 
on day 35. IgG was first produced between 5 and 9 days 
post-infection, rising until day 15 and was still present on day 
35.
4.2.3.2 Cell-Mediated Immune Responses in Lambs After Oral
9
Infection with 10 CFU of S25/laroA
Initially, I attempted to determine the specific DTH response 
following oral vaccination with S25/laroA. However, large 
non-specific increases in skinfold thickness were recorded in all 
lambs challenged with heat-killed S25/laroA irrespective of whether 
they had been vaccinated, making the results impossible to 
interpret. I therefore attempted to examine the in vitro
responsiveness of the PBMC to Salmonella antigen in an LTT, 23 days 
after infection [Fig 4.3]. However the lymphocytes from all 3 
infected lambs responded poorly and these responses were not
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Figure 4.2 Salmonella-Suecifle Serum Antibody Responses in Lambs
9
following Oral Inoculation with 10 CFU of S25/laroA
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The sera of 3 Iambs [no. 13-15], Inoculated orally with 9 x 10 CFU 
of S25/laroA. were tested in an ELISA at times post-infection. The 
results show the IgM and IgG at a 1:40 dilution of
serum.
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Figure 4.3 Salmonella-Specific Proliferative Responses of PBMC
9
from Lambs Inoculated Orally with 10 CFU of S25/1 
aroA
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PBMC from each of the 3 lambs were cultured with Salmonella antigen
9
in an LTT before, and 23 days after oral infection with 9 x 10 CFU 
S25/laroA and the proliferative responses compared.
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significantly higher than those recorded using PBMC taken from the 
same lambs before infection. Thus, a single oral infection with 
the aroA strain was not effective in eliciting Salmonella-specific 
cell-mediated immune responses.
114.2.4 Oral Infection of Lambs with a Triple Dose of 10 CFU of
S25/laroA
In an effort to obtain greater colonisation of the lambs by the
S25/1 aroA strain and thus perhaps generate greater cellular and
humoral immunity, both the size and number of the infecting dose
were increased. 6  lambs [numbered 16-21] were infected orally on
11
each of days 0, 2 and 4 with 5 x 10 CFU of S25/laroA. None of
the lambs developed severe clinical symptoms. A temperature rise 
was seen [1.5-2.5°C] in 2 of the lambs 24 h after receiving either 
the first [lamb 16] or second [lamb 17] dose, but this returned to 
normal after a further 24 h and was not observed in any of the
additional 15 lambs used in section 4.2.4.1. None of the 6
animals described here developed diarrhoea or showed a visible 
softening of the faeces. In the subsequent experiments, 1 lamb
out of 15 developed diarrhoea with a drop in %DW of faeces [from 
43%-11%]. However, the remaining 14 showed no change in the %DW of 
faeces throughout the course of the experiment. No
haemoconcentration was recorded in any of these groups of lambs.
3 5Within 24-48 h, large numbers of salmonellae [ 10 -10 CFU\g] were 
found in the faeces of all 6  lambs, but after 5-6 days, the 
organism was seldom isolated. The organism was never isolated from
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TABLE 4.4
Recovery of S25/laroA from the Organs of Lambs After Oral
Infection with 3 Doses of 1011 CFU
No. CFU\g of Tissue
Groups DAY 6 [a] DAY 12 [b]
Lamb 16 17 18 19 20 21
HEART 2 180 10 400 457 40
LUNG 0 290 0 50 3 X 10^ 689
BLN 8 60 0 0 55 0
LIVER 26 1 X 10^ 50 111 721 139
HLN 28 12 15 0 801 23
SPLEEN 0 28 7 1 0 283 4
KIDNEY 0 440 6 13 636 700
MLN 180 2 X 10^ 2 X 10^ 3 X 10^ 86 122
ABOMASUM + 40 4 X 10^ 238 615 1 X 10^
ILEUM + + + 0 0 0
CAECUM + + + 0 0 0
COLON + + 0 0 0
BLN = Bronchial Lymph Node 
HLN = Hepatic Lymph Node 
MLN = Mesenteric Lymph Node
+ “ Organism only detected after enrichment in selenite broth 
0 = Organism not detected, even after enrichment
Lambs were inoculated orally with 3 doses of 10 CFU of S25/laroA 
on days 0, 2 and 4. 3 lambs were culled on days 6  [a] and day 12
[b] and the no. CFU/g of tissue determined for each lamb.
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the blood even after culture in selenite broth enrichment media. 3 
lambs were culled on days 6  [lambs 16-18] or 12 [lambs 19-21] 
post-infection and the no. CFU/g of tissue determined. The 
mesenteric lymph nodes of all the lambs contained substantial 
levels of the vaccine strain [Table 4.4] and varying levels of 
colonisation occurred in the the majority of the other tissues 
taken from each lamb at both times. These results indicate the 
relative efficacy of this multiple vaccination strategy. Moreover, 
histological studies revealed that there was no cell damage in the 
GALT or liver and there were no neutrophils present in the lymph 
nodes.
4.2.4.1 Humoral Immune Responses in Lambs After Oral Infection 
with Multiple Doses of 10^^ CFU of S25/laroA
3 separate groups of 5 lambs [numbered 22-26; 27-31 and 32-36 for
Groups 1-3 respectively] were vaccinated with the aroA strain for 
use in the studies examining protection against the wildtype S25/1 
strain described in section 4.2.7.
Lambs were inoculated orally with 5-9 x 10^^ CFU S25/laroA on days 
0, 2, 4 and 24 and the serum examined for the presence of both
vaccine-specific IgM and IgG at times post-infection [Figures 
4.4.1-4.4.3]. All lambs produced detectable levels of IgM. The 
lambs in Group 1 produced considerably higher levels than those in 
either of the other 2 groups. IgM first appeared 5 days 
post-infection, reaching peak levels between days 8  and 1 2  and 
gradually decreasing thereafterwards. However detectable levels
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Figure 4.4.1 Salmonella-Specific Serum Antibody Responses in Lambs
11
Inoculated Orally with 10 CFU of S25/laroA
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11Lambs were inoculated orally with 4 doses of 5-9 x 10 CFU of 
S25/laroA on days 0, 2, 4 and 24 and the sera tested in an ELISA at 
times post-infection. Each point represents the mean ®^492nm ^
sheep [Group 1] at serum dilutions of 1:200 and 1:80 for IgM and 
IgG respectively. Mean OD values are expressed as a percentage
where 100% represents 1.8.
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Figure 4.4.2 Salmonella-Specific Serum Antibody Responses in Lambs
Inoculated Orallv with 10^^ CFU of S25/laroA
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11Lambs were inoculated orally with 4 doses of 5-9 x 10 CFU of 
S25/laroA on days 0, 2, 4 and 24 and the sera tested in an ELISA 
at times post-infection. Each point represents the mean 
5 sheep [Group 2] at serum dilutions of 1:80 and 1:20 for IgM and 
IgG respectively. Mean OD values are expressed as a percentage
where 100% represents 1.8.
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Figure 4.4.3 Salmonella-Specific Serum Antibody Responses in Lambs
11
Inoculated Orally with 10 CFU of S25/laroA
Group 3 Lambs
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11Lambs were inoculated orally with 4 doses of 5-9 x 10 CFU of 
S25/laroA on days 0, 2, 4 and 24 and the sera tested in an ELISA 
at times post-infection. Each point represents the mean ^^^92nm 
5 sheep [Group 3] at serum dilutions of 1:40 and 1:16 for IgM and 
IgG respectively. Mean OD values are expressed as a percentage
where 100% represents *^^492nm
126
present on day 35. The levels of IgG in all of the 15 lambs was
low In comparison to IgM, but were usually seen around 8  days 
post-infection, and remained relatively constant throughout the 
course of the experiments.
Only 2 of the 15 lambs [1 from Group 1 and 1 from Group 2] produced 
detectable levels of specific intestinal IgA on day 16, but the 
levels were very low in both animals and the remaining 13 lambs 
produced no specific coproantibody at any time post-infection.
4.2.4.2 Cell-Mediated Immune Responses After Oral Infection with 
Multiple Doses of 10^^ S25/laroA 
Lymphocytes were removed from the 15 lambs before and at various 
times following infection with the S25/laroA strain, and assayed 
for specific proliferation against the vaccine strain. The results 
are shown in Figures 4,5.1-4.5.3 which represent Groups 1-3 
respectively. All 15 Iambs showed strong proliferative responses to 
the vaccine strain. In each of the 3 groups, all the responses
recorded post-infection were significantly greater than the 
pre-infection responses, with the exception of the day 17
responses in Group 1. The high levels of lymphocyte responsiveness 
continued in all of the animals until challenge with virulent S25/1 
on days 40, 87 and 40 for Groups 1, 2 and 3 respectively.
Challenge did not result in a significant increase in the 
proliferative responses in Groups 1 and 2 [Group 3 lambs not 
tested].
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Figure 4.5.1 Salmonella-Specific Proliferative Responses of PBMC
11from Lambs Inoculated Orally with 10 CFU of 
S25/laroA
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115 lambs [Group 1] were vaccinated orally with 4 doses of 5-9 x 10
CFU of S25/laroA on days 0, 2 , 4 and 24 and the PBMC cultured
with Salmonella antigen in an LTT before, and at various times
9
after vaccination, and after challenge* with 8  x 10 CFU wildtype 
S25/1. Both the mean CPM and SI are given for each time-point.
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Figure 4.5.2 Salmonella-Specific Proliferative Responses of PBMC
from Lambs Inoculated Orally with 10^^ CFU of
S25/laroA
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o
3 
è
o
s
sT)
«O
"3e
CO
dcd
3
P < 0 . 0 1
P < 0 . 0 1
P < 0 . 0 1
P < 0 . 0 1
0 34 51 58 94*
Time Post Infection [Days]
P < 0 . 0 1
P < 0 . 0  1
P < 0 . 0 1
P < 0 . 0 1
0 34 51 58 94*
Time Post Infection [Days]
5 lambs [Group 2] were vaccinated orally with 4 doses of 5-9 x 10^^ 
CFU of S25/laroA on days 0, 2, 4 and 24 and the PBMC cultured
with Salmonella antigen in an LTT before, and at various times 
after vaccination, and after challenge* with 1 x 10^^ CFU wildtype 
S25/1. Both the mean CPM and SI are given for each time-point.
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Figure 4.5.3 Salmonella-Specific Proliferative Responses of PBMC
11
from Lambs Inoculated Orallv with 10 CFU of 
S25/laroA
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5 lambs [Group 3] were vaccinated orally with 4 doses of 5-9 x 10^^ 
CFU of S25/laroA on days 0, 2, 4 and 24 and the PBMC cultured with 
Salmonella antigen in an LTT before, and at various times after 
vaccination. Both the mean CPM and SI are given for each 
time-point.
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4.2.5 Production of IFN-g by PBMC from Lambs Inoculated with S25/1 
aroA following Stimulation with Specific Antigen in an LTT
To study the presence of Salmonella-specific T cell responses 
further, I examined for the presence of IFN-g in supernatants of 
PBMC cultures from the 3 groups of lambs following stimulation 
with antigen and ConA.
Supernatants were removed after 24, 48 and 96 h of culture with
antigen. The responses of the lambs in Group 1 were variable at 
each time post-infection [Table 4.5]. However, all the lambs 
produced IFN-g at some stage, although the titres were very low. 
The lymphocytes from all of the lambs in Group 1 also produced 
IFN-g following mitogenic stimulation with ConA. None of the PBMC 
supernatants from any of the lambs in Groups 2 and 3 contained IFN 
of any kind, at any time post-infection, suggesting that there was 
no specific T cell responses in these animals. Also, none of the 
ConA supernatants from any of the lambs in these 2 groups produced 
IFN-g, suggesting that the the PBMC from these lambs inherently 
produced low levels of IFN-g whether stimulated with antigen or 
mitogen.
4.2.6 Phenotype Analysis of Cells Responding to Salmonella 
Antigen in an LTT
As all 15 lambs had produced strong proliferative responses to 
Salmonella but not IFN-g, this suggested that the proliferation was 
not due to T cells. I therefore attempted to determine the
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TABLE 4.5
Titres of IFN-g Produced bv PBMC from Lambs Inoculated with S25/1 
aroA following Stimulation with Salmonella Antigen
GROUP 1 LAMBS
Titres of IFN-g
TIME POST-VACCINATION WITH S25/laroA
Stimulant PREVACCINATION DAY 24 DAY 35
Unstimulated 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
ConA
[1 0 ug\ml]
2 2 2 < 2 < 2 2 2 2 2 0 2 2 2 2 2
S25/laroA
[60ug\well]
0 0 0 0 0 0 0 8 8 0 0 0 0 2 < 2
S25/laroA
[24ug\well]
0 0 0 0 0 0 8 16 16 0 4 0 2 0 4
S25/laroA
[1 2 ug\well]
0 0 0 0 0 0 8 16 16 0 2 0 2 0 8
S25/laroA
[6 ug\well]
0 0 0 0 0 0 0 0 8 0 2 0 2 0 4
LAMB 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5
Group 1 lambs were inoculated orally with 10 CFU of S25/laroA on 
days 0, 2, 4 and 24. Before vaccination, and on days 24 and 35,
PBMC from each lamb were cultured without antigen, with ConA and 
with decreasing dilutions of Salmonella antigen for 24, 48 and 96
h when titres of IFN-g in cell supernatants were determined. Only 
the 96-h results are shown as they were virtually identical to the 
24- and 48-h readings.
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phenotype of the cells that were proliferating in response to the 
Salmonella antigen. The percentages of the total cells and blast 
cells that expressed either CD4, CDS, the TcR g-d or the Ig LC
were determined for lambs in Groups 2 [Fig. 4.6,1] and 3 
[Fig.4.6 .2] following stimulation of PBMC with Salmonella antigen, 
before and after vaccination with the aroA strain. The responses 
of both groups were very similar and were considered together. 
Before vaccination, the proliferative responses in the LTTs were 
very low [see Figs 4.5.2 and 4.5.3], and 26% of the total cells 
were B cells of which 78% were blast cells [Figs. 4.6.1 and 
4.6.2]. After vaccination, proliferative responses were high and 
there was approximately a 2-fold increase in the percentage of B 
cells, of which approximately 90% were blast cells. There was no 
increase in either the total number of CD4+, CD8 + or TcR g-d+ 
cells, or in the number of blast cells expressing these molecules 
following vaccination.
It would seem that most of the proliferation to Salmonella antigen 
in the LTTs was due to B cells, which would explain the absence of 
IFN-g in response to antigen in these 2 groups and the low levels 
of serum IgG.
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Figure 4.6.1 Phenotype of Cells Responding to Salmonella Antigen 
in the LTTs
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PBMC from 5 lambs [Group 2] were stimulated with Salmonella antigen
11before and 51 days after vaccination with 4 doses of 5-9 x 10 CFU 
S25/laroA. The mean percentage of both the whole [total] cells and 
the blast cells that were CD4+, CD8 +, TcR g-d+ and Ig LC+ were
compared at these 2  time-points.
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Figure 4.6.2 fhenotype of Cell; Re,pund,nP to Sa1 mnn.1 i.
In the LTTs
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PBMC from 5 lambs [Group 3] were stimulated with Salmonella antigen 
before and 35 days after vaccination with 4 doses of 5-9 x lO^^ CFU 
S25/laroA. The mean percentage of both the whole [total] cells and 
the blast cells that were CD4+, CD8 +, TcR g-d+ and Ig LC+ were
compared at these 2  time-points.
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4.2.7 Challenge Of Vaccinated Lambs with Lethal Doses of Virulent 
S25M
11The 3 groups of lambs vaccinated orally with 10 CFU of S25/1 
aroA. were challenged with virulent S25\l in 3 separate challenge 
experiments.
4.2.7.1 Challenge Experiment 1
9
The lambs in Group 1 were challenged orally with 8  x 10 CFU of 
virulent S25\l, 40 days after the first vaccination dose. A
control group of 5 unvaccinated lambs [numbered 37-41] was 
challenged in the same way. The mean rectal temperature responses 
after challenge are shown in Figure 4.7. After 48 h, pyrexia was 
observed in all the vaccinated lambs [0.7-2.4°C], but they all 
looked well and retained healthy appetites throughout the course of 
the challenge. By 72 h, the temperatures of the lambs had 
dropped, although pre-vaccination temperatures were not reached in 
all the lambs until 14 days post-challenge. The mean rectal 
temperatures were significantly lower in the vaccinated lambs than 
in the unvaccinated lambs on each day after infection.
Only 1 lamb [22] developed diarhoea [from days 7-12], but it
remained clinically well throughout and, of the other 4 lambs, one 
produced normal faecal pellets throughout the course of the 
challenge and the other 3 showed only a slight softening of the 
faeces. When the lambs were culled on day 18 after challenge, most
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Figure 4.7 Rectal Temperature Responses in Vaccinated and
9
Unvaccinated Lambs After Oral Challenge with 10 CFU 
of Wildtype S25/1
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5 lambs [Group 1] vaccinated orally 40 days previously with 4 doses 
11of 5-9 X 10 CFU of S25/laroA. and 5 unvaccinated lambs were
9
challenged orally with 8  x 10 CFU of wildtype S25/1 and the mean 
rectal temperatures for the 2  groups recorded on each day 
post-challenge.
137
TABLE 4.6
Recovery of the Wildtype Strain from aroA-Vaccinated and
9
Unvaccinated Lambs Challenged with 10 CFU of Wildtype S25/1
No. CFU/g of Tissue
GROUP VACCINATED UNVACCINATED
LAMB NO. 2 2 23 24 25 26 37 38 39 40 41
HEART 0 6 0 0 0 4 0 1 0 ^ 250 0
LUNG 0 0 0 0 0 41 1 2 437 0 1 0 ^
BRONCHIAL LN 0 0 0 0 6 0 6 6 1 0 ^ 0 lo'
LIVER 0 0 0 0 0 87 19 1 0 ^ 2 1 51
HEPATIC LN 0 0 0 0 0 172 28 487 + 294
SPLEEN 0 0 0 0 0 8 4 1 0 ^ 50 95
KIDNEY 0 0 0 0 0 + 0 1 0 ^ 5 286
MESENTERIC LN 0 0 2 4 0 lo"^ 1 0 ^ 1 0 ^ lo"^ 1 0 ^
ILEUM 0 0 0 0 0 400 6 1 0 ^ 153 184
CAECUM 0 0 0 15 0 1 0 ^ 1 0 ^ 1 0 ^ 1 0 ^ 1 0 ^
COLON 0 0 0 3 0 1 0 ^ 1 0 ^ 1 0 ^ 1 0 ^ 1 0 ^
LN “ Lymph Node
+ = Organism only detected after enrichment in selenite broth 
0 = Organism not detected, even after enrichment 
NT = Not Tested
115 lambs vaccinated 40 days previously with 4 doses of 10 CFU 
S25/^aroA. and 5 unvaccinated lambs were challenged orally with 8  
X 10 CFU of wildtype S25/1. The unvaccinated lambs were culled in 
extremis on day 3 and the vaccinated lambs were culled on day 18 
when the no. CFU/g of tissue were determined for each lamb.
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of the tissues tested from the 5 animals were free of the challenge 
strain and where the strain was recovered, it was only present at 
very low levels [Table 4.6]. The aroA vaccine strain could still 
be cultured from the organs of 3 of the lambs at this time.
In contrast to these mild clinical responses to virulent challenge 
in vaccinated animals, unvaccinated lambs developed a lethal 
infection as described earlier [4.2.1]. Pyrexia, loss of appetite 
and lethargy were observed and the lambs were culled in extremis on 
day 3. At this time, the colon, caecum and mesenteric lymph nodes 
of all the lambs harboured large numbers of virulent salmonellae, 
but lamb 39 was the only one to harbour high numbers in other 
tissues [Table 4.6].
4.2.7.2 Challenge Experiment 2
The lambs in Group 2 were inoculated orally with 1 x 10^^ CFU of 
virulent S25\l, 87 days post-vaccination with S25/laroA. 2
unvaccinated control animals [numbered 42 and 43] were challenged 
in the same way. The mean rectal temperatures of the vaccinated 
and unvaccinated groups are shown in Fig 4.8. After 48 h, pyrexia 
was observed in all of the vaccinated lambs [ 1.2- 2.0°C], although 
they remained bright and had good appetites throughout the course 
of the challenge. Temperatures had returned to normal by day 5 in 
all vaccinated lambs. The mean rectal temperatures were lower in 
the vaccinated lambs than in the unvaccinated lambs on day 1  and 
days 3-8 after infection. All lambs showed a drop in the %DW of
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Figure 4.8 Rectal Temperature Responses in Vaccinated and
Unvaccinated Lambs After Oral Challenge with 10^^ CFU
of Wildtype S25/1
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5 lambs [Group 2] vaccinated orally 87 days previously with 4 doses 
11
of 5-9 X 10 CFU of S25/laroA. and 2 unvaccinated lambs were 
challenged orally with 1 x 10^^ CFU of wildtype S25/1 and the mean 
rectal temperatures for the 2  groups recorded on each day 
post-challenge.
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TABLE 4.7
Recovery of the Wildtype Strain from aroA-Vaccinated and 
Unvaccinated Lambs Challenged with 10^^ CFU of Wlldtvpe S25/1
No. GFU\g of Tissue
GROUP VACCINATED UNVACCINATED
LAMB NO. 27 28 29 30 31 42 43
HEART 0 0 0 0 0 0 0
LUNG 0 0 0 0 0 0 30
BRONCHIAL LN 0 0 0 0 0 0 0
LIVER 0 0 0 0 0 800 241
HEPATIC LN 2 0 0 0 0 326 1 0 ^
SPLEEN 0 2 0 0 0 420 0
KIDNEY 0 0 0 0 0 0 0
MESENTERIC LN 0 0 6 0 0 1 0 ^ 1 0 ^
ILEUM 0 0 0 0 0 + 800
CAECUM 0 0 0 0 0 0 0
COLON 0 3 0 0 0 + 400
LN = Lymph Node
+ = Organism only detected after enrichment in selenite broth 
0 = Organism not detected, even after enrichment 
NT = Not Tested
115 lambs inoculated orally 87 days previously with 4 doses of 10 
CFU of S25/laroA. and 2 unvaccinated lambs were challenged orally 
with 1 X 10 CFU of wildtype S25/1. Vaccinated lambs were culled 
on day 18 and the unvaccinated lambs on days 13 and 18 for lambs 42 
and 43 respectively, when the no. CFU/g of tissue were determined 
for each lamb.
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faeces [mean decrease of 10%], but none scoured. On day 18, only 
4 of the organs tested from all of the lambs harboured detectable 
levels of the virulent strain [Table 4.7] and only 3 contained 
levels of the S25/laroA vaccine strain.
After 24 h, a dramatic rise in rectal temperature was seen in both 
unvaccinated lambs [increases of 2.1^0 and 2.8°C for lambs 42 and 
43 respectively]. By day 3, the temperature of both the lambs was 
off the thermometer scale [>42^C] and they showed a loss of
appetite although they never looked as clinically ill as the 
unvaccinated lambs challenged previously. However lamb 42 began to 
scour on day 7 but within 2 days was producing faecal pellets 
again. Lamb 43 showed an appreciable drop in the %DW of faeces 
between days 4 and 7 [from 52% to 19%] but was producing normal
pellets by day 9, The temperatures of of both lambs had returned
to pre-vaccination readings by day 10. Lamb 42 was culled on day 13 
and lamb 43 on day 18 and the no. CFU\g of tissue determined 
[Table 4.7], Only the mesenteric lymph nodes harboured substantial 
levels of the virulent organism. The failure of these 2 lambs to 
develop a lethal infection similar to that found in the
unvaccinated animals in the previous section given a lower 
challenge dose, was surprising. However it should be noted that 
one lamb given the wildtype strain in section 4.2.2 also failed to 
develop a lethal infection.
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4.2.7.3 Challenge Experiment 3
11The lambs in Group 3 were inoculated orally with 2 x 10 CFU of 
wildtype S25/1, 40 days post-vaccination with S25/laroA. A
control group of 3 unvaccinated lambs [numbered 44-46] was 
challenged in the same way. The mean rectal temperatures of both 
vaccinated and unvaccinated lambs are shown in Figure 4.9, After 48 
h, a dramatic increase in the rectal temperature of all 5 
vaccinated lambs was seen [range 1.5-2.4^0], However the animals 
remained bright and retained their appetite throughout the 
experiment. By day 6 , the rectal temperatures of all the 
vaccinated animals had returned to pre-vaccination readings. One 
lamb[34] started to scour on day 5, but within 24 h was pelleting 
again. The other 4 lambs produced faecal pellets throughout the 
course of the challenge. On day 14 only the mesenteric lymph node 
of lamb 33 was shown to harbour the challenge strain, albeit at 
very low levels [Table 4.8], The aroA vaccine strain was detected 
in trace amounts in only 3 of all the organs tested.
All 3 unvaccinated lambs showed a dramatic increase in rectal
temperature, and there was an appreciable drop in the %DW of
faeces. However the mean rectal temperatures were only 
significantly higher [p<0.05] than the vaccinated lambs on days 4 
and 5. Lamb 4 was culled in extremis on day 4 and the virulent 
organism was recovered in high numbers from all tissues tested
[Table 4.8], Of the remaining lambs, lamb 45 remained bright
throughout the study and by day 14, its temperature and %DW of
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Figure 4.9 Rectal Temperature Responses in Vaccinated and
11Unvaccinated Lambs After Oral Challenge with 10 CFU 
of Wildtype S25/1
Challenge Experiment 3
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5 lambs [Group 3] vaccinated orally 40 days previously with 4 doses 
of 5-9 X 10^^ CFU of S25/laroA. and 3 unvaccinated lambs were 
challenged orally with 3 x 10^^ CFU of wildtype S25/1 and the mean 
rectal temperatures for the 2  groups recorded on each day 
post-challenge.
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TABLE 4.8
Recovery of the Wlldtvpe Strain from aroA-Vaccinated and 
Unvaccinated Lambs Challenged with 10^^ CFU of Wildtype S25/1
No. CFU\g of Tissue
GROUP VACCINATED UNVACCINATED
LAMB NO. 32 33 34 35 36 44 45 46
HEART 0 0 0 0 0 1 0 ^ 0 0
LUNG 0 0 0 0 0 1 0 ^ 0 0
BRONCHIAL LN 0 0 0 0 0 1 0 ^ 1 0 ^ 0
LIVER 0 0 0 0 0 1 0 ^ + 0
HEPATIC LN 0 0 0 0 0 1 0 « 350 0
SPLEEN 0 0 0 0 0 1 0 « 0 0
KIDNEY 0 0 0 0 0 lo' 35 0
MESENTERIC LN 0 0 0 29 0 1 0 « 1 0 ^ 1 0 ^
ILEUM 0 0 0 0 0 1 0 « NT NT
CAECUM NT NT NT NT NT 1 0 ^ NT NT
COLON NT NT NT NT NT NT NT NT
LN = Lymph Node
+ = Organism only detected after enrichment in selenite broth 
0 = Organism not detected, even after enrichment 
NT = Not Tested
5 lambs inoculated orally 40 days previously with 4 doses of 10 
CFU of S25/laroA. and 3 unvaccinated lambs were challenged orally 
with 2 X 10 CFU of wildtype S25/1. The vaccinated lambs were 
culled on day 14 and the unvaccinated lambs were culled on days 5, 
9 and 14 for lambs 44, 45 and 46 respectively, when the no. CFU/g
of tissue were determined for each lamb.
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faeces had returned to normal and only the mesenteric lymph node 
harboured virulent salmonellae. Lamb 46 started to look clinically 
ill on day 6 , despite normal temperature, and was culled in 
extremis on day 9. However, only the mesenteric lymph node
contained substantial amounts of the challenge organism. This was 
the first animal that had succumbed to infection without excreting 
or harbouring in the tissues, large numbers of the challenge 
strain.
The results of these challenge studies have shown that the 
S25/laroA strain can protect lambs from a lethal challenge dose of 
wildtype S25/1, however the failure of some of the unvaccinated 
lambs to develop a lethal infection has highlighted the variability 
in the susceptibility of lambs to experimental salmonellosis.
4.3 Discussion
The initial studies described in this chapter sought to 
characterise the infection established in lambs following oral
9
challenge with wildtype S25\l. Lambs inoculated with 10 CFU or
higher succumbed to infection and high numbers of the organism were 
recovered from the tissues. These findings are in contrast to 
those of Brown et al. [1976], who estimated an oral LD^^ for
S.typhimurium in lambs to be 2 x 10^^ CFU, suggesting that the 
S25/1 isolate was particularly virulent for sheep.
Following these studies, parallel studies were undertaken using
9
the S25/1 aroA vaccine strain. Lambs inoculated orally with 10 or 
1110 CFU S25/laroA did not develop any of the clinical symptoms
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associated with the virulent strain, harboured only low levels of 
the organism in the tissues, and did not succumb to infection. The 
relative virulence of the wildtype and aroA strains reflected the 
fact that only the wildtype organism grew in large numbers in the 
gut wall, menteric lymph nodes and other tissues.
The immune responsiveness of animals given the aroA strain
9
reflected the levels of organ colonisation. Lambs given 10 CFU of
the mutant strain, harboured very few organisms in the tissues and
consequently were immunologically unresponsive to the vaccine
11strain. Lambs given 4 doses of 10 CFU of the vaccine strain 
harboured greater numbers of the aroA strain in the tissues and all 
lambs produced Salmonella-specific serum IgM. However levels of 
Salmonella- specific IgG were much lower than IgM levels and 
Salmonella-specific coproantibody [slgA] was virtually absent.
Mukkur et al. [1987] detected Salmonella-specific serum antibody
following oral vaccination with aroA S.typhimurium. However 
susequent studies by the same group showed that only intravenous 
administration of the aroA strain produced specific serum antibody 
[Begg et al., 1990]. The specific serum antibody responses
described in this chapter are encouraging in view of these results. 
The absence of specific sIgA in the lambs may not be surprising in 
view of the findings of Lascelles et al. [1988] who were unable to 
detect Salmonella-specific IgA-producing cells in intestinal lymph
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following repeated oral vaccination with an aroA S.typhimurium 
strain. The lack of a mucosal immune response may be a result of 
low level mucosal stimulation by the aroA strain [discussed in 
Chapter 7].
The PBMC from the lambs given 10^^ of the S25/laroA strain showed 
strong specific responses following vaccination. The Sis often 
varied considerably from one time-point to another post-infection 
as a result of variation in background counts between assays. The 
CPM values were relatively unaffected by background variability and 
may give a clearer indication of lymphocyte responsiveness. As 
sheep lymphocytes are unresponsive to the mitogenic effects of LPS 
[Burrells and Wells, 1977] compared to murine lymphocytes [Peavey 
et al., 1974], the polyclonal stimulation of B cells by the LPS in
the heat-killed antigen preparation, which clouded specific 
responses in the mouse studies, was not a problem here, perhaps as 
a result of tolerance through repeated exposure to bacterial 
endotoxin.
Unlike earlier studies [Mukkur et al.. 1987], I was unable to 
detect specific DTH responses to aroA S.typhimurium after oral 
inoculation. However subsequent studies have confirmed my findings 
[Begg et al., 1990]. The choice of LPS as a measure of T cell
responsiveness by these groups was a curious one, as it is a T 
cell- independent B cell mitogen. The increases in skinfold 
thickness to the LPS observed by Mukkur et al. [1987] was probably 
an inflammatory response to the pyrogenic LPS.
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Although strong Salmonella-specific responses were observed in 
LTTs, very few lambs produced IFN-g, suggesting that it was the B 
cells, which do not produce IFN-g, that were responding. The 
other possibility was that a population of T cells that does not 
produce IFN-g, such as Th2 cells, was responding specifically in 
the LTT. The lack of IFN-g production following ConA stimulation
was surprising. However, such findings have been reported by
others for both normal mouse and sheep lymphocytes [A. McI,Mowat,
M. Bruce, MRI, personal communications] where IFN-g production
may be dependent on the time of exposure of the cells to ConA, The 
fact that those sheep that produce IFN-g to antigen stimulation 
also produced IFN-g to ConA, suggests that some sheep inherently 
produce greater levels of IFN-g than others, perhaps as a result 
of increased mucosal stimulation by gut flora which may make the 
lymphocytes more responsive to antigen or mitogen. These 
differences may also reflect the outbred nature of the animals.
Phenotypic analysis showed that the cells responding to antigen 
were predominantly B cells. This could account for the lack of 
IFN-g in PBMC culture superntants from these lambs, predominance 
of IgM in the serum and lack of IgG\IgA, as these latter responses 
are T cell-dependent. However the levels of proliferation to 
Salmonella antigen in the LTTs were too high to be solely a result 
of B cell proliferation. IL-2 and IL-4 from Th cells would be 
required to effect such B cell proliferation, but phenotype 
analysis did not reveal the presence of such T cells. One
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possibility is that T cell proliferation did occur in these 
cultures, but that this was before the time I observed the B cell 
proliferation on day 4. However, there was no increase in the 
absolute numbers of T cells suggesting that this was not the case.
Despite the absence of strong vaccine-specific responses, oral
vaccination with 4 doses 10^^ CFU S25/laroA protected lambs from
9 10 11
oral challenge with 8  x 10 , 1 x 10 and 2 x 10 CFU of S25\l,
with much reduced clinical symtoms following challenge. However the
results were clouded somewhat by the failure of 3 of 10
unvaccinated lambs [2 given 1 x 10^^ CFU and 1 given 2 x 10^^ CFU]
to succumb to infection. Similar problems were encountered by
other workers. Mukkur et al. [1987] showed that doses of 1 x 10^
CFU of virulent S.typhimurium were sufficient to cause mortality in
all unvaccinated animals. However when this experiment was
repeated using the same challenge dose, none of the unvaccinated
animals succumbed to infection and a ten-fold higher dose had to be
given to invoke death in all the unvaccinated animals [Begg et al.,
1990]. Thus, there appears to be considerable variation in the
susceptibility of these outbred animals to a lethal infection with
wildtype S.typhimurium. Nevertheless, when considering all the
challenge studies carried out throughout this chapter, the results
of the protection studies were encouraging. A total of 18
unvaccinated lambs were challenged with a potentially lethal dose
of the wildtype strain, of which 14 succumbed to infection while
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none of 15 vaccinated lambs died. However, since aroA-vaccinated 
lambs were protected in the absence of strong vaccine-specific 
responses, the nature of the protective response operating in these 
animals is unclear.
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Chapter 5
The Immune Response to the Ma1or Outer Membrane Protein TMOMPI 
of C.PSittael Expressed bv the S25/laroA Vaccine Strain
5.1 Introduction
The previous 2 chapters highlighted the ability of the S25/laroA 
vaccine strain to colonise the organs of mice and sheep and induce 
protective immunity against wildtype challenge in these species. 
The next stage was to examine whether this vaccine strain could act 
as a vector for delivery of a heterologous antigen.
In this chapter, the ability of the S25/laroA strain to deliver 
the MOMP of C.psittaci to the immune system of both mice and lambs 
was examined. Two recombinant Salmonella strains were available. 
The pD strain expressed the first 4 variable domains of the MOMP 
and the pC strain expressed domains 2-4 constituting a truncated 
form of the MOMP. The in vivo expression of the protein was 
monitored and an attempt was made to relate this to the production 
of MOMP-specific immune responses.
5.2 Results
5.2.1 Immunogenicltv of Recombinant MOMP in Mice
Initial studies sought to determine if the recombinant MOMP [rec 
MOMP] protein itself was immunogenic in mice to give some idea of 
the responses likely to be induced when presented by the vaccine 
strain.
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Figure 5.1 Levels of MOMP-Speclflc Serum IgM and IgG in Mice After 
Immunisation with MOMP in CFA
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Mice were culled at times post-infection and the sera examined in 
an ELISA in which the coating antigen was SDS-purified rec MOMP. 
Each point represents the mean obtained with the sera of 5
mice. The mean OD405nm is expressed as a percentage where 1 0 0 %
represents 1.8. Serum was diluted 1:100 and 1:400 for IgM
and IgG respectively.
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The primary immune response to 4 ug of rec MOMP in CFA was 
examined, MOMP-specific IgM started to appear as early as 3 days 
following injection of the antigen preparation and rose steadily 
thereafter, peaking on day 18 [Figure 5.1]. IgG levels started to 
rise on day 1 0  and continued to rise, remaining high until the 
termination of the experiment on day 32. The levels of IgM were 
considerably lower than IgG levels.
T Cell Responses
Spleen cells from 6  immunised and 4 control mice were examined on 
day 36 for their in vitro responsiveness to either Elementary 
Bodies [EBs] of C.psittaci [which represent native MOMP] or with 
synthetic peptides of MOMP, VD2 and VD4 [constructed and kindly 
gifted by Dr. A. Herring, MRI], which contain sequences of the 
second and fourth variable domains of MOMP respectively. 
Recombinant MOMP was not used, as the purified rec MOMP protein 
used to challenge the mice [and used in the ELISA] contained high 
levels of SDS from the purification procedure which was toxic to 
the lymphocytes. The responses to all 3 preparations in the 
MOMP-challenged mice were not significantly greater than those in 
the unvaccinated group [results not shown].
5.2.2 Specific Immune Responses in Mice following Infection with 
Live C.psittaci
As no T cell responses were detectable after immunisation with 
purified MOMP, it was important to determine if murine T cells 
would recognise native MOMP and/or the peptides after infection
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TABLE 5.1
Specific Humoral and Cellular Responses of Mice Infected 
with Live EBs of C.psittaci
GROUP MOUSE ANTIBODY TITRE GPM SI IFN to EB
[a] TO MOMP [b] to EBs to EBs STIMULATION
1 32 36,314 36.5 NT
1 2 128 5,510 8.5 NT
3 128 8,320 6 . 0 NT
1 4096 25,965 21.5 +
2 256 16,590 25.7 +
2
3 64 3,504 10.5 +
4 NT 55,626 17.2 NT
1 128 2,277 37.7 +
3
2 128 12,335 63.2 +
1 32 12,028 69.3 +
4 2 128 11,931 26.8 +
3 128 42,961 74.6 +
1 16 62,606 36.5 +
5
2 128 49,592 48.9 +
1 0 820 4.5
6
UNVACC 2 0 1 0 2 0 5.2 -
+/- = Presence/absence of IFN in EB-stimulated spleen cell
supernatants.
NT = Not Tested.
Mice infected with live C.psittaci were culled on day 36 and the 
sera assayed in a rec MOMP ELISA and the proliferative responses 
and production of IFN to stimulation with Elementary Bodies [EBs^ 
by spleen cells was determined. _ [a] Groups 1-5 received 1x10 
Inclusion Forming Units [IFU], 4x10 IFU, 2x10 IFU, 1x10 IFU and 
5x10 IFU respectively. Group 6  was the uninfected control group, 
[b] Titres are expressed as the inverse of the highest serum 
dilution with greater than NMS.
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with the live organism. Mice were infected intraperitoneally with 
different doses of live EBs of an ovine abortion strain, S26/3, of 
C.psittaci [kindly gifted by M.McCafferty, MRI]. 36 days
post-challenge, all mice produced MOMP-specific antibodies although 
the levels did not correlate with the size of the infecting dose 
[Table 5.1].
T Cell Responses
On day 36, spleen cells were also cultured with EBs and synthetic 
peptides VD2 and VD4 in an ITT. None of the Chlamydia-challenged or 
the unvaccinated mice responded to either of the peptides [results 
not shown]. However, all of the Chlamydia-challenged mice 
responded strongly to the EB preparation [Table 5,1] and the 
responses of the unvaccinated mice were negligible by comparison. 
The levels of lymphocyte responsiveness did not correlate with the 
infecting dose, nor with the antibody levels in the same mouse. The 
majority of responsive cultures also produced IFN, although the 
neutralisation assays were not performed to prove the identity of 
IFN-g [Table 5.1]
5.2.3 Inoculation of Mice with S25/laroA Expressing the MOMP of 
C.psittaci
The previous sections indicated that both recombinant and native 
MOMP could be recognised by the murine immune system, and I went on 
to examine if it would be possible to evoke an immune response to 
the MOMP expressed by a Salmonella vaccine strain. First, I
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Investigated if the presence of the plasmid and /or the production 
of a foreign protein altered the growth of the S25/laroA strain in 
vitro and in vivo. or Its capacity to evoke a Salmonella-specific 
immune response in the murine host.
5.2.3.1 In Vitro Growth Rates of the Recombinant Strains
The relative in vitro growth rates of the strains are shown in
Appendix 6 . The growths of the pD, pC and pUC8  strains did not vary
significantly from that of the S25/1 aroA strain without a 
plasmid,
5.2.3.2 Production of rec MOMP bv the pD and pC Strains
Both the pD and pC strains were shown to contain plasmids, with 
inserts of the correct size [see Table 2,1] and samples of each 
strain were checked for the production of MOMP. Bacterial cell 
lysates were separated by SDS-PAGE, blotted onto nitrocellulose and 
probed with the MOMP-specific monoclonal antibody, 4/11. Lysates 
of the pUC8  strain [without an insert] were also run as was a 
preparation of rec MOMP [produced in Salmonella]. The results are 
shown in Figure 5.2. The pD strain [lane 2] was shown to express
the full 39K rec MOMP protein. Both the pC strain isolates [Lanes
3 and 4] were shown to produce the 26K truncated form of the MOMP, 
but in slightly greater quantities than the MOMP produced by the pD 
strain.
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Figure 5.2 Production of MOMP bv the p D and uC Stork -«îrrflln*-
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5.2.3.3 Invasiveness of the pD and pUC8  Strains in Vivo 
Mice were allocated randomly into groups, one of which was 
inoculated orally with 5 x 10^ CFU of the pD strain and the other 
with an identical dose of the control pUC8  strain. 4-5 mice from 
each group were culled on each of days 3, 4, 5, 6 , 10, 12, 17 and 
24 and the no. GFU/g of tissue determined for the faeces, liver, 
spleen and Peyer's patches. The results are shown in Figure 5.3. 
There was no significant difference in the levels of the pD and 
pUCB strains recovered from the mice at any time, which were 
similar to those obtained previously with the S25/laroA strain 
without a plasmid [see 3.2.3].
5.2.3.4 Maintenance of the Plasmid and MOMP Expression in Vivo
I next determined if the recombinant strains maintained expression 
of the MOMP gene in vivo. using ampicillin-resistance as a marker. 
Mice were orally inoculated with 3 x 10^ CFU of the pD strain. 3-5 
mice were culled on each of days 3, 4, 5, 6 , 10, 12, 15 and 20 and
the percentage of the colonies that were ampicillin-resistant was 
determined. The results are shown in Figure 5.4. On days 2 and 3, 
most of the recovered colonies were ampicillin-resistant. However, 
a significant level of plasmid segregation occurred after day 6 . 
This continued until day 21, when virtually all the recovered 
colonies were sensitive to ampicillin. The liver sustained the
level of plasmid expression for longer than the other organs.
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Figure 5.3 Recovery of the pD and pUC8 Strains fom Mice After Oral
Infection
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2  groups of mice were established of which one was inoculated 
orally with 5 x 10^ CFU of the pD strain and the other with an 
identical dose of the pUC8  strain. 4-5 mice were culled from each 
group on the stated days post-infection and the mean no. CFU/g 
determined on each time-point for faeces, liver, spleen and 
Peyer's patches. Levels are expressed as log^^ CFU/g.
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Figure 5.4 Levels of Plasmid Expression bv the pD Stain In Vivo
After Oral Infection of Mice
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Mice were inoculated orally with 3 x 10 CFU of the pD strain. 3-5 
mice were culled on the stated days post-infection and the mean 
percentage of colonies recovered from the faeces, liver, spleen and 
Peyer's patches [PPs] that were ampicillin-resistant was determined 
for each time-point.
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[A]
1  : pD stock isolate 1
2  : pD stock isolate 2
3 : pUC8 stock isolate 1
4 : pUCB stock isolate 2
5 ; rec MOMP
6 : pD, recovered from Peyer's patches,
7 ; pD, recovered from faeces, day 5
8  ; pD, recovered from liver, day 7
9 : pUC8 , recovered from liver, day 2
1 0 : pD, recovered from Peyer's patches,
1 1 : pUC8 , recovered from liver, day 5
[B]
Lane 1: pD, recovered from liver, day 10
2 pD, recovered from faeces, day 15
3 pUG8 , recovered from Peyer's patches, day 4
4 pUC8 , recovered from Peyer's patches, day 5
5 pD, recovered from spleen, day 2
6  rec MOMP
7 pUC8  stock isolate 1
8  pD stock isolate 1
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Figure 5.5 Production of MOMP bv the d D Strain Recovered from Mice
After Oral Infection
[A]
39
106 K
8 0
49
33  
27 
1 9
1 2 3  4 5 6  7 8 0  10 11
106K
80
49
33
39
8
163
In an effort to reduce plasmid segregation in vivo. mice were fed 
0.07 mg/ml ampicillin in their drinking water 48 h prior to 
inoculation and every 3 days thereafter, until termination of the 
experiment. It was found that this treatment had no effect on the 
levels of plasmid segregation [results not shown].
Bacterial lysates were made of ampicillin-resistant colonies 
recovered at the above times post-infection, and blotted proteins 
were probed with the 4/11 monoclonal antibody. The results are 
shown in Figure 5.5[A+B]. The pD colonies isolated on days 2,5,7,9, 
10 and 15 post-inoculation all produced a unique band at 39 K 
representative of the rec MOMP protein and this band was absent 
from the pUC8  colonies. Thus the rec MOMP is expressed by the pD 
strain recovered from mice.
5.2.3.5 MOMP-Specific Immune Responses in Mice After Oral 
Infection with the pD Strain
g
Mice were inoculated orally with 5 x 10 CFU of either the pD or 
the pUC8  strain. 30 days post-challenge, the mice were culled and 
the serum examined for the presence of rec MOMP-specific and 
Salmonella-specific antibodies. The results are shown in Figure
5.6. All the mice produced detectable levels of IgG to Salmonella. 
although the levels varied considerably between individual mice. 
However, only 4 mice produced MOMP-specific IgG levels above those
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Figure 5.6 Salmonella- and MOMP-Spec if ic Serum IgG in Mice After
Oral Infection with the pD and pUC8 Strains
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[a] Each pair of columns represents an individual mouse. [b] Mice
1-10 were inoculated orally with 5 x 10^ CFU of the pD strain and
mice 11-20 received an identical dose of the pUC8  strain. [c]
Serum was removed 30 days post-infection and diluted 1:200 for
Salmonella and 1:16 for MOMP. [d] Hatched columns show IgG to
Salmonella and filled columns show IgG to MOMP. [e] 0D,_^ values
405nm
of the tests were obtained by subtracting the of NMS. A
line was drawn across the highest OD value of pUC8 - infected mice 
and values above this were taken to be MOMP-specific.
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found In mice vaccinated with the non-MOMP-expressing pUC8  strain. 
The levels of IgG to MOMP were much lower than for Salmonella and 
there was no correlation between the levels of antibodies to 
Salmonella and MOMP in individual mice.
T Cell Responses
On day 35, spleen cells from immunised mice were examined for in 
vitro responses against both Salmonella and MOMP. On this occasion, 
I used rec MOMP, prepared following blotting of lOug of 
SDS- solubilised rec MOMP [to remove the SDS][see 2.8 .2,5], as well 
as EBs and the synthetic peptides VD2 and VD4.
As shown in Chapter 3 for the S25/laroA strain, all mice infected 
with either the pD or pUCB strains produced strong proliferative 
responses to heat-killed Salmonella antigen [results not shown]
which was accompanied by the production of IFN-g [titres of 4-16].
Table 5.2 shows the proliferative responses of 3 pD-infected, 3 
pUCB-infected mice and 3 unvaccinated mice. Mouse 3 responded to 
EBs more strongly than any of the other mice. This mouse also 
responded to the VD2 peptide, as did mouse 2 which also reponded 
to VD4. None of the 3 pUCB- infected mice [mice 4-6] responded to 
either of the synthetic peptides or to the EBs. However 1 of the 
unvaccinated mice [mouse 8 ] also responded to both synthetic 
peptides, suggesting that the responses of mice 2 and 3 were
non-specific. All 3 pD-infected mice responded to rec MOMP,
however one of the pUC8 -infected mice also responded 
suggesting that again these responses were non-specific. This
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TABLE 5.2
Proliferative Responses of Spleen Cells from Mice Inoculated 
Orally with the pD or pUC8  Strains
GPM
pD-infected [a] pUCS-infected [b] Control [c]
MOUSE 1 2 3 4 5 6 7 8 9
EBs 859 528 2,003 63 33 332 1 1 593 422
VD2 0 1,311 1,591 323 0 276 49 3,376 25
VD4 0 1,524 548 173 0 116 0 2,239 0
recMOMP 3,855 767 720 328 0 3,028 0 320 0
SI
pD-infected [a] pUC8 -infected [b] Control [c]
MOUSE 1 2 3 4 5 6 7 8 9
EBs 5 5.5 2 0 1.5 1.5 4 1.5 5 5
VD2 < 1 1 2 16 5 < 1 3.5 1 28 1
VD4 < 1 14 6 3 < 1 2 < 1 19 1
recMOMP 11.5 6.5 6.5 4 < 1 26.5 < 1 2.5 1
[a] Mice received 5 x 10^ CFU of the pD strain. [b] Mice received 
5 X 10^ CFU of the pUC8  strain. [c] Uninfected control. All mice 
were culled on day 35 and the proliferative responses of the spleen 
cells to EBs, VD2, VD4 and rec MOMP examined in an LTT.
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assay was repeated with many more mice, with similar findings. 
Thus, it would seem that the MOMP expressed by the pD strain was 
incapable of eliciting specific T cell responses, however it may 
be that the rec MOMP preparation available may not have been ideal 
for the detection of MOMP-specific responses in mice.
5.2,3. 6  MOMP-Soecific Immune Responses of Mice Inoculated
Repeatedly with the pD and pC Strains
In an effort to engender greater immune responses to the MOMP, mice 
were given multiple doses of the recombinant strains. Also, as 
strains harbouring the pC had been shown to produce slightly 
greater amounts of recombinant protein [see Figure 5.2], some mice 
were infected with this strain on this occasion. In addition, 
highly purified urea-solubilised rec MOMP had become available, 
which would maximise the chances of detecting MOMP-specific 
lymphocyte responses.
9
One group of mice was inoculated orally with 5 x 10 CFU of the pD
strain on days 0 and 14 and with an identical dose of the pC strain
9
on days 7 and 21. A control group received 5 x 10 CFU of the pUC8
strain on days 0, 7, 14 and 21. On days 21, 28 and 35, mice were
culled and the serum and spleens removed and on this occasion, gut 
washes were also taken to examine for specific intestinal 
responses.
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All mice in both groups produced Salmonella-specific IgG which were 
low on day 2 1 , but had risen by day 28 and had reached high levels 
by day 35 [Figure 5.7]. However, only 5 mice given the pD/pC 
strains produced antibody to MOMP that was greater than those in 
the control mice infected with pUC8 . As in the previous experiment, 
there was little correlation between the levels of 
Salmonella-specific antibody and MOMP-specific antibody.
The levels of Salmonella-specific and MOMP-specific intestinal IgA 
are shown in Figure 5.8. All infected mice had Salmonella-specific 
intestinal IgA with these being highest on day 35. Only 5 of the 
15 mice given the pD/pC strains produced MOMP-specific IgA higher 
than that obtained in the gut washes from mice given the 
non-MOMP-expressing pUC8  strain, and again the levels were very 
low compared with the levels of Salmonella-specific IgA.
T Cell Responses
Spleen cells from mice culled on day 35 were removed and cultured 
with urea-solubilised purified rec MOMP [produced in Salmonella and 
gifted by M. McCafferty, MRI] and with synthetic peptides VD2 and 
VD4 in an LTT. The responses to Salmonella were also examined. The 
responses of 5 pD/pC-vaccinated and 3 pUC8 -vaccinated mice are 
shown in Table 5.3. All mice produced strong proliferative 
responses to Salmonella which was associated with the production of 
IFN-g [titres of 8-16]. All the mice showed some responses to the 
rec MOMP, irrespective of whether they had been vaccinated with
169
Figure 5.7 Salmonella- and MOMP-Sueclfic Serum IgG in Mice After
Oral Infection with the pD/nC Strains or with the
pUG8 Strain
À Salmonella MOMP
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[a] Each pair of columns represents an Individual mouse. [b] Mice
1-15 received 2 doses each of the pD and pC strains and mice 16-26
were given identical doses of the pUC8  strain. [c] Mice 1-5 and
16-18 were culled on day 21, mice 6-10 and 19-22 on day 28 and
mice 11-15 and 23-26 on day 35. [d] sera was diluted 1:100 for
Salmonella and 1:16 for MOMP. fe] Hatched columns represent IgG to
Salmonella and filled columns show IgG to MOMP. [f] 0D,__ values° 405nm
of the tests were obtained by subtracting the ^^^05nm NMS. A 
line was was drawn across the highest OD value of the pUC8 -infected 
mice and values above this were taken to be MOMP-specifc.
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Figure 5.8 Salmonella- and MOMP-Specific Intestinal IgA in Mice
After Oral Infection with the p D/p C Strains and with
the pUC8 Strain
Salmonella MOMP
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Legend as for Figure 5.7, except: [a] Gut lavages were diluted 1:2 
for both Salmonella and MOMP. [b] values of the test were
obtained by subtracting the mean OD of gut lavage from 5 uninfected 
mice,
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TABLE 5,3
Proliferative Responses of Spleen Cells from Mice Inoculated Orally 
with the pD and pC Strains or with the pUC8 Strain
CPM
pD/pC-infected [a] pUCB-infected [b]
MOUSE NO 1 2 3 4 5 6 7 8
rec MOMP 2,438 6,557 9,981 4,427 4,607 4,339 9,131 8,421
VD2 411 1,067 1,794 737 1,402 532 1,050 8 6 8
VD4 238 877 1,349 713 1,524 477 832 752
SI
pD/pC-infected [a] pUC8 -infected [b]
MOUSE NO 1 2 3 4 5 6 7 8
rec MOMP 33 48 125 131 58 78 69 1 0 0
VD2 6 9 24 23 18 1 1 8 1 1
VD4 4 7 18 2 2 2 0 1 0 6 1 0
[a] received 5 x 10 CFU of the pD strain on days 0 and 2, [b]
received the same vaccine regime as [a] with the pUC8  strain. Mice 
were culled on day 35 and the proliferative responses of the spleen 
cells to urea-purified MOMP, VD2 and VD4 determined in an LTT.
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the pD/pC strains or the non-MOMP-expressing pUC8  strain and there 
were no clear differences between the groups [Table 5.3]. This 
assay was repeated twice with similar results. None of these 
responses were accompanied by IFN-g production, suggesting that 
the proliferation observed may have been due to stimulation of B 
cells by residual amounts of Salmonella proteins or LPS in the 
antigen preparation. Proliferative responses to the peptides were 
low with no clear differences between the 2 groups [Table 5.3].
5.2.3.7 Challenge of Mice with Live C.psittaci following Oral 
Vaccination with the pD Strain
Although there was only limited evidence of MOMP-specific responses 
in vaccinated mice, it was decided to challenge them with 
C.psittaci. 2 groups of 10 mice, vaccinated 40 days previously
with the pD strain and the pUC8  strains respectively, were 
challenged intraperitoneally with 5 x 10^ IFU of C.psittaci S26/3. 
No mortalities were recorded in either of the 2 groups, suggesting 
that BALB/c mice are resistant to chlamydial infection.
I therefore examined the susceptibility of other mouse strains to 
C.psittaci challenge and found that 6 -week-old CBA mice were the 
most susceptible, dying within 8  days of challenge. However in 
subsequent experiments with these mice, mortalities were not 
consistently recorded, hence the challenge studies were abandoned.
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5.2.4 Sheep Experiments
As the primary aim of this thesis was to develop a safe multivalent 
vaccine for sheep, despite the poor responses to the MOMP 
expressed from the pD and pC strains in mice, I decided to examine 
the responses to MOMP expressed from the same strains in sheep.
5.2.4.1 Immune Responses in Ewes After Challenge with Live
C.psittaci
I first sought to determine if ovine T cells could recognise native 
MOMP following a natural infection with C.psittaci. PBMC from ewes 
that had been challenged with 1.3 x 10^ IFU of a mixed inoculum of 
C.psittaci strains S26/1 and A22 one year previously were cultured 
with EBs, peptides VD2 or VD4, and urea-purified rec MOMP in an 
LTT. The results are shown in Table 5.4. All 4 challenged ewes 
responded strongly to EBs and rec MOMP although the responses to 
the protein were much lower. These responses were much greater
than those of the unvaccinated animal. None of the ewes responded 
to peptide VD2, but ewes 1, 3 and 4 responded strongly to VD4.
5.2.4.2 ImmunogenicItv of Rec MOMP in Sheep
I next examined the immunogenicity of rec MOMP in sheep when given
with adjuvant. Ewes were immunised 4 weeks apart with 25ug rec
MOMP in alum and Marco1/Aralacel A and the sera tested in a rec 
MOMP ELISA. All 4 ewes produced very high levels of MOMP-specific 
IgG with titres of 2400, 4800, 2400 and 9600 for ewes 1, 2, 3 and
4 respectively. As before, the PBMC from each ewe were also
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TABLE 5.4
Proliferative Responses of PBMC from Ewes 
Challenged with Live EBs of C.psittaci
GPM
C.psittaci-challenged [a] Control[b]
EWE NO. 1 2 3 4 5
EBs 44,444 26,742 28,360 38,420 7,230
recMOMP 6,018 6,076 8,920 10,040 893
VD2 1,090 50 1 , 1 1 0 1,360 920
VD4 14,804 0 9,360 10,140 921
SI
C.psittaci-challenged [a] Control[b]
EWE NO. 1 2 3 4 5
EBs 53 72 27 32.6 8
recMOMP 8 17 8.5 8.5 1
VD2 2 . 2 1 1 1 1
VD4 18 1 9 8.5 1
[a] Ewes were challenged 17 months previously with 1.3 x 10 IFU of 
a mixed inoculum of C.psittaci strains S26/3 and A22. [b]
Unvaccinated control animal. PBMC were cultured with EBs,
urea-purified rec MOMP and the synthetic peptides in an LTT and the 
proliferative responses determined.
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TABLE 5.5
Proliferative Responses of PBMC from Ewes 
Immunised with rec MOMP in Adjuvant
CPM
rec MOMP-immunised [a] Control[b]
EWE NO, 1 2 3 4 5
EBs 39,375 38,183 93,871 80,854 4.320
rec MOMP 88,097 138,970 163,306 128,673 7,220
VD2 645 1,724 4,032 6,284 830
VD4 1,945 29,295 9,505 17,330 740
SI
rec MOMP-immunised [a] Control[b]
EWE NO, 1 2 3 4 5
EBs 45 1 2 27 32 4.5
rec MOMP 99 41 46 50 8
VD2 1,7 1,5 2 . 1 3.4 1.5
VD4 3,2 1 0 3,6 7,6 1
[a] Ewes were immunised intradermally, 2 months previously with
25ug of MOMP in alum, [b] Unvaccinated control animal. The 
proliferative responses of the PBMC from each lamb to EBs, 
urea-purified rec MOMP and the synthetic peptides were determined 
in an LIT.
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cultured with EBs, synthetic peptides VD2 and VD4 and
urea-purified rec MOMP in an LTT. The responses of an unvaccinated 
animal were also examined. The results are shown in Table 5.5. All 
4 immunised animals responded strongly to the EBs and the responses 
to rec MOMP were even greater. The responses to the peptides were 
more varied. Only ewe 4 responded to VD2 and this response was 
very small. However, ewes 2, 3 and 4 clearly reponded to VD4, The 
responses of the unvaccinated animal to all the antigen 
preparations were negligible. Thus there were generally better 
responses to MOMP and the peptides [particularly VD4 ] in sheep 
than in mice, especially at the T cell level.
5.2.4.3 Oral Inoculation of Lambs with the PD and PC Strains
The results of both the rec MOMP-challenged and 
Chlamydia-challenged ewes demonstrate the highly immunogenic nature 
of MOMP in sheep, They also showed that the antigen preparations I 
used to detect MOMP-specific responses should have been appropriate 
in the mouse studies. I next went on to examine the immune 
responses of sheep to rec MOMP expressed by the aroA vaccine 
strains.
8  conventional lambs were placed into negative-pressure isolators 
[2/isolator] 7 days post-partum and randomly allocated into 2
groups of 4 lambs. One group of lambs was inoculated orally with 4
9 11
X 10 CFU and 1 x 10 CFU of the pD strain on days 0 and 4 and
with 5 X 10^^ CFU and 8  x 10^^ CFU of the pC strain on days 2 and
15. A second group of lambs was given identical doses of the pUC8
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TABLE 5.6
Proliferative Responses of PBMC from Lambs Inoculated Orally with 
the pD and pC Strains or with the uUC8 Strain
CPM
pD- and pC-infected [a] pUC8 -infected [b]
1 2 3 4 1 2 3 4
Salmonella 2,043 2,084 2,966 1,019 1,862 905 541 0
EBs 264 1,025 303 149 311 321 604 117
rec MOMP 3,224 49 242 72 0 0 175 0
VD2 1,701 0 0 1 0 2 0 0 0 43
VD4 1,877 0 281 39 0 272 1,546 0
SI
pD- and pC-infected [a] pUC8 -infected [b]
1 2 3 4 1 2 3 4
Salmonella 5 2 0 2 7 1 1 6 2.4 1
EBs 1.5 1 0 2 2 1 4 2.5 1 . 6
rec MOMP 8 1 1 1 1 1 1.7 1
VD2 3.2 1 1 1 1 1 1 1
VD4 5 1 3 1 1 1 4.9 1
9 11[a] Lambs received 4 x 10 CFU and 1 x 10._ CFU of the pD strain on
days 0 and 4 respectively, and 5 x 10 CFU and 8  x 10 CFU of
the pC strain on days 2 and 15 respectively. [b] Lambs received
identical doses as [a] of the pUCB strain. PBMC were removed on day
25 and cultured with Salmonella antigen, EBs, urea-purified MOMP
and the synthetic peptides in an LTT, and the proliferative
responses recorded.
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strain. None of the lambs produced detectable levels of 
Salmonella-specific IgM or IgG at any time post-infection and none 
given MOMP-expressing strains produced detectable levels of 
MOMP-specific IgM or IgG. In parallel, the PBMC had very low 
Salmonella-specific proliferative responses, and only one Iamb 
produced a proliferative response to rec MOMP that was greater than 
the those of the pUC8 -vaccinated lambs [Table 5.6]. Thus the pD 
and pC strains were incapable of inducing either 
Salmonella-specific or MOMP-specific responses in these lambs.
5.3 Discussion
The experiments in this chapter demonstrated that the MOMP of 
C.psittaci was immunogenic for both mice and sheep. Both species 
produced MOMP-specific humoral responses when immunised with rec 
MOMP in adjuvant or with live chlamydial EBs. In sheep, specific 
cellular responses against rec MOMP, EBs and also synthetic 
peptides of MOMP, in particular VD4 were detected in both 
MOMP-immunised and Chlamydia-infected animals. The VD2 peptide did 
not prove to be as effective which is surprising, as epitope 
mapping and computer epitope prediction data suggest that both 
these peptides contain T cell epitopes [Tan, 1990]. The stronger 
T cell responses to rec MOMP in MOMP/CFA-immunised ewes than in 
Chlamydia-infected ewes demonstrates that, while MOMP is not 
presented very well during live infection with EBs, it is highly 
immunogenic on its own. The reduced responses to EBs may be a 
result of masking of MOMP epitopes by LPS and other surface 
components making them less immunoaccessible.
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In murine assays, specific T cell responses could be detected only 
against EBs and these occurred only in Chlamydia-challenged mice. 
The lack of T cell responses to VD2 and VD4 in mice is consistent 
with the results of Ishizaki et al. [1992] who generated
Chlamydia-specific mouse T cell lines which responded only to the 
VD3 region of MOMP, but not to VD2 or VD4. In view of the high 
IgG titres in MOMP/CFA-immunised mice, it is surprising that 
MOMP-specific T cells were not demonstrated. However, the 
urea-purified rec MOMP used to detect responses in ewes was not 
available at the time of these mouse studies and may have been 
successful in detecting MOMP-specific responses.
Care should be taken in comparing the responses in MOMP-immunised 
mice and sheep. Mice were given only a single immunising dose of 
rec MOMP whereas ewes were also given a secondary boosting dose, 
which may account for the different responses in the 2  species. 
However, the stronger responses in sheep suggests that in sheep 
there are less stringent criteria governing the presentation of the 
MOMP protein to the immune system. Ovine antigen-presenting cells 
may be able to process the MOMP more effectively into 
suitably-sized peptides for MHC Class II association whether it is 
in the cell wall of EBs as a whole protein preparation or in 
peptide form. Also, there may antigen-presenting cell types 
present in sheep but not mice, that can present MOMP more 
effectively. Consequently a greater repertoire of MOMP-specific T 
cells would be generated. Additionally, there may be epitopes of
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MOMP that are recognised by the ovine immune system and not by the 
murine immune system.
Having established the immunogenicity of MOMP, the pD and pC 
strains were assessed for their ability to generate rec 
MOMP-specific immune responses after oral immunisation of mice. 
Only a small number of mice produced MOMP-specific antibodies in 
the gut and serum and the levels were much lower than the levels of 
S.typhimurium-specific antibodies, consistent with the much lower 
mass of chlamydial epitopes present in the vaccine strain. 
Protective studies to assess the protective capacity of the 
detectable MOMP-specific antibodies against C.psittaci infection 
proved entirely unsuccessful, as naive mice were relatively 
resistant to a lethal infection. Others have also found it 
difficult to kill mice with C.psittaci [G.E. Jones. personal 
communication]. Anderson et al. [1986] was able to effect mortality 
in mice with C.psittaci but only at very high doses of EBs which 
were not available to me.
In lambs orally infected with both the pD and pG strains, 
Salmonella-specific antibody was not detected in the serum and this 
was parallelled by very low specific lymphocyte proliferation. It 
was not surprising then that MOMP-specific responses were not 
produced. The responses to Salmonella were surprising in view of 
the results obtained in Chapter 4, but this may reflect the fact 
that the latter lambs were almost 1 year-old compared with the 7 
day-old lambs used in this chapter. Thus the age of the lambs may
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govern the Invasiveness of the strain and its capacity to elicit 
immune responses. However the low immunogenicity of the vaccine 
strain in lambs is more likely to account for the absence of 
specific responses.
The low level responsiveness of the mice to MOMP was interesting in 
view of the high level of responsiveness to the vaccine strain 
itself. It may be that the large Salmonella-specific respones, in 
particular to the LPS, were masking the response to the MOMP.
Alternatively, Salmonella may not have the correct adjuvant 
qualities to boost MOMP-specific responses. I considered the 
possibility that other factors such as route of inoculation, the in 
vivo loss of plasmid and the solubility of the expressed antigen 
could be responsible. However, organisms expressing the rec MOMP 
protein were recovered up to day 15 following challenge and total 
plasmid segregation was not seen until day 20. Molina and Parker 
[1990] demonstrated plasmid segregation as early as day 1 
post-infection but specific immune responses to the heterologous 
antigen still occurred, implying that the immune system only
requires a short time for antigen recognition. These findings make 
it unlikely that plasmid segregation accounted for the low 
responses in my system.
Another explanation for poor MOMP-specific responses could be low 
level expression of the protein by the vaccine strain. However, 
both strains, in particular the pC strain, produced high levels
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of the protein in vitro. while the colonies of the pD strain
recovered from mice also produced MOMP in vivo.
The most likely explanation for the low immunogenicity of the
recombinant strains may reflect the insoluble nature of the 
expressed MOMP protein. Within the cytoplasm of the vaccine
strain, the rec MOMP forms large insoluble inclusion bodies, 
visible by electronmicroscopy. It has been reported by others that 
insoluble proteins are not immunogenic in the cytoplasm of 
Salmonella [Taylor et al.. 1986; Maskell et al.. 1986] whereas 
soluble proteins are [Brown et al., 1987] . These differences may
reflect effects on the processing and presentation of the MOMP to T 
cells. The inclusion bodies consist of linear molecules of MOMP 
that are crosslinked together and these may be more resistant to 
proteolysis within antigen processing compartments. Thus peptides 
of the appropriate size for association with MHC Class II molecules 
and subsequent recognition by T cells may not be formed. However, 
Guzman et al. [1991] expressed the FHA of B.pertussis as
cytoplasmic inclusion bodies in Salmonella and detected 
FHA-specific responses in both the serum and lung demonstrating 
that the insolubility of the antigen does not always prevent the 
generation of specific immune responses.
One means of avoiding problems of protein insolubility would be to 
obtain surface expression of the inserted antigen. Several 
strategies have been developed to achieve this and are discussed in 
Chapter 7.
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Chapter 6
The Immune Response to the Leukotoxln of F .haemolvtlca A1 
Expressed bv the S25/laroA Vaccine Strain
6.1 Introduction
The second heterologous antigen which was available for expression 
by the aroA vaccine strain was the leukotoxln of P.haemolytica A1. 
A 33 K protein, representing the C-terminal end of the leukotoxln, 
was expressed cytoplasmically in a soluble form, to circumvent the 
possible problems of protein insolubility associated with the MOMP 
protein. The behaviour of the pAL12 strain was monitored in vivo 
and vaccine-specific immune responses were examined in both mice 
and sheep. I also attempted to determine how maintenance of the 
plasmid and protein expression was related to the specific humoral 
and cell-mediated immune responses elicited by the leukotoxln.
6.2 Results
Initially, I examined the immunogenicity of the leukotoxln itself 
in mice, to give some indication of the responses likely to occur 
when expressed by the Salmonella vaccine strain.
6.2.1 Immunogenic1tv of Leukotoxln in Mice
Mice were injected intraperitoneally with native leukotoxln in CFA, 
prepared from either the pellet fraction or the supernatant 
fraction of a centrifuged 8 -h culture of P.haemolytica A1. The 
sera of individual mice were examined for leukotoxln-specific IgG
.
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Figure 6.1 Leukotoxln-Specific Antibody in Mice After Immunisation
with Leukotoxln in CFA
1 2 3 4 6 6 7
Lane : 1-5 serum from mice immunised with leukotoxin in CFA
NMS
leukotoxin-specific monoclonal antibody
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by immunoblotting against recombinant leukotoxin [rec leukotoxin] 
[produced in E.colil. Although an ELISA was available for the 
detection of leukotoxin-specific antibody, it was not used, as the 
sensitivity was poor and there was only a limited supply of rec 
leukotoxin available for coating. The results are shown in Figure 
6.1. Mice immunised with either the supernatant fraction [lanes 
1-2] or the pellet fraction [lanes 3-5] produced antibodies which 
reacted with the 33 K leukotoxin protein [although the response in 
lane 5 was poor]. A similar band was produced by the monoclonal 
antibody, MM601B [lane 7], but was absent in the strip probed
with NMS [lane 6 ].
Spleen cells from both immunised and control mice were removed and 
stimulated with purified rec leukotoxin in an LTT [Table 6.1]. The 
responses of the immunised mice were significantly greater [p<0.05] 
than those of the unvaccinated mice with 4 out of 5 [1, 3, 4 and
5], given either the pellet or the supernantant fraction, 
responding specifically to the leukotoxin. There were no responders 
within the unvaccinated group. All of the immunised mice also 
produced IFN in vitro in response to stimulation with rec 
leukotoxin, while none of the 5 control animals produced IFN. Due
to a short supply of antigen, there was insufficient supplies of
supernatant to test in a IFN-g neutralisation assay. Collectively, 
these studies indicate that the leukotoxin is fully immunogenic in 
mice.
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TABLE 6.1
Rec Leukotoxln-Specific Responses of Spleen Cells from 
Mice Immunised with Native Leukotoxin in CFA
Leukotoxin-immunised [a] Unvaccinated [b]
MOUSE NO. 1 2 3 4 5 1 2 3 4
CPM 4,426 2,958 6,879 7,672 2,940 872 208 804 1,340
SI 6 . 2 4 8 1 0 6.5 1 . 8 1.7 2 . 1 3.1
IFN TITRE 2 2 4 4 < 2 0 0 0 0
[a] Mice were immunised intraperitoneally on day 0 with native 
leukotoxin in CFA. [b] Unvaccinated control group. Mice were culled 
on day 28 and spleen cells cultured with rec leukotoxin in an LTT. 
Both the proliferative responses and the IFN titres are shown.
I
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6.2.2 Oral Inoculation of Mice with the t>AL12 Strain
I then went on to examine if it would be possible to evoke 
detectable immune responses to the leukotoxin when produced by the 
pAL12 Salmonella vaccine strain.
6.2.2.1 Production of Rec Leukotoxin bv the pAL12 Strain
The plasmid DNA from the pAL12 strain was shown to contain the 
correct size of insert by restriction endonuclease analysis. 5 
samples of pAL12 strain isolates were checked for the production of 
leukotoxin. Bacterial cell lysates were separated by SDS-PAGE and 
blotted onto nitrocellulose, which was probed with the
leukotoxin-specific monoclonal antibody, MM601B. Lysates of the 
non-transformed pUC8  strain were also run [lanes 6  and 7], as was 
a preparation of rec leukotoxin pAL12 [produced in E.colil [lane 
8 ]. The results are shown in Figure 6.2. All 5 isolates of the 
pAL12 strain produced a unique band of 33 K which corresponded with 
the rec leukotoxin and which was absent in the pUC8  strain 
isolates.
6.2.2.2 Maintenance of the Plasmid in Vivo
Mice were inoculated orally with 5 x 10^ CFU of the pAL12 strain 
and culled on days 2, 6 , 9, 12, 18 and 28 and the no. CFU\g of
organ determined. The results are shown in Fig 6.3. The levels of 
colonisation were much reduced compared with those described 
previously for the S25/laroA strain as well as the MOMP-expressing 
pD and pC strains, with only small numbers being recovered from the
188
Figure 6.2 Production of Leukotoxin bv the pAL12 Stock Isolates
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Figure 6.3 Recovery of the pALI2 Strain from Mice After Oral
Infection
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Mice were inoculated orally with 5 x 10 CFU of the pAL12 strain. 
3-5 mice were culled on the stated days post-infection and the mean 
no. CFU/g determined on each time-point for faeces, liver, spleen 
and Payer's patches [PPs]. Levels are expressed as log^^ CFU/g.
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livers, spleens and Peyer's patches. The pAL12 strain also had a 
considerably reduced in vitro growth rate than all of the other 
strains used in this thesis [Appendix 6 ], perhaps explaining its 
poor ability to grow in vivo.
To determine the retention of the plasmid in vivo. the colonies 
recovered from the mice were replica-plated from XLD agar onto LB 
agar containing ampicillin. As early as day 6 , there was 
significant plasmid segregation, as only poor growth was observed 
in the presence of ampicillin. By day 10, no ampicillin-resistant 
colonies could be recovered from the spleens and by day 15, all 
the colonies recovered from all the organs were sensitive to 
ampicillin. In addition, very few bacterial lysates prepared from 
ampicillin-resistant colonies were found to contain leukotoxin when 
probed with leukotoxin-specific monoclonal antibody, MM601B 
[Figure 6.4]. Only colonies isolated on day 6  post-inoculation 
[lanes 9-11] displayed very feint bands corresponding to the 
protein. Thus It would seem that not only does the organism grow 
slowly in vitro. but the plasmid is lost very rapidly from the 
bacterial cell in vivo.
The above experiment was repeated with a further 10 mice which were 
culled on days 2, 3, 5 and 8  post-infection in an effort to try
and detect colonies that were clearly producing the leukotoxin
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Figure 6.4 Production of Leukotoxin bv pAL12 Colonies Recovered
from Mice After Oral Infection
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6 pAL12, recovered from faeces, day 6
7 pAL12, recovered from liver, day 6
8 pAL12, recovered from liver, day 1 2
9 pAL12, recovered from Peyer's patches, day 6
1 0 pAL12, recovered from Peyer's patches, day 6
1 1 pAL12, recovered from spleen, day 6
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protein. The results [not shown] were even less encouraging than 
in the previous experiment. Very few ampicillin-resistant colonies 
were obtained on any of the days tested and efforts to subsequently 
inoculate LB-ampicillin broth proved unsuccessful.
6 .2.2.3 Leukotoxin-Specific Immune Responses in Mice After Oral 
Infection with the pAL12 Strain
On day 25, 4 of the above mice [1st group] were culled and the
serum examined for the presence of leukotoxin-specific antibodies 
by probing strips of blotted pAL12 leukotoxin [Figure 6.5]. 1 out
of 4 mice given the pAL12 strain [lane 2] produced a single 
detectable band at 33 K identical to that produced by the serum 
from a leukotoxin\CFA-immunised mouse [lane 8 ]. In a further 
experiment, 1 of 8  mice infected with the pAL12 strain produced 
leukotoxin-specific antibody.
T Cell Responses
Spleens cells from the same mice showed no significant
proliferative responses or IFN production to the rec leukotoxin 
[Table 6.2]. Similar results were obtained in mice vaccinated with 
the pAL12 strain 50 days before. Thus, the leukotoxin expressed by 
the pAL12 strain was unable to elicit specific CMI and specific 
antibody was seen in only a small proportion of the mice.
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Figure 6.5 Leukotoxin-Specific Antibody in Mice After Oral
Q
Inoculation with 10 CFU of the pAL12 Strain
9 4 5 6 7 8
g
Lane 1-4 ; serum from 4 mice inoculated orally with 5 x 10 CFU of 
the pAL12 strain
g
5-7 : serum from 3 mice given 5 x 10 CFU of the pUC8  strain 
8  : serum from mouse immunised with leukotoxin in CFA
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TABLE 6.2
Rec Leukotoxin-Specifle Responses of Spleen Cells from Mice 
Orally Inoculated with the pAL12 or PÜC8  Strains
[A] Mice Culled 25 Days Post-Vaccination
pAL12-infected [a] pUCB-infected [b]
CPM 1 , 1 2 0 1,229 1,353 1,377 1,258 1 , 2 2 0 1,234 1,510
SI 3.7 4.2 3.4 2.5 4.2 2 . 8 3.3 5.1
IFN TITRE 0 0 0 < 2 0 0 0 0
[B] Mice Culled 50 Days Post-Vaccination
pAL12-infected [a]
CPM 1,232 800 1,240 960 750 800 836 741
SI 2.9 2 2.9 1.5 2.5 2.3 2.3 2 . 1
IFN TITRE 0 0 0 0 0 0 0 0
Mice were inoculated orally with 5 x 10 CFU of the pAL12 strain
[a] or with an identical dose of the pUC8  strain [b] on day 0.
Mice were culled on day 25 [A] and day 50 [B] and spleen cells
cultured with rec leukotoxin in an LTT. Both the proliferative
responses and the IFN titres are shown.
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6.2.3 Sheep Experiments
Despite the failure of the pAL12 strain to elicit 
leukotoxin-specific immune responses in mice, I thought it 
important also to perform similar experiments in lambs.
6 .2.3.1 Confirmation that Rec Leukotoxin Lacks Biological Activity 
in Vitro
Leukotoxin has been shown to be toxic for ovine but not murine 
macrophages [Sutherland et al., 1983]. Before administration of
the pAL12 strain to lambs, it had to be confirmed that the rec 
leukotoxin produced by the Salmonella strain lacked this 
cytotoxicity. Both the pALl2 and pUC8  strains were added separately 
to ovine alveolar macrophages [prepared by J. Wood, MRl] at a 
bacteria : cell ratio of 100:1 for 30 min at 37°C. After this time 
the percentage cell death was calculated by the trypan blue 
exclusion test. Neither of the bacterial strains lysed the ovine 
alveolar macrophages, with 84% of the cells treated with the pAL12 
strain being viable compared with 8 6 % viability using the pUC8  
strain.
6*2.3.2 Oral Inoculation of Lambs with the pAL12 Strain
In all these experiments, germ-free lambs were used to circumvent 
the problems of pre-existing immunity to Pasteurella in 
conventional animals [W. Donachie, personal communication],
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TABLE 6.3
Recovery of Bacteria from the Organs of Germ-Free Lambs After Oral 
Infection with the pAL12 or pUC8 Strains
No. CFU/g
GROUP pAL12-infected [a] pUC8 -infected [b]
CULLED DAY 7 DAY 7 DAY 3 DAY 7 DAY 4 DAY 7
HEART 1 x1 0 ^ 6 x 1 0 ^ 4x10^ 1 x1 0 ^ 1 x1 0 ® NT
LIVER 6 x1 0 ^ 3x10^ 7x10^ 4x10^ 8 x1 0 ® 24
SPLEEN 1 x1 0 ^ 3x10^ 1 x1 0 ^ 8 x1 0 ® 2 x1 0 ^ 1 x1 0 ^
MLN 1 x1 0 ^ 4x10^ 1 x1 0 ^ 1 x1 0 ^ 5x10® 3x10®
KIDNEY 2 x1 0 ^ 6 x1 0 ^ 1 x1 0 ^ 6 x1 0 ^ 1 x1 0 ® 3
ILEUM 3x10^ 7x10^ 1 x1 0 ® 1 x1 0 ® 2 x1 0 ® NT
COLON NT NT 1 x1 0 ® NT NT NT
JOINTS 2 x1 0 ^ 1 x1 0 ^ NT 4x10^ NT 1 x1 0 ^
NT= Not Tested
MLN= Mesenteric Lymph Node
Lambs were inoculated orally with 4 x 10 CFU of the pAL12 strain 
[a], or with an identical dose of the pUC8  strain [b]. Lambs were 
culled on the stated days post-infection and the no. CFU/g 
of tissue determined.
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8  lambs were Inoculated orally with 4 x 10^ CFU of the pAL12 
strain. A control group of 4 lambs was given an identical dose of 
the pUC8  strain. 48 h after challenge, the lambs displayed a loss 
of appetite and there was a dramatic increase in the rectal 
temperatures of all the lambs [ranging from 40.4-41.7^C]. All the 
animals developed severe diarrhoea, with watery faeces containing 
mucus and sometimes blood. The faeces from all the lambs contained 
high levels of salmonellae when examined using XLD medium. 
However, the colonies obtained on this agar were black, rather 
than the pinky-yellow colonies expected from the aroA strains, 
suggesting that the vaccine strain had reverted to virulence in the 
lambs. This was confirmed when 6  of the lambs were culled in
extremis on days 3-7. The guts of all these lambs were inflamed,
the lymph nodes were greatly enlarged and all their tissues
harboured large numbers of virulent black colonies [Table 6.3]. 
Virulent salmonellae were recovered from blood and from the hind 
knee-joint, indicating the presence of septicaemia and septic 
arthritis.
6 .2.3.3 Immune Responses in Lambs After Oral Infection with the 
PAL12 Strain
All 6  surviving lambs [4 given the pAL12 strain and 2 given the
pUC8  strain] produced Salmonella-specific IgM by day 15, although 
the levels varied greatly in individual lambs [Table 6.4]. The 
levels of Salmonella-specific IgG were very low in all the lambs.
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TABLE 6.4
Titres of Salmonella-Specific Antibody in Lambs After Oral 
Infection with the pAL12 or pUC8  Strains
TITRE
pAL12-Infected [a] pUC8 -Infected [b]
LAMB NO 1 2 3 4 5 6
IgM 512 512 320 640 80 40
IgG 8 4 4 8 2 2
Lambs were inoculated orally with 4 x 10 CFU of the pAL12 [a] or 
the pUCS [b] strains on day 0 and titres of Salmonella-specific IgM 
and IgG determined on day 15. Titres of individual lambs are 
expressed as the inverse of the highest dilution of test serum that 
produced an reading greater than the pre-vaccination
reading.
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I next examined for leukotoxin-specific antibody. No bands were 
produced by any of the pre-vaccination sera [Figure 6 .6 ] confirming 
the lack of previous exposure to Pasteurella in these germ-free 
animals. However sera from both the pALl2- and pUC8 -infected lambs 
reacted with the 33K protein, making it impossible to determine if 
leukotoxin-specific responses had transpired. As several other 
bands were also seen in all these sera, these represent 
anti-Salmonella antibodies which were cross-reacting with E.coli 
proteins in the pALl2 preparation used in the blotting.
PBMC from the same 6  lambs were tested for reactivity against 
Salmonella and leukotoxin [both rec and native] in an LTT. All 
lambs responded to the Salmonella antigen [Table 6.5], although 
there was great variation in the responses of individual lambs as 
in the previous chapter. Lambs 1, 2 and 3 given the pAL12 strain 
clearly responded to rec leukotoxin and the latter 2  lambs also 
responded to the native leukotoxin. Lamb 4 was the only 
pAL12-infected lamb that did not respond to either preparation. 
Neither of the pUC8 -infected lambs responded to either of the 2 
antigen preparations. The Salmonella-specific responses did not 
correlate well with the responses to leukotoxin within individual 
lambs.
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Figure 6.6 Leukotoxin-Specifle Antibody in Lambs After Oral
Inoculation with 4 x 10^ CFÜ of the pALI2 Strain
33
2 3 4 5 0 0 10 11 12
LANE NO. LAMB NO. VACCINE STRAIN TIME OF SAMPLING
1 1 pAL12 pre-vaccination
2 1 day 15
3 2 pAL12 pre-vaccination
4 2 day 15
5 5 pUCS pre-vaccination
6 5 day 15
7 6 pUCB pre-vaccination
8 6 day 15
9 3 pAL12 day 24
1 0 4 pAL12 day 24
1 1 5 pUCB day 24
1 2 6 pUCB day 24
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TABLE 6,5
Rec Leukotoxln-Specifle Responses of PBMC from Lambs Inoculated 
Orally with the pAL12 or pUC8  Strains
CPM
pAL12-infected [a] pUC8 “infected[b]
1 2 3 4 5 6
Salmonella 27,277 8 , 2 2 0 4,088 1,013 2 , 6 6 6 2,539
rec leukotoxin 1,076 1,075 1.094 50 70 104
native leukotoxin 338 3,162 2,911 0 223 163
SI
pAL12-infected [a] pUC8 - infected[b]
1 2 3 4 5 6
Salmonella 272 41 21.5 3 31 37
rec leukotoxin 11.3 11.5 6.7 1 1 . 8 2
native leukotoxin 4.2 2 0 16 1 2.7 4.1
Lambs were inoculated orally with 4 x 10 CFU of the pAL12 strain 
[a] or the pUC8  strain [b] on day 0. PBMC were removed on day 15 
and the proliferative responses to Salmonella. rec leukotoxin and 
native leukotoxin determined in an LTT.
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6.2.4 Studies on the Reversion to Virulence
In view of the potential problems that could arise with the 
S25/laroA strain, I decided to investigate the reversion to 
virulence of the pALl2 vaccine strain in lambs in more detail.
6 .2.4.1 Demonstration of the Aromatic-Independency and
Ampleillin-Sensitivity of Recovered Colonies
All the black colonies on XLD agar recovered from the faeces and 
organs of each of the vaccine-infected lambs grew on minimal agar, 
with or without addition of aromatic compounds, whereas the 
original stock strain and the pAL12 colonies recovered from 
conventional mice would only grow on the supplemented minimal agar. 
Thus the vaccine strain had lost its dependence on aromatic 
compounds following passage in lambs. This was associated with 
loss of the plasmid, as the black colonies obtained from the lambs 
had also lost their ability to grow on LB agar containing 
ampicillin. This loss of ampicillin-resistance was seen as early 
as 18 h following inoculation of the strain into lambs.
6 .2.4.2 Oral Inoculation of Germ-Free Mice with the S25/laroA 
Strain and its Recombinant Derivatives
One difference between the mice and lambs used in these experiments 
was that the mice which survived the infection were not germ-free, 
while the susceptible lambs were. I therefore investigated whether 
the germ-free environment allowed reversion to the virulent form by 
infecting germ-free mice with all the vaccine strains used in this 
thesis. Faecal samples were removed from each of the mice on days
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2, 4 and 6 and 1 ml plated onto XLD agar and minimal agar with and
without aromatic metabolites [see Appendix 1]. All the XLD plates 
from all the mice showed confluent growth of yellow colonies which 
were H^S- when tested by API and would only grow on minimal agar 
that was supplemented with the aromatic compounds. 1 mouse [given 
the S25/laroA strain] died on day 11 and was seen to harbour 2-5 x 
10^ CFU/g in the liver and spleens. These colonies were yellow on 
XLD and did not grow on unsupplemented minimal agar. None of the 
remaining mice became ill. Thus, the strains did not revert to 
virulence in germ-free mice.
6.3 Discussion
Specific humoral and cell-mediated immune responses were evoked 
when native leukotoxin was administered with adjuvant to mice, but 
none of the mice inoculated orally with the pAL12 strain produced 
leukotoxin-specific lymphocyte responses and only 2 of 12 mice 
given the pAL12 strain produced leukotoxin-specific antibody.
There are a number of possible reasons for the low level 
responsiveness to leukotoxin expressed by the pAL12 strain in mice. 
Firstly, the pAL12 strain had a reduced in vitro growth rate 
compared with the other aroA strains and was recovered from the 
organs at lower levels than the other aroA strains. However, all 
the mice produced Salmonella-specific humoral and cellular 
responses indicating that the invasiveness of the strain should 
have been sufficient to potentiate the generation of 
leukotoxin-specific responses. As the leukotoxin is produced
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intracytoplasmically by the salmonellae as a soluble protein, 
thereby circumventing the problems encountered with insoluble 
antigens [Maskell et al., 1986], the most likely reason for the
low leukotoxin responses appears to have been plasmid loss from the 
pAL12 strain, which was seen as early as 2 days post-infection and 
resulted in limited in vivo production of the protein.
In germ-free lambs given the pAL12 [or pUCB] strain, reversion to 
wildtype was seen, causing severe clinical symptoms and death. In 
these lambs, leukotoxin-specific antibody was not produced, 
although specific cellular responses were detected. However the 
specificity of these responses was questioned by the low responses 
to Salmonella in these lambs which may be due to oral tolerance 
following administration of high doses of bacteria to young lambs. 
More likely, the low responses are due to the low imunogenicity of 
the vaccine strain. The lack of leukotoxin-specific responses in 
the lambs would not be surprising in view of the reversion events 
which were associated with plasmid loss and limited production of 
leukotoxin in vivo.
The reasons for this reversion to virulence are unclear. In earlier 
chapters, conventional lambs and mice showed no signs of disease 
when given the aroA vaccine strains and only low level colonisation 
by aromatic-dependent bacteria was observed. In contrast, here 
almost all of the pAL12 colonies recovered from the germ-free lambs 
after 18 h were biochemically wildtype. This rapid switch to 
aromatic-independence argues against the possibility that low
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numbers of revertants gradually multiplied in the lambs until 
numbers capable of causing a lethal infection were reached. 
Reversion was also not due to the presence of the the aromatic 
metabolites in the milk, as the pD and pC strains given to 
conventional lambs of the same age and fed in the same way did not 
revert [Chapter 5].
One way that the aroA strains could revert to virulence would be to 
regain the deleted piece of the aroA gene by transduction from 
other intestinal bacteria. However, the absence of gut flora in 
the germ-free animals would surely have precluded from such DNA 
transfer events from taking place.
The aroA gene in our mutant strain has not been sequenced and hence 
the size of the deletion, if any, is undefined. The only way that 
a strain could be tetracycline-sensitive and yet aromatic-dependent 
without a deletion of aroA gene sequences would be if the 
transposon caused an insertion mutation rather than a deletion. 
Transposons have been shown to be lost from host DNA but some of 
their sequences remain which interrupt the coding sequences of the 
host DNA [insertion mutations]. Insertion mutations are known to 
revert, as there is selection for the loss of the insertion 
sequences, which would allow normal gene function. Rapid 
multiplication in the gut of germ-free animals would have provided
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optimal conditions for loss of insertion sequences if they exist in 
our strain. However repeated in vitro culture of the strain did 
not reveal any such revertants, suggesting that insertion 
sequences do not cause the attenuation of the S25/laroA strain.
If the germ-free nature of the lambs facilitated the reversion 
events, why did the strain not revert in germ-free mice? Although 
species differences seem the most obvious reason, the faeces of 
the infected germ-free mice contained both Salmonella and 
Pseudomonas species, implying that the mice were not entirely 
germ-free to begin with which may account for the failure of the 
strain to revert in these mice. It will therefore be important to 
repeat these studies with the the aroA strains in genuine germ-free 
mice.
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Chapter 7
General Discussion
The results outlined in this thesis have demonstrated the 
effectiveness of the S25/laroA strain in eliciting strong specific 
immune responses in both mice and sheep and conferring immunity to 
salmonellosis in these species. However its potential as a vector 
for vaccination against other antigens was not clearly 
demonstrated, as immune responses to MOMP and leukotoxin 
incorporated into S25/laroA were very low in mice and absent in 
sheep. Furthermore, the S25/laroA strain reverted to virulence in 
germ-free lambs, further undermining its potential as a candidate 
vaccine vector.
Although the S25/laroA strain protected both mice and sheep from 
wildtype challenge, Salmonella-specific intestinal IgA and CMI 
occurred in mice but not sheep, suggesting that the mechanisms 
governing protection may be different in these species. This could 
reflect differences in the gastrointestinal physiology of mice and 
sheep which may influence the interaction of the salmonellae with 
the immune system. Sheep digest food by rumination and orally 
administered aroA salmonellae are likely to sit in the rumen for up 
to 5 h, by which time they may be competed out by other bacteria 
or regurgitated back up the oesophagus for secondary mastication. 
As a result, many organisms are likely to be destroyed thereby 
reducing the numbers that enter the small intestine and can
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subsequently stimulate the GALT. Rumination may therefore account 
for absence of intestinal IgA and the low level of colonisation of 
the internal organs which I found in sheep given S25/laroA. In 
contrast, the stomach contents in mice pass rapidly to the small
intestine therefore increased numbers of salmonellae are available
for uptake by Peyer's patches and stimulation of mucosal immune 
responses.
The startling differences in the immune responsiveness of mice and 
sheep to the vaccine strain suggest that Salmonella infection in 
mice may not always be an ideal system for testing candidate 
vaccine strains destined for use in other species. Nevertheless the 
mouse system does seem to be relevant for humans as oral 
administration of the live Salmonella vaccine strain Ty21xresults 
in the production of both mucosal and systemic antibody and strong 
CMI [Cancellieri and Fara, 1985; Sarasombath et al.. 1984, 1987; 
Bartholomeuz et al., 1990].
The absence of specific mucosal antibody to the vaccine strain in
lambs may limit the usefulness of the aroA strain as a vaccine
vector in this species, particularly for the delivery of 
heterologous antigens derived from mucosal pathogens such as 
V.cholerae. Shigella. enterotoxigenic E.coli and numerous 
gastrointestinal parasites. Stimulation of the GALT can also 
result in the generation of specific protective IgA responses at 
other mucosal sights such as the lung [Guzman et al., 1991] and
such lung responses are likely to prevent the development of lung
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consolidation seen in lambs infected with e.g. P.haemolvtica [W.
Donachie, personal communication]. The lack of vaccine-specific 
intestinal IgA responses in sheep suggests that the respiratory IgA 
responses likely to be important in protection against this 
infection may also not be generated by the pAL12 strain. Similarly, 
the aroA vector did not stimulate systemic CMI in sheep thus 
reducing the possible usefulness of these vectors in vaccinating 
this species against obligate intracellular parasites such as 
Chlamydia where protective responses are likely to be T
cell-mediated. Strategies should be adopted to try and increase 
the mucosal and cellular responses to the S25/laroA strain 
following oral vaccination. The S25/laroA strain could be
administered orally with adjuvants to try and evoke specific 
mucosal immune responses. Husband et al. [1979] detected high
numbers of Salmonella-specific IgA-producing B cells in the 
intestinal lamina propria of sheep following oral immunisation with 
killed antigen only if the animals had first been immunised 
intraperitoneally with antigen in CFA. It may be that such a 
vaccination regime is necessary to elicit specific mucosal antibody 
in sheep to the live S25/laroA strain and the use of an adjuvant 
might also stimulate greater Salmonella-specific CMI. However any 
vaccination procedure involving intraperitoneal injection would be 
of very limited field use.
The strong Salmonella-specific responses in mice allowed me to 
examine the potential use of aroA strains as carriers of
heterologous antigens. However, only very poor MOMP-specific and
210
leukotoxin-specific antibody responses were detectable in immunised 
mice and no antigen-specific CMI was evoked. These experiments thus 
highlight possible difficulties in expressing foreign genes in an 
immunogenic form by live Salmonella vaccine strains. The low or 
absent responses to MOMP and leukotoxin expressed from S25/laroA 
were not a result of an innate lack of imunogenicity of the 
proteins, as both the mice and the sheep made specific immune 
responses to the proteins when administered with adjuvant. The low 
response to the vaccine-expressed MOMP may reflect a combination of 
its intracytoplasmic expression and its insolubility within the
vaccine strain. In contrast, the low or absent response to the
leukotoxin was most likely a result of rapid loss of the pAL12 
plasmid in vivo thus limiting the expression of the protein. Some 
of the strategies currently under investigation to circumvent these 
problems of antigen expression by Salmonella vectors are discussed 
below.
Although the immune system can recognise foreign proteins expressed 
from the cytoplasm of Salmonella strains [Brown et al.. 1987], one 
possibility would be to obtain surface expression of MOMP or the
leukotoxin in S25/laroA. This can be achieved by expressing
antigens as fusion proteins with E.coli outer membrane proteins. 
Mice produce very strong responses to outer membrane proteins such 
as OmpA protein and lipoprotein [Brown and Hormaeche, 1989] and it 
is not clear whether this is due to their surface location or 
intrinsic immunogenicity. Epitopes of foot-and-mouth disease virus, 
hepatitis B virus, polio virus and Plasmodium falciparum are all
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immunogenic in Salmonella when expressed as fusions with outer 
membrane proteins such as OmpA, PhoE and LamB [Leclerc et al., 
1989; O'Callaghan et al.. 1990; Agterberg et al.. 1990; Schorr et
al., 1992]. However MOMP epitopes expressed on the surface of
S.typhimurium aroA by fusion with the LamB protein produced only 
low MOMP-specific responses, very similar to those described in 
this thesis [Hayes et al., 1991]. Nevertheless these studies used
C3H/He/0la mice which are less susceptible to Salmonella infection 
[Hormaeche, 1979a] and clear the organism very rapidly. In 
addition, these workers employed only short sequences of MOMP 
compared with the full length MOMP gene expressed in our system and 
obtained relatively low Salmonella-specific responses with no 
Salmonella-specific IgA in the gut. As my studies showed long-term 
persistence of the organism in the murine tissues with strong
vaccine-specific responses, it would now be important to examine
immunity to the full MOMP protein when expressed as a surface 
protein with LamB. Alternatively, surface expression of MOMP or 
leukotoxin could be achieved by incorporating them into the 
flagella of the S25/laroA strain, as both LT-B and hepatitis B 
virus epitopes are immunogenic in Salmonella when expressed in this 
way [Newton et al.. 1989, 1991; Wu et al.. 1989]. Studies to
obtain surface expression of MOMP in S25/laroA are already
underway. The pUC8 plasmid containing the MOMP gene with a leader 
peptide has been transformed into S25/laroA. However, although the
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MOMP protein was surface-expressed in high quantities, this proved 
lethal for the salmonellae and hence new strategies are currently 
being developed to obtain non-lethal surface expression [A.Herring, 
personal communication].
Plasmid expression of foreign antigens in Salmonella may also not 
be an ideal expression system for potential multivalent vaccines. 
As well as its instability in vivo. the pUC8 plasmid possesses an 
antibiotic-resistance gene which is not permissable according to 
Food and Drug Administration Standards for live vaccines. Hence if 
S25/laroA is to be used as a multivalent vaccine in sheep or other 
larger animals, other ways of expressing foreign proteins must be 
exploited. Nakayama et al. [1988] described the use of recombinant
plasmids expressing foreign antigens that did not contain 
drug-resistance markers hence the problems of in vivo deselection 
were also avoided. Normally lethal mutations were made in the asd 
gene [coding for diaminopimelic acid] in the Salmonella chromosome. 
A plasmid containing the intact asd gene and the spa A gene of 
Streptococcus sobrinus was transformed into the asd mutant strain 
which balanced the effect of the mutation. Thus only
plasmid-containing organisms survived in vivo and it would be 
interesting to investigate the use of this strategy for expression 
of MOMP and leukotoxin in S25/laroA.
A second approach to avoid the problems of plasmid instability 
would be to express the leukotoxin from the chromosome of 
S25/laroA. Such chromosomal expression has been effected in a novel
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expression system which utilises an invertible DNA sequence 
resulting in spontaneous segregation of cells with very high levels 
of expression of the recombinant antigen; the system was capable 
of inducing antibodies to cholera toxin CT-B [Yan et al., 1990].
Another way of expressing foreign genes from the chromosome of the 
salmonellae is by homologous recombination, using cloning vectors 
with flanking regions of homology to host genes such as his [Hone 
et al.. 1988; Clements and Cardenas, 1990] or aroC [Strugnell et 
al., 1990]. The aroC gene system has the added advantage of
creating an additional attenuating lesion in the vaccine strain. 
This expression system would be particularly useful in the 
S25/laroA strain which harbours only a single mutation and, as I 
found, was capable of reverting to virulence in germ-free animals. 
Thus in one step, the S25/laroA strain could be made to express 
the MOMP or leukotoxin from the chromosome and additionally be 
given a second attenuating mutation. As these double mutants are no 
less invasive than single mutants [Dougan et al.. 1988], this 
system provides a suitable alternative to previously described 
double mutants which are less invasive than single mutant strains 
and are ineffective in stimulating Salmonella-specific immune 
responses [O'Callaghan et al.. 1988; Sigwart et al.. 1989].
The discussed strategies for circumventing plasmid instability and 
for obtaining surface expression of the proteins should be applied. 
However before MOMP, leukotoxin or other antigens are expressed in 
S25/laroA. it may prove beneficial to express well-defined
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antigens such as nucleoprotein, LT-B and B-galactosidase from the 
S25/laroA strain, solely to demonstrate its vector potential.
The reversion seen in germ-free animals gives further credence to 
the view that if live Salmonella vaccines are to be given to humans 
or large animals, double mutant strains must be used to further 
reduce the chances of reversion to virulence. It would be important 
in future studies to sequence the aroA gene in the S25/laroA strain 
before and after reversion, to provide a molecular explanation for 
its reversion to virulence. When the strain I used was constructed, 
several isolate colonies were produced that were all 
tetracycline-sensitive and aromatic-dependent. However it is 
possible that each individual mutant isolate harbours a different 
deletion as a result of the transposon mutagenesis. These other 
isolates should also be sequenced and tested for reversion in 
germ-free lambs and comparisons made with the isolate used in this 
thesis. Thus it may be possible to predict the possibility of 
reversion to virulence from the extent of the deletion in the aroA 
gene of individual isolates.
Once the S25/laroA strain has been fully characterised at the 
molecular level, experiments should be set up to define the 
protective response against Salmonella in sheep. The effect on 
protection from wildtype challenge in vaccinated and unvaccinated 
lambs following administration of specific monoclonal antibodies 
against IgG, IgM and IgA, as well as against T cell subsets and 
IFN-g, might demonstrate the relative importance of these immune
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mechanisms. Also, lymphocyte populations from vaccinated animals 
should be isolated by cell sorting and the ability of passively 
transferred B and T cells to confer protection from virulent 
challenge determined. Although these experiments have been 
performed extensively in mice [Morris et al.. 1976; Eisenstein et
al., 1984; Paul et al.. 1985; Killar and Eisenstein, 1985;
Hormaeche et al.. 1990; Muotiala and Makela, 1990] and have shown 
that immunity to Salmonella is both T cell-dependent and T 
cell- independent, no such studies have been performed in sheep and 
hence the mechanisms of protection are completely unknown.
It seems unlikely that the relatively low levels of 
Salmonella-specific IgM that I detected in S25/laroA-vaccinated 
lambs could be the sole protective factor and that either CMI or 
local intestinal responses are not involved. That Salmonella 
itself is a facultative intracellular parasite would suggest that 
cellular immunity should be involved. My failure to detect systemic 
T cells and only low levels of serum antibody following oral 
vaccination with aroA S.typhimurium is supported by previous 
findings [Mukkur et al.. 1987; Begg et al.. 1990; Mukkur and
Walker, 1992] and suggests that systemic immune responses are not 
essential for protection. Together with the absence of intestinal 
IgA responses, these findings might suggest an important role for 
mucosal T cells in protection. The failure to recover the wildtype 
organism from most of the systemic organs following oral challenge
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of aroA-vaccinated lambs indicates that strong vaccine-specific 
local immune mechanisms must be operating in vaccinated animals. 
The mucosal T cell response following vaccination could be 
investigated by examining the Salmonella-specific responses of T 
cells in intestinal lymph following cannulation of the intestinal 
lymphatic duct of vaccinated animals. Also, T cells from the 
mesenteric lymph node, intestine and Peyer's patches as well as
intraepithélial lymphocytes should be removed from aroA-vaccinated 
lambs and examined for Salmonella-specific responses.
In conclusion, it is hoped that the work described in this thesis 
will provide the groundwork for developing more effective systems 
of expression of foreign proteins in Salmonella vaccine strains. It 
has highlighted the quite different immune responses in mice and 
sheep following oral vaccination, and has outlined the need for 
careful consideration of both the origin and the nature of the 
antigen before expression in these vaccine strains. Furthermore it 
has emphasised the need for detailed molecular characterisation of 
candidate strains to avoid problems of reversion to virulence which 
clearly may undermine the safety and effectiveness of aroA strains 
of Salmonella.
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Appendix 1
1 Bacterial Culture Media
All media were sterilised by autoclaving unless otherwise stated.
lA Lurla-Bertanl FLBI Medium
Per litre : Bacto-tryptone [Difco Laboratories 
Detroit, MX, USA.]
lOg *1
Bacto-yeast extract [Difco] 5g *2
NaCl 5g *3
Bacto-agar [Difco] 5g *4
For agar [LB agar], all of the above.
For broth [LB broth], 1, 2 and 3 only.
Antibiotics may be added to broth or agar 
to a final concentration of;
Ampleillin [Sigma Chemical Company,
Poole, Dorset, UK.]
Tetracycline [Sigma]:
60ug/ml
50ug/ml
IB Nutrient Broth
Per litre : Nutrient broth No.2 [CM67]
[Oxoid, Basingstoke, Hampshire, UK.]
25.Og
1C Xvlose Lactose Deoxvcholate TXLDI Medium
Per litre : XLD [Oxoid CM467]
Sterilised by melting in a microwave.
53.Og
ID Selenite Broth
Per litre : Selenite broth base [Oxoid CM395]
Sodium biselenite [Oxoid L121]
19. Og 
4.0g
IE Blood Agar
Per litre : Blood agar base [Gibco, Paisley,
Strathclyde, UK],
44ml whole sheep blood containing 
Trisodium citrate.
40. Og
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IF Minimal Agar
Per litre ; Bacto agar [Difco] 15.Og
Thiamine B1 [Img/ml] 2ml
20% Glucose 10ml
Spizizen salts 5X 200ml
The bacto-agar was dissolved in 700 ml distilled water and 
autoclaved. After cooling, the other 3 compounds were added and 
the final volume made up to 1 litre with distilled water.
When testing bacterial strains for aromatic metabolite 
dependence, the following compounds were added to 1 litre of 
minimal agar prior to pouring.
lOOul PABA [lOOmg/ml][Sigma] in 100% ethanol. 
lOOul DHB [lOOmg/ml][Sigma] in 100% ethanol.
20ml Tryptophan [2mg/ml]. Filter sterilise.
20ml Tyrosine [2mg/ml]. Filter sterilise.
20ml Phenylalanine [2mg/ml]. Autoclave.
251
Appendix 2
2 Materials for SDS-PAGE
2A Sample Buffer
For 8ml: Distilled water
0.5M Tris-HCl, pH 6.8
Glycerol
10% [w/v] SDS
2-b-mercaptoethanol
0.05% [w/v] bromophenol blue [Sigma]
4. 0ml 
1.0ml 
0.8ml 
1.6ml 
0. 4ml 
0.2ml
2B Stacking Gel Preparation For 4% gels. 
For 10ml: Distilled water
0.5M Tris-HCl, pH 6.8 
10% [w\v] SDS
Acrylamide/bis [30% stock]
10% ammonium persulphate 
TEMED [Sigma]
6. 1ml 
2.5ml 
lOOul 
1.3ml 
5 Oui 
5 Oui
2C Separating Gel Preparation For 7.5% gels 
For 10ml: Distilled water
1.5M Tris-HCl, pH 8.8 
10% [w\v] SDS
Acrylamide/bis [30% stock]
10% ammonium persulphate 
TEMED
4.85ml 
2.5ml 
lOOul 
2.5ml 
50ul 
5ul
2D Tris-Glvcine Electrode Buffer. pH8.3
For 1 Litre: Tris-[hydroxymethyl]-methylamine 
Glycine 
SDS
30.3g 
144.Og 
5.0g
Made up to 1 litre with distilled water. Sterilised by 
autoclaving and stored at 4°C.
Methanol may be added to 20%.
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3 Buffers for Use in ELISAs
3A Antigen Coating Buffer: 0.03M Carbonate Buffer, pH 9.6 
For 1 litre: Di-sodium carbonate. 1.59g
Sodium hydrogen carbonate. 2.93g
Sodium azide. 0.20g
Made up to 1 litre with distilled water. Diluted 1 in 2 prior to 
use.
SB ELISA Buffer pH 7.2.
For 1 litre: Tris hydrochloride 15.79g
Sodium chloride 29.22g
Ethylenediamine tetra-acetic 0.372g
acid [EDTA]
Bovine serum albumin [BSA] [Sigma] 20,Og
Triton-X 100 [Sigma] 30ml
Tween 20 30ml
Made up to 1 litre with distilled water.
3C Substrate Buffer: 10% Diethanolamine Buffer, pH 9.8,
For 1 litre: Diethanolamine. 100ml
Magnesium chloride x 6 H^O 0.102g
Sodium azide 0.200g
Distilled water 800ml
IM hydrochloric acid added [approximately 60ml] to adjust to the 
the correct pH. Made up to 1 litre with distilled water and 
stored in the dark.
For use with p-nitrophenyl phosphate [PNPP] substrate.
3D Substrate Buffer: Citrate Phosphate Buffer, pH 5.
[A] Citric acid 21.01g\l
[B] Di-sodium hydrogen phosphate 28.40g\l
Both reagents made up separately to 1 litre with distilled water 
and 48.5mls of [A] was added to 51.5mls of [B] producing a pH of 
approximately 5. For use with 0-phenylenediamine [OPD] substrate.
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4 Tissue Culture Media
4A Supplemented RPMI 1640 Medium TsRFMI 16401
For 500ml:420ml RPMI 1640 without L-glutamine [Gibco]
5ml IM HEPES
10ml [2%] Penicillin\Streptomycin [10,OOOu/ml][Sigma] 
10ml [2%] Glutamine [0.IM][Gibco]
5ml [1%] Preservative-free heparin [lOOOu/ml][Sigma] 
50ml [10%] Foetal bovine serum [FBS] [Sigma], heat- 
inactivated at 56^C,
_3
50ul 5 X 10 M 2-mercaptoethanol [Sigma]
4B Supplemented Iscove's Modification of Dulbecco's Medium FsIMDMl
For 500ml;460ral IMDM [IX][Gibco]
50ul 5 X 10 2-mercaptoethanol [Sigma]
10ml [2%] Penicillin/streptomycin [10,OOOu/ml]
5ml [1%] Preservative-free heparin [lOOOu/ml]
25ml [5%] FBS [Northumbria Biologicals Ltd [NBL], 
Northumberland, UK]
4C Supplemented Hank's Balanced Salt Solution FsHBSSl
For 500ml:483ml HBSS [IX] [see below]
5ml [1%] Preservative-free heparin [lOOOu/ml]
10ml [2%] FBS [NBL]
2ml Sodium bicarbonate [8%] containing phenol red 
[0.4%][Gibco]
FHBSS1 rioxi
This solution was prepared as a lOX.
Solution A
Magnesium sulphate 3.0g
Distilled water 1000ml
Solution B
Magnesium chloride 5.0g
Distilled water 1000ml
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Solution C
Calcium chloride 9.3g
Distilled water 1000ml
Solution D
Sodium chloride 400,0g
Potassium chloride 20.0g
Di“sodium hydrogen orthophosphate 7.6g
Potassium di-hydrogen orthophosphate 3.0g
Distilled water 2000ml
Solutions A, B, C and D were mixed together before being dispensed
into litre amounts and stored at 4^C.
HBSS n x i
This solution was prepared by diluting the lOX stock ten-fold with 
distilled water.
HBSS [lOX] 500ml
0.4% Phenol red 25ml
Distilled water 4475ml
The solution was dispensed into 500ml amounts before being 
autoclaved at 10lbs for 20 min,
4D Supplemented Earle's Balanced Salt Solution FsEBSSl
For 500ml: 50ml BBSS [lOX] [see below]
10ml [2%] FBS [NBL]
0.5g [0.1%] sodium azide
Volume made up to 500ml with sterile distilled 
water.
EBSS F10X1
This solution was prepared as a lOX 
For 1 litre:
Solution A
Calcium chloride 2 . 6g
Distilled water 200ml
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Solution B
Magnésium sulphate 
Distilled water
2.0g
200ml
Solution C
Sodium chloride 68g
Potassium chloride 4.0g
Sodium di-hydrogen orthophosphate 1.45g
Distilled water 600ml
Each solution was filter sterilised and the 3 were added together
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5 Additional Solutions
5A Phosphate Buffered Saline TPBSI pH 7.2
For 1 litre: Disodium hydrogen phosphate 1.15g
Potassium di-hydrogen phosphate 0.20g
Sodium chloride 8.00g
Potassium chloride 0.20g
Made up to 1 litre with distilled water. Sterilised by autoclaving.
5B Tris-Borate Buffer. pH8.3
For 1 litre; Tris [89mM] 10.76g
EDTA [2.5mM] 0.93g
Boric acid [89mM] 5.50g
Made up to 1 litre with distilled water. Sterilised by autoclaving.
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Appendix 6 In Vitro Growth of the Salmonella Strains
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1 = pD; 2 = pC; 3 = pAL12; 4 = pUC8
1 ml of an overnight LB broth culture of each of the strains were 
subcultured into fresh LB broth and incubated at 37^C with shaking. 
Aliquots were taken at the stated times and the UV absorbance 
measured at 600 im
